MADELEINEDUVICMADELEINE DUVIC8533DUVIC, MADELEINEProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25376389Ni X, Jorgensen JL, Goswami M, Challagundla P, Decker WK, Kim YH, Duvic MAClinical cancer research : an official journal of the American Association for Cancer ResearchReduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and S?zary syndrome. Clin Cancer Res. 2015 Jan 15; 21(2):274-85.Clin Cancer Res2014-11-05T00:00:002014Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and S?zary syndrome.1400 Pressler StHouston77030-4008TXAuthorship 1632011Authorship 1632331Authorship 1633874Authorship 1641971Authorship 1642125Authorship 1647346Authorship 1647354Authorship 1653021Authorship 1653171Authorship 1653364Authorship 1655911Authorship 1657015Authorship 1658274Authorship 165885Authorship 1662388Authorship 1664142Authorship 1664575Authorship 1669511Authorship 16713410Authorship 1678707Authorship 1679742Authorship 1683058Authorship 1683376Authorship 1684824Authorship 1684857Authorship 1685571Authorship 1686031Authorship 1689526Authorship 1692031Authorship 1692451Authorship 1694463Authorship 1694511Authorship 1695073Authorship 1697573Authorship 1700404Authorship 1702604Authorship 1708191Authorship 1709605Authorship 1709827Authorship 1711624Authorship 1713393Authorship 1717015Authorship 1723113Authorship 1727839Authorship 1729753Authorship 1732493Authorship 17340312Authorship 1736662Authorship 1742361Authorship 1742413Authorship 1745107Authorship 1747263Authorship 1748944Authorship 1753301Authorship 1756512Authorship 1759145Authorship 1760042Authorship 1762805Authorship 17659811Authorship 1767465Authorship 1770531Authorship 1771743Authorship 1772815Authorship 1774734Authorship 1779227Authorship 1782305Authorship 1782614Authorship 1785478Authorship 1786217Authorship 1786752Authorship 1788296Authorship 17894612Authorship 1789853Authorship 1792975Authorship 1794073Authorship 17951511Authorship 1803026Authorship 1811613Authorship 18117610Authorship 1812067Authorship 1812197Authorship 1820892Authorship 1825275Authorship 1828344Authorship 1829296Authorship 1830006Authorship 1831684Authorship 1834157Authorship 1838605Authorship 1839141Authorship 1845645Authorship 1853533Authorship 1860744Authorship 1861041Authorship 1862062Authorship 1865457Authorship 1874842Authorship 1876533Authorship 1882493Authorship 1908508Authorship 1909233Authorship 1913633Authorship 1916182Authorship 1917546Authorship 1919432Authorship 1920753Authorship 1921355Authorship 1929685Authorship 1931414Authorship 1934862Authorship 19573221670917Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveille JDArchives of dermatologyHLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. Arch Dermatol. 1991 Jan; 127(1):64-8.Arch Dermatol1991-01-01T00:00:001991HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance.1747848Duvic MClinics in dermatologyIn situ hybridization. Clin Dermatol. 1991 Apr-Jun; 9(2):129-35.Clin Dermatol1991-04-01T00:00:001991In situ hybridization.2664740Forman AB, Prendiville JS, Esterly NB, Hebert AA, Duvic M, Horiguchi Y, Fine JDPediatric dermatologyKindler syndrome: report of two cases and review of the literature. Pediatr Dermatol. 1989 Jun; 6(2):91-101.Pediatr Dermatol1989-06-01T00:00:001989Kindler syndrome: report of two cases and review of the literature.2740180Gross DM, Robinson LK, Smith LT, Glass N, Rosenberg H, Duvic MPediatricsSevere perinatal Marfan syndrome. Pediatrics. 1989 Jul; 84(1):83-9.Pediatrics1989-07-01T00:00:001989Severe perinatal Marfan syndrome.3688900Duvic MArchives of dermatologyStaphylococcal infections and the pruritus of AIDS-related complex. Arch Dermatol. 1987 Dec; 123(12):1599.Arch Dermatol1987-12-01T00:00:001987Staphylococcal infections and the pruritus of AIDS-related complex.3805370Duvic M, Goldberg G, Prawer SE, Brenn P, Hefter HSJournal of the American Academy of DermatologyClimatotherapy of psoriasis at the Dead Sea. J Am Acad Dermatol. 1986 Dec; 15(6):1298-301.J Am Acad Dermatol1986-12-01T00:00:001986Climatotherapy of psoriasis at the Dead Sea.7738397Duvic M, Welsh EA, Jackow C, Papadopoulos E, Reveille JD, Amos CThe Journal of investigative dermatologyAnalysis of HLA-D locus alleles in alopecia areata patients and families. J Invest Dermatol. 1995 May; 104(5 Suppl):5S-6S.J Invest Dermatol1995-05-01T00:00:001995Analysis of HLA-D locus alleles in alopecia areata patients and families.7798612Welsh EA, Clark HH, Epstein SZ, Reveille JD, Duvic MThe Journal of investigative dermatologyHuman leukocyte antigen-DQB1*03 alleles are associated with alopecia areata. J Invest Dermatol. 1994 Dec; 103(6):758-63.J Invest Dermatol1994-12-01T00:00:001994Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata.8202117Duvic M, Grossman DThe New England journal of medicineMore on acyclovir for chickenpox. N Engl J Med. 1994 Jul 07; 331(1):59.N Engl J Med1994-07-07T00:00:001994More on acyclovir for chickenpox.8543688Stricker RB, Goldberg BJournal of the American Academy of DermatologyZidovudine and psoriasis. J Am Acad Dermatol. 1996 Jan; 34(1):152.J Am Acad Dermatol1996-01-01T00:00:001996Zidovudine and psoriasis.8701383Morris LF, Lemak NA, Arnett FC, Jordon RE, Duvic MSouthern medical journalSystemic lupus erythematosus diagnosed during interferon alfa therapy. South Med J. 1996 Aug; 89(8):810-4.South Med J1996-08-01T00:00:001996Systemic lupus erythematosus diagnosed during interferon alfa therapy.8781434Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WCBloodAmplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Blood. 1996 Sep 01; 88(5):1771-9.Blood1996-09-01T00:00:001996Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.8859287Duvic M, Hester JP, Lemak NAJournal of the American Academy of DermatologyPhotopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 1996 Oct; 35(4):573-9.J Am Acad Dermatol1996-10-01T00:00:001996Photopheresis therapy for cutaneous T-cell lymphoma.8959347Nagpal S, Thacher SM, Patel S, Friant S, Malhotra M, Shafer J, Krasinski G, Asano AT, Teng M, Duvic M, Chandraratna RACell growth & differentiation : the molecular biology journal of the American Association for Cancer ResearchNegative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis. Cell Growth Differ. 1996 Dec; 7(12):1783-91.Cell Growth Differ1996-12-01T00:00:001996Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.8959951Davis DA, Cohen PR, McNeese MD, Duvic MJournal of the American Academy of DermatologyLocalized scleroderma in breast cancer patients treated with supervoltage external beam radiation: radiation port scleroderma. J Am Acad Dermatol. 1996 Dec; 35(6):923-7.J Am Acad Dermatol1996-12-01T00:00:001996Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: radiation port scleroderma.9295084Byers PH, Duvic M, Atkinson M, Robinow M, Smith LT, Krane SM, Greally MT, Ludman M, Matalon R, Pauker S, Quanbeck D, Schwarze UAmerican journal of medical geneticsEhlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. Am J Med Genet. 1997 Oct 03; 72(1):94-105.Am J Med Genet1997-10-03T00:00:001997Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen.9843971DiSepio D, Ghosn C, Eckert RL, Deucher A, Robinson N, Duvic M, Chandraratna RA, Nagpal SProceedings of the National Academy of Sciences of the United States of AmericaIdentification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci U S A. 1998 Dec 08; 95(25):14811-5.Proc Natl Acad Sci U S A1998-12-08T00:00:001998Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene.9860281Konstantinova NV, Lemak NA, Duvic MArchives of dermatological researchNerve growth factor in normal and psoriatic skin equivalent models. Arch Dermatol Res. 1998 Nov; 290(11):610-4.Arch Dermatol Res1998-11-01T00:00:001998Nerve growth factor in normal and psoriatic skin equivalent models.9874668Lee BN, Duvic M, Tang CK, Bueso-Ramos C, Estrov Z, Reuben JMClinical and diagnostic laboratory immunologyDysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Clin Diagn Lab Immunol. 1999 Jan; 6(1):79-84.Clin Diagn Lab Immunol1999-01-01T00:00:001999Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma.10189188Breuer-McHam JN, Marshall GD, Lewis DE, Duvic MViral immunologyDistinct serum cytokines in AIDS-related skin diseases. Viral Immunol. 1998; 11(4):215-20.Viral Immunol1998-01-01T00:00:001998Distinct serum cytokines in AIDS-related skin diseases.10462713Hazarika P, Dham N, Patel P, Cho M, Weidner D, Goldsmith L, Duvic MJournal of cellular biochemistryFlotillin 2 is distinct from epidermal surface antigen (ESA) and is associated with filopodia formation. J Cell Biochem. 1999 Oct 01; 75(1):147-59.J Cell Biochem1999-10-01T00:00:001999Flotillin 2 is distinct from epidermal surface antigen (ESA) and is associated with filopodia formation.11208831Sarris AH, Braunschweig I, Medeiros LJ, Duvic M, Ha CS, Rodriguez MA, Hagemeister FB, McLaughlin P, Romaguera J, Cox J, Cabanillas FJournal of clinical oncology : official journal of the American Society of Clinical OncologyPrimary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy. J Clin Oncol. 2001 Jan 15; 19(2):398-405.J Clin Oncol2001-01-15T00:00:002001Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.11369904Duvic M, Olsen EA, Omura GA, Maize JC, Vonderheid EC, Elmets CA, Shupack JL, Demierre MF, Kuzel TM, Sanders DYJournal of the American Academy of DermatologyA phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2001 Jun; 44(6):940-7.J Am Acad Dermatol2001-06-01T00:00:002001A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma.11464202Hwong H, Nichols T, Duvic MJournal of the American Academy of Dermatology"Invisible" mycosis fungoides? J Am Acad Dermatol. 2001 Aug; 45(2):318.J Am Acad Dermatol2001-08-01T00:00:002001"Invisible" mycosis fungoides?11568750Sober AJ, Chuang TY, Duvic M, Farmer ER, Grichnik JM, Halpern AC, Ho V, Holloway V, Hood AF, Johnson TM, Lowery BJ, Guidelines/Outcomes CommitteeJournal of the American Academy of DermatologyGuidelines of care for primary cutaneous melanoma. J Am Acad Dermatol. 2001 Oct; 45(4):579-86.J Am Acad Dermatol2001-10-01T00:00:002001Guidelines of care for primary cutaneous melanoma.11678256McMullan DM, Radovaneevic B, Jackow CM, Frazier OH, Duvic MTexas Heart Institute journalCutaneous T-cell lymphoma in a cardiac transplant recipient. Tex Heart Inst J. 2001; 28(3):203-7.Tex Heart Inst J2001-01-01T00:00:002001Cutaneous T-cell lymphoma in a cardiac transplant recipient.11703521Pielop JA, Jones D, Duvic MInternational journal of dermatologyTransient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment. Int J Dermatol. 2001 Aug; 40(8):505-11.Int J Dermatol2001-08-01T00:00:002001Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment.11707823Duvic M, Feasel AM, Schwartz CA, Cather JCClinical lymphomaEnterococcal eschars in cutaneous T-cell lymphoma tumors: a distinct clinical entity. Clin Lymphoma. 2000 Sep; 1(2):141-5.Clin Lymphoma2000-09-01T00:00:002000Enterococcal eschars in cutaneous T-cell lymphoma tumors: a distinct clinical entity.11707865Duvic MClinical lymphomaBexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms. Clin Lymphoma. 2000 Nov; 1 Suppl 1:S51-5.Clin Lymphoma2000-11-01T00:00:002000Bexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms.12020236Kandyil R, Maloney D, Tarrand J, Duvic MArchives of dermatologyRed nodule on the finger of an immunosuppressed woman. Arch Dermatol. 2002 May; 138(5):689-94.Arch Dermatol2002-05-01T00:00:002002Red nodule on the finger of an immunosuppressed woman.12762834Apisarnthanarax N, Ha CS, Duvic MAmerican journal of clinical dermatologyMycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation : successful treatment using radiation therapy plus oral bexarotene combination therapy. Am J Clin Dermatol. 2003; 4(6):429-33.Am J Clin Dermatol2003-01-01T00:00:002003Mycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation : successful treatment using radiation therapy plus oral bexarotene combination therapy.12883733Dang NH, Hagemeister FB, Duvic M, Romaguera JE, Younes A, Jones D, Samuels B, Fayad LE, Pro B, Samaniego F, Sarris A, Goy A, McLaughlin P, Tong AT, Walker PL, Tiongson LP, Smith TL, Huh YO, Morimoto C, Rodriguez MAOncology reportsPentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes. Oncol Rep. 2003 Sep-Oct; 10(5):1513-8.Oncol Rep2003-09-01T00:00:002003Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.14639420Barahmani N, Whaley K, Duvic MJournal of the American Academy of DermatologyAlopecia areata after allogeneic bone marrow transplantation from an affected, human leukocyte antigen-matched sibling. J Am Acad Dermatol. 2003 Dec; 49(6):1192.J Am Acad Dermatol2003-12-01T00:00:002003Alopecia areata after allogeneic bone marrow transplantation from an affected, human leukocyte antigen-matched sibling.14964752Gaylor ML, Duvic MJournal of drugs in dermatology : JDDGeneralized pustular psoriasis following withdrawal of efalizumab. J Drugs Dermatol. 2004 Jan-Feb; 3(1):77-9.J Drugs Dermatol2004-01-01T00:00:002004Generalized pustular psoriasis following withdrawal of efalizumab.15338005Whitmore SEJournal of the American Academy of DermatologyOptimizing bexarotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2004 Sep; 51(3):482; author reply 482-3.J Am Acad Dermatol2004-09-01T00:00:002004Optimizing bexarotene therapy for cutaneous T-cell lymphoma.16179379Donato ML, Feasel AM, Weber DM, Prieto VG, Giralt SA, Champlin RE, Duvic MBloodScleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood. 2006 Jan 15; 107(2):463-6.Blood2005-09-22T00:00:002005Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.16533224Rubenstein M, Duvic MInternational journal of dermatologyCutaneous manifestations of Hodgkin's disease. Int J Dermatol. 2006 Mar; 45(3):251-6.Int J Dermatol2006-03-01T00:00:002006Cutaneous manifestations of Hodgkin's disease.16635663Berger TG, Duvic M, Van Voorhees AS, VanBeek MJ, Frieden IJ, American Academy of Dermatology Association Task ForceJournal of the American Academy of DermatologyThe use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol. 2006 May; 54(5):818-23.J Am Acad Dermatol2006-05-01T00:00:002006The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.16879770Duvic M, Talpur R, Wen S, Kurzrock R, David CL, Apisarnthanarax NClinical lymphoma & myelomaPhase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma. Clin Lymphoma Myeloma. 2006 Jul; 7(1):51-8.Clin Lymphoma Myeloma2006-07-01T00:00:002006Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.16966250Duvic MLeukemia & lymphomaPhotopheresis versus transimmunization? Leuk Lymphoma. 2006 Aug; 47(8):1449.Leuk Lymphoma2006-08-01T00:00:002006Photopheresis versus transimmunization?17013097Doherty SD, Prieto VG, George S, Hazarika P, Duvic MMelanoma researchHigh flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res. 2006 Oct; 16(5):461-3.Melanoma Res2006-10-01T00:00:002006High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma.17241575Poonawalla T, Chen W, Duvic MJournal of cutaneous medicine and surgeryMycosis fungoides with tinea pseudoimbricata owing to Trichophyton rubrum infection. J Cutan Med Surg. 2006 Jan-Feb; 10(1):52-6.J Cutan Med Surg2006-01-01T00:00:002006Mycosis fungoides with tinea pseudoimbricata owing to Trichophyton rubrum infection.17284964May SA, Jones D, Medeiros LJ, Duvic M, Prieto VG, Lazar AJThe American Journal of dermatopathologyOral-cutaneous CD4-positive T-cell lymphoma: a study of two patients. Am J Dermatopathol. 2007 Feb; 29(1):62-7.Am J Dermatopathol2007-02-01T00:00:002007Oral-cutaneous CD4-positive T-cell lymphoma: a study of two patients.17298108Hultgren TL, Jones D, Duvic MAmerican journal of clinical dermatologyTopical nitrogen mustard for the treatment of granulomatous slack skin. Am J Clin Dermatol. 2007; 8(1):51-4.Am J Clin Dermatol2007-01-01T00:00:002007Topical nitrogen mustard for the treatment of granulomatous slack skin.17498443Doherty SD, Giancola A, Nash J, Lazar A, Duvic MDermatology online journalPapulo-vesicular eruption. Dermatol Online J. 2007 May 01; 13(2):24.Dermatol Online J2007-05-01T00:00:002007Papulo-vesicular eruption.17577020Olsen EA, Kim YH, Kuzel TM, Pacheco TR, Foss FM, Parker S, Frankel SR, Chen C, Ricker JL, Arduino JM, Duvic MJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. J Clin Oncol. 2007 Jul 20; 25(21):3109-15.J Clin Oncol2007-06-18T00:00:002007Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.17638852Shin J, Monti S, Aires DJ, Duvic M, Golub T, Jones DA, Kupper TSBloodLesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Blood. 2007 Oct 15; 110(8):3015-27.Blood2007-07-16T00:00:002007Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome.17902733Vu J, Wallace GR, Singh R, Diwan H, Prieto V, Rady P, Tyring S, Duvic MAmerican journal of clinical dermatologyCommon variable immunodeficiency syndrome associated with epidermodysplasia verruciformis. Am J Clin Dermatol. 2007; 8(5):307-10.Am J Clin Dermatol2007-01-01T00:00:002007Common variable immunodeficiency syndrome associated with epidermodysplasia verruciformis.18280345Leitenberger JJ, Berthelot CN, Polder KD, Pro B, McLaughlin P, Jones D, Duvic MJournal of the American Academy of DermatologyCD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate. J Am Acad Dermatol. 2008 Mar; 58(3):480-4.J Am Acad Dermatol2008-03-01T00:00:002008CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.18346181Sun G, Berthelot C, Duvic MClinical and experimental dermatologyA second case of dermatitis herpetiformis and cutaneous T-cell lymphoma. Clin Exp Dermatol. 2008 Jul; 33(4):506-7.Clin Exp Dermatol2008-03-16T00:00:002008A second case of dermatitis herpetiformis and cutaneous T-cell lymphoma.18433606Zelenetz AD, Advani RH, Byrd JC, Czuczman MS, Damon LE, Duvic M, Fayad L, Forero A, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kaminski MS, Kim YH, Lacasce AS, Nademanee A, Olsen EA, Porcu P, Press O, Prosnitz L, Smith MR, Sotomayor EM, Vose JM, Yahalom J, Yunus F, National Comprehensive Cancer NetworkJournal of the National Comprehensive Cancer Network : JNCCNNon-Hodgkin's lymphomas. J Natl Compr Canc Netw. 2008 Apr; 6(4):356-421.J Natl Compr Canc Netw2008-04-01T00:00:002008Non-Hodgkin's lymphomas.18433609Horwitz SM, Olsen EA, Duvic M, Porcu P, Kim YHJournal of the National Comprehensive Cancer Network : JNCCNReview of the treatment of mycosis fungoides and s?zary syndrome: a stage-based approach. J Natl Compr Canc Netw. 2008 Apr; 6(4):436-42.J Natl Compr Canc Netw2008-04-01T00:00:002008Review of the treatment of mycosis fungoides and s?zary syndrome: a stage-based approach.19126022Hicks LD, Duvic MInternational journal of dermatologyWiskott-Aldrich syndrome and molluscum contagiosum: a therapeutic challenge after reaction to cidofovir. Int J Dermatol. 2008 Dec; 47(12):1304-5.Int J Dermatol2008-12-01T00:00:002008Wiskott-Aldrich syndrome and molluscum contagiosum: a therapeutic challenge after reaction to cidofovir.19196298Kunishige JH, McDonald H, Alvarez G, Johnson M, Prieto V, Duvic MClinical and experimental dermatologyLymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients. Clin Exp Dermatol. 2009 Jul; 34(5):576-81.Clin Exp Dermatol2009-01-16T00:00:002009Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients.19682769Talpur R, Vu J, Bassett R, Stevens V, Duvic MJournal of the American Academy of DermatologyPhase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata. J Am Acad Dermatol. 2009 Oct; 61(4):592.e1-9.J Am Acad Dermatol2009-08-14T00:00:002009Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata.19770455Terushkin V, Dusza SW, Mullani NA, Duvic M, Zouridakis G, Weinstock M, Drugge R, Prieto VG, Dhawan A, Terry C, Talpur R, Marghoob AAArchives of dermatologyTransillumination as a means to differentiate melanocytic lesions based on their vascularity. Arch Dermatol. 2009 Sep; 145(9):1060-2.Arch Dermatol2009-09-01T00:00:002009Transillumination as a means to differentiate melanocytic lesions based on their vascularity.20308564Khan O, Fotheringham S, Wood V, Stimson L, Zhang C, Pezzella F, Duvic M, Kerr DJ, La Thangue NBProceedings of the National Academy of Sciences of the United States of AmericaHR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy. Proc Natl Acad Sci U S A. 2010 Apr 06; 107(14):6532-7.Proc Natl Acad Sci U S A2010-03-22T00:00:002010HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy.20888065Kim YH, Girardi M, Duvic M, Kuzel T, Link BK, Pinter-Brown L, Rook AHJournal of the American Academy of DermatologyPhase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma. J Am Acad Dermatol. 2010 Dec; 63(6):975-83.J Am Acad Dermatol2010-12-01T00:00:002010Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma.21036417Bi MY, Curry JL, Christiano AM, Hordinsky MK, Norris DA, Price VH, Duvic MJournal of the American Academy of DermatologyThe spectrum of hair loss in patients with mycosis fungoides and S?zary syndrome. J Am Acad Dermatol. 2011 Jan; 64(1):53-63.J Am Acad Dermatol2010-10-30T00:00:002010The spectrum of hair loss in patients with mycosis fungoides and S?zary syndrome.21344783Horwitz SM, Duvic M, Hsi EDClinical advances in hematology & oncology : H&OClinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides. Clin Adv Hematol Oncol. 2010 Dec; 8(12):1-15.Clin Adv Hematol Oncol2010-12-01T00:00:002010Clinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides.21658657Martin SJ, Duvic MClinical lymphoma, myeloma & leukemiaTreatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab. Clin Lymphoma Myeloma Leuk. 2011 Jun; 11(3):286-8.Clin Lymphoma Myeloma Leuk2011-04-20T00:00:002011Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab.21863906Williams VL, Torres-Cabala CA, Duvic MAmerican journal of clinical dermatologyPrimary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category. Am J Clin Dermatol. 2011 Dec 01; 12(6):389-401.Am J Clin Dermatol2011-12-01T00:00:002011Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.22952039Jahan-Tigh RR, Huen AO, Lee GL, Pozadzides JV, Liu P, Duvic MCancerHydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series. Cancer. 2013 Feb 15; 119(4):825-31.Cancer2012-09-05T00:00:002012Hydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series.22994666Martin SJ, Duvic MInternational journal of dermatologyPrevalence and treatment of palmoplantar keratoderma and tinea pedis in patients with S?zary syndrome. Int J Dermatol. 2012 Oct; 51(10):1195-8.Int J Dermatol2012-10-01T00:00:002012Prevalence and treatment of palmoplantar keratoderma and tinea pedis in patients with S?zary syndrome.23069814Lessin SR, Duvic M, Guitart J, Pandya AG, Strober BE, Olsen EA, Hull CM, Knobler EH, Rook AH, Kim EJ, Naylor MF, Adelson DM, Kimball AB, Wood GS, Sundram U, Wu H, Kim YHJAMA dermatologyTopical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides. JAMA Dermatol. 2013 Jan; 149(1):25-32.JAMA Dermatol2013-01-01T00:00:002013Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.23294328Kim S, Jahan-Tigh R, Duvic MLeukemia & lymphomaPapuloerythroderma of Ofuji associated with an indolent CD3(-), CD4(+), TCR(-) peripheral T-cell lymphoma. Leuk Lymphoma. 2013 Sep; 54(9):2059-61.Leuk Lymphoma2013-03-20T00:00:002013Papuloerythroderma of Ofuji associated with an indolent CD3(-), CD4(+), TCR(-) peripheral T-cell lymphoma.23595169Wang CM, Duvic M, Dabaja BSBMJ case reportsAcral erosive mycosis fungoides: successful treatment with localised radiotherapy. BMJ Case Rep. 2013 Apr 16; 2013.BMJ Case Rep2013-04-16T00:00:002013Acral erosive mycosis fungoides: successful treatment with localised radiotherapy.23879247Curry JL, Torres-Cabala CA, Kim KB, Tetzlaff MT, Duvic M, Tsai KY, Hong DS, Prieto VGInternational journal of dermatologyDermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions. Int J Dermatol. 2014 Mar; 53(3):376-84.Int J Dermatol2013-07-24T00:00:002013Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions.24326557Mendoza TR, Osei JS, Shi Q, Duvic MThe journal of investigative dermatology. Symposium proceedingsDevelopment of the alopecia areata symptom impact scale. J Investig Dermatol Symp Proc. 2013 Dec; 16(1):S51-2.J Investig Dermatol Symp Proc2013-12-01T00:00:002013Development of the alopecia areata symptom impact scale.LeukemiaRadiation OncologySurgical OncologyMD Anderson30.15130.003703551356research areas6.172540.0108723129coauthor of640.66485.939260similar to11671selected publicationsJEFFREY EGERSHENWALDJEFFREY E GERSHENWALD8667GERSHENWALD, JEFFREY EProfessorXIAONIXIAO NI8882NI, XIAOAssociate ProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorMICHAELTETZLAFFMICHAEL TETZLAFF9684TETZLAFF, MICHAELAssociate ProfessorPHYU PAUNGPHYU P AUNG9707AUNG, PHYU PAssistant ProfessorBOUTHAINA SHBIBDABAJABOUTHAINA SHBIB DABAJA8729DABAJA, BOUTHAINA SHBIBProfessorJONATHAN LCURRYJONATHAN L CURRY9543CURRY, JONATHAN LAssociate ProfessorVICTORPRIETOVICTOR PRIETO8828PRIETO, VICTORProfessorAuthorship 2122285Authorship 2123481Authorship 2124321Authorship 2126095Authorship 2126623Authorship 21272210Authorship 2129894Authorship 212992Authorship 2129964Authorship 2132072Authorship 2132122Authorship 2132132Authorship 2133613Authorship 2135741Authorship 2137113Authorship 2138731Authorship 2138761Authorship 2139263Authorship 2141222Authorship 2141302Authorship 2142656Authorship 2144791Authorship 2145191Authorship 2145695Authorship 2151613Authorship 2151985Authorship 2152464Authorship 2152875Authorship 2154143Authorship 2154291Authorship 2154751Authorship 2155506Authorship 2158942Authorship 215940Authorship 2160925Authorship 2162476Authorship 2166158Authorship 2166573Authorship 2166844Authorship 2167812Authorship 216821Authorship 2169112Authorship 2170685Authorship 2170814Authorship 2174941Authorship 2178461Authorship 2178671Authorship 2178891Authorship 2180642Authorship 2182204Authorship 2187934Authorship 2188285Authorship 2188512Authorship 2189501Authorship 2190804Authorship 2191195Authorship 2194782Authorship 2200442Authorship 2201323Authorship 2204212Authorship 2207163Authorship 2207531Authorship 2209677Authorship 2212546Authorship 2215745Authorship 2216965Authorship 2218634Authorship 2220122Authorship 2221864Authorship 2233547Authorship 2233563Authorship 2238472Authorship 2240123Authorship 22416111Authorship 2243065Authorship 2244535Authorship 2248285Authorship 2248601Authorship 2249622Authorship 2254061Authorship 2258311Authorship 22591010Authorship 2260428Authorship 2265263Authorship 2265275Authorship 2266124Authorship 2266695Authorship 2273023Authorship 2278969Authorship 2279028Authorship 2279232Authorship 2281192Authorship 2283171Authorship 2283993Authorship 2285526Authorship 2298942Authorship 2310354Authorship 2311255Authorship 2314718Authorship 2315582Authorship 2321565Authorship 2323166Authorship 2323983Authorship 2326302Authorship 2326981Authorship 23323919Authorship 2337782Authorship 2339582Authorship 2342792Authorship 2342821Authorship 2345008Authorship 2349312Authorship 2350872306824Duvic M, Steinberg AD, Klassen LWArthritis and rheumatismEffect of the anti-estrogen, Nafoxidine, on NZB/W autoimmune disease. Arthritis Rheum. 1978 May; 21(4):414-7.Arthritis Rheum1978-05-01T00:00:001978Effect of the anti-estrogen, Nafoxidine, on NZB/W autoimmune disease.1850960Tseng CK, Hughes MA, Hsu PL, Mahoney S, Duvic M, Sell SThe American journal of pathologySyphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits. Am J Pathol. 1991 May; 138(5):1149-64.Am J Pathol1991-05-01T00:00:001991Syphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits.1976808Arnett FC, Bias WB, McLean RH, Engel M, Duvic M, Goldstein R, Freni-Titulaer L, McKinley TW, Hochberg MCThe Journal of rheumatologyConnective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies. J Rheumatol. 1990 Aug; 17(8):1029-35.J Rheumatol1990-08-01T00:00:001990Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies.1994732Duvic MThe American journal of the medical sciencesIntegrins and cellular adherence molecules in skin. Am J Med Sci. 1991 Jan; 301(1):62.Am J Med Sci1991-01-01T00:00:001991Integrins and cellular adherence molecules in skin.2041889Arnett FC, Reveille JD, Duvic MRheumatic diseases clinics of North AmericaPsoriasis and psoriatic arthritis associated with human immunodeficiency virus infection. Rheum Dis Clin North Am. 1991 Feb; 17(1):59-78.Rheum Dis Clin North Am1991-02-01T00:00:001991Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection.2204310Farmer KL, Kurzrock R, Gutterman JU, Duvic MArchives of dermatologyNecrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites. Arch Dermatol. 1990 Sep; 126(9):1243-4.Arch Dermatol1990-09-01T00:00:001990Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites.2230207Zhuang H, Bai J, Chang JY, Yuan Z, Wang POncotargetMTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694.Oncotarget2016-12-20T00:00:002016MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma.2380573Konohana A, Konohana I, Schroeder WT, O'Brien WR, Amagai M, Greer J, Shimizu N, Gammon WR, Siciliano MJ, Duvic MThe Journal of investigative dermatologyPlacental glutathione-S-transferase-pi mRNA is abundantly expressed in human skin. J Invest Dermatol. 1990 Aug; 95(2):119-26.J Invest Dermatol1990-08-01T00:00:001990Placental glutathione-S-transferase-pi mRNA is abundantly expressed in human skin.2554820Magee KL, Rapini RP, Duvic M, Adler-Storthz KArchives of dermatologyHuman papillomavirus associated with keratoacanthoma. Arch Dermatol. 1989 Nov; 125(11):1587-9.Arch Dermatol1989-11-01T00:00:001989Human papillomavirus associated with keratoacanthoma.2684028Schulze KE, Rapini RP, Duvic MArchives of dermatologyMalignant melanoma in oculocutaneous albinism. Arch Dermatol. 1989 Nov; 125(11):1583-6.Arch Dermatol1989-11-01T00:00:001989Malignant melanoma in oculocutaneous albinism.2953313Duvic M, Reisman M, Finley V, Rapini R, DiLuzio NR, Mansell PWArchives of dermatologyGlucan-induced keratoderma in acquired immunodeficiency syndrome. Arch Dermatol. 1987 Jun; 123(6):751-6.Arch Dermatol1987-06-01T00:00:001987Glucan-induced keratoderma in acquired immunodeficiency syndrome.3016654Goldstein R, Gruhn J, Arnett FC, Duvic MNucleic acids researchA frequent polymorphism of the complement component C4 gene. Nucleic Acids Res. 1986 Jul 11; 14(13):5570.Nucleic Acids Res1986-07-11T00:00:001986A frequent polymorphism of the complement component C4 gene.3668011Duvic M, Rapini R, Hoots WK, Mansell PWJournal of the American Academy of DermatologyHuman immunodeficiency virus-associated vitiligo: expression of autoimmunity with immunodeficiency? J Am Acad Dermatol. 1987 Oct; 17(4):656-62.J Am Acad Dermatol1987-10-01T00:00:001987Human immunodeficiency virus-associated vitiligo: expression of autoimmunity with immunodeficiency?3688903Duvic M, Johnson TM, Rapini RP, Freese T, Brewton G, Rios AArchives of dermatologyAcquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol. 1987 Dec; 123(12):1622-32.Arch Dermatol1987-12-01T00:00:001987Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome.3717971Fahrner L, Duvic MArchives of dermatologyLupus panniculitis. Arch Dermatol. 1986 Jun; 122(6):625-6.Arch Dermatol1986-06-01T00:00:001986Lupus panniculitis.3720351Kay MH, Duvic MCutisReactive annular erythema after intramuscular vitamin K. Cutis. 1986 Jun; 37(6):445-8.Cutis1986-06-01T00:00:001986Reactive annular erythema after intramuscular vitamin K.3722509Lemak MA, Duvic M, Bean SFJournal of the American Academy of DermatologyOral acyclovir for the prevention of herpes-associated erythema multiforme. J Am Acad Dermatol. 1986 Jul; 15(1):50-4.J Am Acad Dermatol1986-07-01T00:00:001986Oral acyclovir for the prevention of herpes-associated erythema multiforme.6600810Surwit RS, Allen LM, Gilgor RS, Schanberg S, Kuhn C, Duvic MLife sciencesNeuroendocrine response to cold in Raynaud's syndrome. Life Sci. 1983 Feb 28; 32(9):995-1000.Life Sci1983-02-28T00:00:001983Neuroendocrine response to cold in Raynaud's syndrome.6614959Surwit RS, Gilgor RS, Duvic M, Allen LM, Neal JAArchives of dermatologyIntra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit. Arch Dermatol. 1983 Sep; 119(9):733-5.Arch Dermatol1983-09-01T00:00:001983Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit.7065672Graham WR, Duvic MArchives of dermatologyNodular secondary syphilis. Arch Dermatol. 1982 Mar; 118(3):205-6.Arch Dermatol1982-03-01T00:00:001982Nodular secondary syphilis.7406525Duvic M, Jegasothy BVArchives of dermatologyAcquired ichthyosis with systemic lupus erythematosus. Arch Dermatol. 1980 Aug; 116(8):952-4.Arch Dermatol1980-08-01T00:00:001980Acquired ichthyosis with systemic lupus erythematosus.7712642Duvic M, Lemak NADermatologic clinicsWerner's syndrome. Dermatol Clin. 1995 Jan; 13(1):163-8.Dermatol Clin1995-01-01T00:00:001995Werner's syndrome.7716609Cho M, Cohen PR, Duvic MSouthern medical journalVitiligo and alopecia areata in patients with human immunodeficiency virus infection. South Med J. 1995 Apr; 88(4):489-91.South Med J1995-04-01T00:00:001995Vitiligo and alopecia areata in patients with human immunodeficiency virus infection.7751462Duvic M, Moore D, Menter A, Vonderheid ECJournal of the American Academy of DermatologyCutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol. 1995 Jun; 32(6):939-42.J Am Acad Dermatol1995-06-01T00:00:001995Cutaneous T-cell lymphoma in association with silicone breast implants.7810940Cabanillas F, Armitage J, Pugh WC, Weisenburger D, Duvic MAnnals of internal medicineLymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma. Ann Intern Med. 1995 Feb 01; 122(3):210-7.Ann Intern Med1995-02-01T00:00:001995Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma.7902493Grossman D, Duvic MLancet (London, England)Cutaneous T-cell lymphoma after blood transfusion. Lancet. 1993 Dec 11; 342(8885):1483.Lancet1993-12-11T00:00:001993Cutaneous T-cell lymphoma after blood transfusion.8116614Milewicz DM, Duvic MAmerican journal of human geneticsSevere neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15. Am J Hum Genet. 1994 Mar; 54(3):447-53.Am J Hum Genet1994-03-01T00:00:001994Severe neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15.8160929Mahoney SE, Paddock SW, Smith LC, Lewis DE, Duvic MThe American Journal of dermatopathologyThree-dimensional laser-scanning confocal microscopy of in situ hybridization in the skin. Am J Dermatopathol. 1994 Feb; 16(1):44-51.Am J Dermatopathol1994-02-01T00:00:001994Three-dimensional laser-scanning confocal microscopy of in situ hybridization in the skin.8188865Wolf P, Cohen PR, Duvic MJournal of the American Academy of DermatologyAmbivalent response of lymphomatoid papulosis treated with 8-methoxypsoralen and UVA. J Am Acad Dermatol. 1994 Jun; 30(6):1018-20.J Am Acad Dermatol1994-06-01T00:00:001994Ambivalent response of lymphomatoid papulosis treated with 8-methoxypsoralen and UVA.8294589Grossman D, Rapini RP, Osborne B, Duvic MJournal of the American Academy of DermatologyEmergence of leprosy in a patient with mycosis fungoides. J Am Acad Dermatol. 1994 Feb; 30(2 Pt 2):313-5.J Am Acad Dermatol1994-02-01T00:00:001994Emergence of leprosy in a patient with mycosis fungoides.8601727Nagpal S, Patel S, Asano AT, Johnson AT, Duvic M, Chandraratna RAThe Journal of investigative dermatologyTazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J Invest Dermatol. 1996 Feb; 106(2):269-74.J Invest Dermatol1996-02-01T00:00:001996Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin.8647968Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, Kurzrock RJournal of the American Academy of DermatologyCombined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 1996 Jun; 34(6):1022-9.J Am Acad Dermatol1996-06-01T00:00:001996Combined modality therapy for cutaneous T-cell lymphoma.8752679Jackson M, Thomson KE, Laker R, Norval M, Hunter JA, McKenzie RCThe Journal of investigative dermatologyLack of induction of IL-10 expression in human keratinocytes. J Invest Dermatol. 1996 Jun; 106(6):1329-31.J Invest Dermatol1996-06-01T00:00:001996Lack of induction of IL-10 expression in human keratinocytes.8823370Konstantinova NV, Duong DM, Remenyik E, Hazarika P, Chuang A, Duvic MThe Journal of investigative dermatologyInterleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts. J Invest Dermatol. 1996 Oct; 107(4):615-21.J Invest Dermatol1996-10-01T00:00:001996Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts.8919863Milewicz DM, Byers PH, Reveille J, Hughes AL, Duvic MJournal of molecular evolutionA dimorphic Alu Sb-like insertion in COL3A1 is ethnic-specific. J Mol Evol. 1996 Feb; 42(2):117-23.J Mol Evol1996-02-01T00:00:001996A dimorphic Alu Sb-like insertion in COL3A1 is ethnic-specific.8978274Jackow CM, Cather JC, Hearne V, Asano AT, Musser JM, Duvic MBloodAssociation of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion. Blood. 1997 Jan 01; 89(1):32-40.Blood1997-01-01T00:00:001997Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion.9185908Cohen PR, Ulmer R, Theriault A, Leigh IM, Duvic MThe American Journal of dermatopathologyEpidermolytic acanthomas: clinical characteristics and immunohistochemical features. Am J Dermatopathol. 1997 Jun; 19(3):232-41.Am J Dermatopathol1997-06-01T00:00:001997Epidermolytic acanthomas: clinical characteristics and immunohistochemical features.9209643Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WCAnnals of oncology : official journal of the European Society for Medical OncologyLong-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Ann Oncol. 1997; 8 Suppl 2:59-63.Ann Oncol1997-01-01T00:00:001997Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.9216528Weinstein GD, Krueger GG, Lowe NJ, Duvic M, Friedman DJ, Jegasothy BV, Jorizzo JL, Shmunes E, Tschen EH, Lew-Kaya DA, Lue JC, Sefton J, Gibson JR, Chandraratna RAJournal of the American Academy of DermatologyTazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol. 1997 Jul; 37(1):85-92.J Am Acad Dermatol1997-07-01T00:00:001997Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect.9300632Weitzul S, Duvic MSeminars in cutaneous medicine and surgeryHIV-related psoriasis and Reiter's syndrome. Semin Cutan Med Surg. 1997 Sep; 16(3):213-8.Semin Cutan Med Surg1997-09-01T00:00:001997HIV-related psoriasis and Reiter's syndrome.9366841Smith KJ, Yeager J, Skelton HGJournal of the American Academy of DermatologyLocalized scleroderma in breast cancer patients treated with supervoltage external beam radiation: radiation port scleroderma. J Am Acad Dermatol. 1997 Nov; 37(5 Pt 1):806-8.J Am Acad Dermatol1997-11-01T00:00:001997Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: radiation port scleroderma.9777791Marks RJournal of the American Academy of DermatologyPharmacokinetics and safety review of tazarotene. J Am Acad Dermatol. 1998 Oct; 39(4 Pt 2):S134-8.J Am Acad Dermatol1998-10-01T00:00:001998Pharmacokinetics and safety review of tazarotene.10365922Diamandidou E, Colome M, Fayad L, Duvic M, Kurzrock RJournal of the American Academy of DermatologyPrognostic factor analysis in mycosis fungoides/S?zary syndrome. J Am Acad Dermatol. 1999 Jun; 40(6 Pt 1):914-24.J Am Acad Dermatol1999-06-01T00:00:001999Prognostic factor analysis in mycosis fungoides/S?zary syndrome.10456362Stevens SR, Bowen GM, Duvic M, King LE, Knobler R, Lim HW, Margolis D, Parry EJ, Rook AH, Stricklin GP, Suchin KR, Tharp MD, Vonderheid E, Zic JAArchives of dermatologyEffectiveness of photopheresis in S?zary syndrome. Arch Dermatol. 1999 Aug; 135(8):995-7.Arch Dermatol1999-08-01T00:00:001999Effectiveness of photopheresis in S?zary syndrome.11016855Breuer-McHam JN, Ledbetter LS, Sarris AH, Duvic MExperimental dermatologyCytokine expression patterns distinguish HIV associated skin diseases. Exp Dermatol. 2000 Oct; 9(5):341-50.Exp Dermatol2000-10-01T00:00:002000Cytokine expression patterns distinguish HIV associated skin diseases.11148494McMillen R, Duvic MJournal of the American Academy of DermatologyAlopecia areata occurring in sisters after administration of rifampicin. J Am Acad Dermatol. 2001 Jan; 44(1):142-3.J Am Acad Dermatol2001-01-01T00:00:002001Alopecia areata occurring in sisters after administration of rifampicin.11208829Olsen E, Duvic M, Frankel A, Kim Y, Martin A, Vonderheid E, Jegasothy B, Wood G, Gordon M, Heald P, Oseroff A, Pinter-Brown L, Bowen G, Kuzel T, Fivenson D, Foss F, Glode M, Molina A, Knobler E, Stewart S, Cooper K, Stevens S, Craig F, Reuben J, Bacha P, Nichols JJournal of clinical oncology : official journal of the American Society of Clinical OncologyPivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol. 2001 Jan 15; 19(2):376-88.J Clin Oncol2001-01-15T00:00:002001Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.11242798Lu D, Duvic M, Medeiros LJ, Luthra R, Dorfman DM, Jones DAmerican journal of clinical pathologyThe T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. Am J Clin Pathol. 2001 Mar; 115(3):413-21.Am J Clin Pathol2001-03-01T00:00:002001The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.11331325Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P, Crowley C, Yocum RC, Bexarotene Worldwide Study GroupJournal of clinical oncology : official journal of the American Society of Clinical OncologyBexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin Oncol. 2001 May 01; 19(9):2456-71.J Clin Oncol2001-05-01T00:00:002001Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results.11346336Duvic M, Martin AG, Kim Y, Olsen E, Wood GS, Crowley CA, Yocum RC, Worldwide Bexarotene Study GroupArchives of dermatologyPhase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol. 2001 May; 137(5):581-93.Arch Dermatol2001-05-01T00:00:002001Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.11397591Duvic M, Nelson A, de Andrade MClinics in dermatologyThe genetics of alopecia areata. Clin Dermatol. 2001 Mar-Apr; 19(2):135-9.Clin Dermatol2001-03-01T00:00:002001The genetics of alopecia areata.11555580Ni X, Hazarika P, Zhang C, Talpur R, Duvic MClinical cancer research : an official journal of the American Association for Cancer ResearchFas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape? Clin Cancer Res. 2001 Sep; 7(9):2682-92.Clin Cancer Res2001-09-01T00:00:002001Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?11705358Apisarnthanarax N, Duvic MDermatologic clinicsCutaneous T-cell lymphoma. New immunomodulators. Dermatol Clin. 2001 Oct; 19(4):737-48.Dermatol Clin2001-10-01T00:00:002001Cutaneous T-cell lymphoma. New immunomodulators.11707837Lee J, Apisarnthanarax N, Jordon RE, Duvic MClinical lymphomaCryofibrinogenemia in a patient with B-cell lymphoma. Clin Lymphoma. 2000 Dec; 1(3):234-7; discussion 238-9.Clin Lymphoma2000-12-01T00:00:002000Cryofibrinogenemia in a patient with B-cell lymphoma.11707858Duvic MClinical lymphomaTreatment of cutaneous T-cell lymphoma from a dermatologist's perspective. Clin Lymphoma. 2000 Nov; 1 Suppl 1:S15-20.Clin Lymphoma2000-11-01T00:00:002000Treatment of cutaneous T-cell lymphoma from a dermatologist's perspective.11908715Talpur R, Apisarnthanarax N, Ward S, Duvic MLeukemia & lymphomaTreatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK). Leuk Lymphoma. 2002 Jan; 43(1):121-6.Leuk Lymphoma2002-01-01T00:00:002002Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK).12006543Zhang C, Hazarika P, Ni X, Weidner DA, Duvic MClinical cancer research : an official journal of the American Association for Cancer ResearchInduction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin Cancer Res. 2002 May; 8(5):1234-40.Clin Cancer Res2002-05-01T00:00:002002Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.12672277Talpur R, Duvic MClinical lymphomaAtypical lymphoid infiltration occurring at the site of a healed varicella zoster infection. Clin Lymphoma. 2003 Mar; 3(4):253-6.Clin Lymphoma2003-03-01T00:00:002003Atypical lymphoid infiltration occurring at the site of a healed varicella zoster infection.12680962Clark SH, Duvic M, Prieto VG, Prietol VGJournal of cutaneous pathologyMycosis fungoides-like reaction in a patient treated with Gleevec. J Cutan Pathol. 2003 Apr; 30(4):279-81.J Cutan Pathol2003-04-01T00:00:002003Mycosis fungoides-like reaction in a patient treated with Gleevec.12890219Hanson M, Hill A, Duvic MThe British journal of dermatologyBexarotene reverses alopecia in cutaneous T-cell lymphoma. Br J Dermatol. 2003 Jul; 149(1):193-6.Br J Dermatol2003-07-01T00:00:002003Bexarotene reverses alopecia in cutaneous T-cell lymphoma.12958700Duvic M, Chiao N, Talpur RJournal of cutaneous medicine and surgeryExtracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Cutan Med Surg. 2003 Jul-Aug; 7(4 Suppl):3-7.J Cutan Med Surg2003-07-01T00:00:002003Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.14686975Zhang C, Duvic MDermatologic therapyRetinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. Dermatol Ther. 2003; 16(4):322-30.Dermatol Ther2003-01-01T00:00:002003Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma.14716770Tsimberidou AM, Giles F, Duvic M, Fayad L, Kurzrock RCancerPhase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series. Cancer. 2004 Jan 15; 100(2):342-9.Cancer2004-01-15T00:00:002004Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series.15034511Apisarnthanarax N, Talpur R, Ward S, Ni X, Kim HW, Duvic MJournal of the American Academy of DermatologyTazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study. J Am Acad Dermatol. 2004 Apr; 50(4):600-7.J Am Acad Dermatol2004-04-01T00:00:002004Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.15245439Zhang C, Ni X, Konopleva M, Andreeff M, Duvic MThe Journal of investigative dermatologyThe novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/S?zary syndrome cells. J Invest Dermatol. 2004 Aug; 123(2):380-7.J Invest Dermatol2004-08-01T00:00:002004The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/S?zary syndrome cells.15328201Jones D, Ibrahim S, Patel K, Luthra R, Duvic M, Medeiros LJClinical cancer research : an official journal of the American Association for Cancer ResearchDegree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy. Clin Cancer Res. 2004 Aug 15; 10(16):5587-94.Clin Cancer Res2004-08-15T00:00:002004Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy.15337988Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, Duvic M, King LE, McMichael AJ, Randall VA, Turner ML, Sperling L, Whiting DA, Norris D, National Alopecia Areata FoundationJournal of the American Academy of DermatologyAlopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation. J Am Acad Dermatol. 2004 Sep; 51(3):440-7.J Am Acad Dermatol2004-09-01T00:00:002004Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation.16231855Poonawalla T, Jones D, Hagemeister F, Duvic MClinical lymphoma & myelomaAcral necrotizing mycosis fungoides. Clin Lymphoma Myeloma. 2005 Sep; 6(2):146-8.Clin Lymphoma Myeloma2005-09-01T00:00:002005Acral necrotizing mycosis fungoides.16507211Berthelot C, Cather J, Jones D, Duvic MClinical lymphoma & myelomaAtypical CD8+ cutaneous T-cell lymphoma after immunomodulatory therapy. Clin Lymphoma Myeloma. 2006 Jan; 6(4):329-32.Clin Lymphoma Myeloma2006-01-01T00:00:002006Atypical CD8+ cutaneous T-cell lymphoma after immunomodulatory therapy.16882161Assaf C, Bagot M, Dummer R, Duvic M, Gniadecki R, Knobler R, Ranki A, Schwandt P, Whittaker SThe British journal of dermatologyMinimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion. Br J Dermatol. 2006 Aug; 155(2):261-6.Br J Dermatol2006-08-01T00:00:002006Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion.16990805Li C, Liu Z, Zhang Z, Strom SS, Gershenwald JE, Prieto VG, Lee JE, Ross MI, Mansfield PF, Cormier JN, Duvic M, Grimm EA, Wei QThe Journal of investigative dermatologyGenetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J Invest Dermatol. 2007 Feb; 127(2):276-80.J Invest Dermatol2006-09-21T00:00:002006Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.17021762Doherty SD, Ni X, Doherty CB, Jones D, Zhao X, Owen LB, Duvic MArchives of dermatological researchAbnormal expression of interleukin-23 in mycosis fungoides/S?zary syndrome lesions. Arch Dermatol Res. 2006 Dec; 298(7):353-6.Arch Dermatol Res2006-09-26T00:00:002006Abnormal expression of interleukin-23 in mycosis fungoides/S?zary syndrome lesions.17026828Poonawalla T, Diwan H, Duvic MClinical lymphoma & myelomaMycosis fungoides with coccidioidomycosis. Clin Lymphoma Myeloma. 2006 Sep; 7(2):148-50.Clin Lymphoma Myeloma2006-09-01T00:00:002006Mycosis fungoides with coccidioidomycosis.17317497Lozano A, Duvic MJournal of the American Academy of DermatologyCutaneous T-cell lymphoma in non-blood-related family members: report of an additional case. J Am Acad Dermatol. 2007 Mar; 56(3):521.J Am Acad Dermatol2007-03-01T00:00:002007Cutaneous T-cell lymphoma in non-blood-related family members: report of an additional case.17351938Baser S, Onn A, Lin E, Morice RC, Duvic MCancerPulmonary manifestations in patients with cutaneous T-cell lymphomas. Cancer. 2007 Apr 15; 109(8):1550-5.Cancer2007-04-15T00:00:002007Pulmonary manifestations in patients with cutaneous T-cell lymphomas.17459308Doherty SD, George S, Prieto VG, Gershenwald JE, Duvic MDermatology online journalSegmental neurofibromatosis in association with a large congenital nevus and malignant melanoma. Dermatol Online J. 2006 Dec 10; 12(7):22.Dermatol Online J2006-12-10T00:00:002006Segmental neurofibromatosis in association with a large congenital nevus and malignant melanoma.17553039Gniadecki R, Assaf C, Bagot M, Dummer R, Duvic M, Knobler R, Ranki A, Schwandt P, Whittaker SThe British journal of dermatologyThe optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol. 2007 Sep; 157(3):433-40.Br J Dermatol2007-06-06T00:00:002007The optimal use of bexarotene in cutaneous T-cell lymphoma.17637820Barahmani N, de Andrade M, Slusser JP, Wei Q, Hordinsky M, Price VH, Christiano A, Norris D, Reveille J, Duvic MThe Journal of investigative dermatologyHuman leukocyte antigen class II alleles are associated with risk of alopecia areata. J Invest Dermatol. 2008 Jan; 128(1):240-3.J Invest Dermatol2007-07-19T00:00:002007Human leukocyte antigen class II alleles are associated with risk of alopecia areata.17940636Duvic M, Vu JDrugs of today (Barcelona, Spain : 1998)Vorinostat in cutaneous T-cell lymphoma. Drugs Today (Barc). 2007 Sep; 43(9):585-99.Drugs Today (Barc)2007-09-01T00:00:002007Vorinostat in cutaneous T-cell lymphoma.18086343Duvic M, Foss FMSeminars in oncologyMycosis fungoides: pathophysiology and emerging therapies. Semin Oncol. 2007 Dec; 34(6 Suppl 5):S21-8.Semin Oncol2007-12-01T00:00:002007Mycosis fungoides: pathophysiology and emerging therapies.18280334Cen P, Duvic M, Cohen PR, Kurzrock RJournal of the American Academy of DermatologyIncreased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides. J Am Acad Dermatol. 2008 Mar; 58(3):382-6.J Am Acad Dermatol2008-03-01T00:00:002008Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides.18489588Talpur R, Bassett R, Duvic MThe British journal of dermatologyPrevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and S?zary syndrome. Br J Dermatol. 2008 Jul; 159(1):105-12.Br J Dermatol2008-07-01T00:00:002008Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and S?zary syndrome.18501089Vidulich K, Jones D, Duvic MClinical lymphoma & myelomaCutaneous gamma/delta T-cell lymphoma treated with radiation and denileukin diftitox. Clin Lymphoma Myeloma. 2008 Feb; 8(1):55-8.Clin Lymphoma Myeloma2008-02-01T00:00:002008Cutaneous gamma/delta T-cell lymphoma treated with radiation and denileukin diftitox.18501103Brownell I, Etzel CJ, Yang DJ, Taylor SH, Duvic MClinical lymphoma & myelomaIncreased malignancy risk in the cutaneous T-cell lymphoma patient population. Clin Lymphoma Myeloma. 2008 Apr; 8(2):100-5.Clin Lymphoma Myeloma2008-04-01T00:00:002008Increased malignancy risk in the cutaneous T-cell lymphoma patient population.18501107Richmond HM, Lozano A, Jones D, Duvic MClinical lymphoma & myelomaPrimary cutaneous follicle center lymphoma associated with alopecia areata. Clin Lymphoma Myeloma. 2008 Apr; 8(2):121-4.Clin Lymphoma Myeloma2008-04-01T00:00:002008Primary cutaneous follicle center lymphoma associated with alopecia areata.18563783Li C, Zhao H, Hu Z, Liu Z, Wang LE, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wei QHuman mutationGenetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum Mutat. 2008 Dec; 29(12):1443-51.Hum Mutat2008-12-01T00:00:002008Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.18567836Senff NJ, Noordijk EM, Kim YH, Bagot M, Berti E, Cerroni L, Dummer R, Duvic M, Hoppe RT, Pimpinelli N, Rosen ST, Vermeer MH, Whittaker S, Willemze R, European Organization for Research and Treatment of Cancer, International Society for Cutaneous LymphomaBloodEuropean Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008 Sep 01; 112(5):1600-9.Blood2008-06-20T00:00:002008European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.18625371Vu BA, Duvic MJournal of the American Academy of DermatologyCentral nervous system involvement in patients with mycosis fungoides and cutaneous large-cell transformation. J Am Acad Dermatol. 2008 Aug; 59(2 Suppl 1):S16-22.J Am Acad Dermatol2008-08-01T00:00:002008Central nervous system involvement in patients with mycosis fungoides and cutaneous large-cell transformation.18684057Duvic M, Talpur RFuture oncology (London, England)Optimizing denileukin diftitox (Ontak) therapy. Future Oncol. 2008 Aug; 4(4):457-69.Future Oncol2008-08-01T00:00:002008Optimizing denileukin diftitox (Ontak) therapy.19026464Sun G, Berthelot C, Li Y, Glass DA, George D, Pandya A, Kurzrock R, Duvic MJournal of the American Academy of DermatologyPoor prognosis in non-Caucasian patients with early-onset mycosis fungoides. J Am Acad Dermatol. 2009 Feb; 60(2):231-5.J Am Acad Dermatol2008-11-20T00:00:002008Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides.19538368Vidulich KA, Rady PL, He Q, Tyring SK, Duvic MInternational journal of dermatologyDetection of high-risk human papillomaviruses in verrucae of patients with mycosis fungoides and S?zary syndrome: a case series. Int J Dermatol. 2009 Jun; 48(6):598-602.Int J Dermatol2009-06-01T00:00:002009Detection of high-risk human papillomaviruses in verrucae of patients with mycosis fungoides and S?zary syndrome: a case series.19608295Barahmani N, Schabath MB, Duvic M, National Alopecia Areata RegistryJournal of the American Academy of DermatologyHistory of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009 Oct; 61(4):581-91.J Am Acad Dermatol2009-07-16T00:00:002009History of atopy or autoimmunity increases risk of alopecia areata.19789316Duvic M, Reddy SA, Pinter-Brown L, Korman NJ, Zic J, Kennedy DA, Lorenz J, Sievers EL, Kim YHClinical cancer research : an official journal of the American Association for Cancer ResearchA phase II study of SGN-30 in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders. Clin Cancer Res. 2009 Oct 01; 15(19):6217-24.Clin Cancer Res2009-09-29T00:00:002009A phase II study of SGN-30 in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders.20212249Prince HM, Duvic M, Martin A, Sterry W, Assaf C, Sun Y, Straus D, Acosta M, Negro-Vilar AJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma. J Clin Oncol. 2010 Apr 10; 28(11):1870-7.J Clin Oncol2010-03-08T00:00:002010Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma.20697094Whittaker SJ, Demierre MF, Kim EJ, Rook AH, Lerner A, Duvic M, Scarisbrick J, Reddy S, Robak T, Becker JC, Samtsov A, McCulloch W, Kim YHJournal of clinical oncology : official journal of the American Society of Clinical OncologyFinal results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma. J Clin Oncol. 2010 Oct 10; 28(29):4485-91.J Clin Oncol2010-08-09T00:00:002010Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma.21505396Ni X, Duvic MGiornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografiaDendritic cells and cutaneous T-cell lymphomas. G Ital Dermatol Venereol. 2011 Apr; 146(2):103-13.G Ital Dermatol Venereol2011-04-01T00:00:002011Dendritic cells and cutaneous T-cell lymphomas.21576639Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre MF, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, Knobler R, Sanches JA, Iwatsuki K, Sugaya M, Dummer R, Pittelkow M, Hoppe R, Parker S, Geskin L, Pinter-Brown L, Girardi M, Burg G, Ranki A, Vermeer M, Horwitz S, Heald P, Rosen S, Cerroni L, Dreno B, Vonderheid EC, International Society for Cutaneous Lymphomas, United States Cutaneous Lymphoma Consortium, Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerJournal of clinical oncology : official journal of the American Society of Clinical OncologyClinical end points and response criteria in mycosis fungoides and S?zary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011 Jun 20; 29(18):2598-607.J Clin Oncol2011-05-16T00:00:002011Clinical end points and response criteria in mycosis fungoides and S?zary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.21649541Querfeld C, Kuzel TM, Kim YH, Porcu P, Duvic M, Musiek A, Rook AH, Mark LA, Pinter-Brown L, Hamid O, Lin B, Bian Y, Boye M, Day JM, Rosen STLeukemia & lymphomaMulticenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma. Leuk Lymphoma. 2011 Aug; 52(8):1474-80.Leuk Lymphoma2011-06-08T00:00:002011Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma.22257096Shiue LH, Ni X, Prieto VG, Jorgensen JL, Curry JL, Goswami M, Sweeney SA, Duvic MInternational journal of dermatologyA case of invisible leukemic cutaneous T cell lymphoma with a regulatory T cell clone. Int J Dermatol. 2013 Sep; 52(9):1111-4.Int J Dermatol2012-01-18T00:00:002012A case of invisible leukemic cutaneous T cell lymphoma with a regulatory T cell clone.22416775Rangwala S, Zhang C, Duvic MFuture medicinal chemistryHDAC inhibitors for the treatment of cutaneous T-cell lymphomas. Future Med Chem. 2012 Mar; 4(4):471-86.Future Med Chem2012-03-01T00:00:002012HDAC inhibitors for the treatment of cutaneous T-cell lymphomas.22521504Talpur R, Duvic MClinical lymphoma, myeloma & leukemiaPilot study of denileukin diftitox alternate dosing regimen in patients with cutaneous peripheral T-cell lymphomas. Clin Lymphoma Myeloma Leuk. 2012 Jun; 12(3):180-5.Clin Lymphoma Myeloma Leuk2012-04-21T00:00:002012Pilot study of denileukin diftitox alternate dosing regimen in patients with cutaneous peripheral T-cell lymphomas.22738414Prince HM, Martin AG, Olsen EA, Fivenson DP, Duvic MLeukemia & lymphomaDenileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and S?zary syndrome. Leuk Lymphoma. 2013 Jan; 54(1):69-75.Leuk Lymphoma2012-09-14T00:00:002012Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and S?zary syndrome.22788808Vij A, Duvic MInternational journal of dermatologyPrevalence and severity of pruritus in cutaneous T cell lymphoma. Int J Dermatol. 2012 Aug; 51(8):930-4.Int J Dermatol2012-08-01T00:00:002012Prevalence and severity of pruritus in cutaneous T cell lymphoma.22891708Duvic M, Martin AG, Olsen EA, Fivenson DP, Prince HMLeukemia & lymphomaEfficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma. Leuk Lymphoma. 2013 Mar; 54(3):514-9.Leuk Lymphoma2012-09-03T00:00:002012Efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma.23073324Guitart J, Weisenburger DD, Subtil A, Kim E, Wood G, Duvic M, Olsen E, Junkins-Hopkins J, Rosen S, Sundram U, Ivan D, Selim MA, Pincus L, Deonizio JM, Kwasny M, Kim YHThe American journal of surgical pathologyCutaneous ?d T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas. Am J Surg Pathol. 2012 Nov; 36(11):1656-65.Am J Surg Pathol2012-11-01T00:00:002012Cutaneous ?d T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas.23457002Lacouture ME, Duvic M, Hauschild A, Prieto VG, Robert C, Schadendorf D, Kim CC, McCormack CJ, Myskowski PL, Spleiss O, Trunzer K, Su F, Nelson B, Nolop KB, Grippo JF, Lee RJ, Klimek MJ, Troy JL, Joe AKThe oncologistAnalysis of dermatologic events in vemurafenib-treated patients with melanoma. Oncologist. 2013; 18(3):314-22.Oncologist2013-03-01T00:00:002013Analysis of dermatologic events in vemurafenib-treated patients with melanoma.23735705Benton EC, Crichton S, Talpur R, Agar NS, Fields PA, Wedgeworth E, Mitchell TJ, Cox M, Ferreira S, Liu P, Robson A, Calonje E, Stefanato CM, Wilkins B, Scarisbrick J, Wain EM, Child F, Morris S, Duvic M, Whittaker SJEuropean journal of cancer (Oxford, England : 1990)A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome. Eur J Cancer. 2013 Sep; 49(13):2859-68.Eur J Cancer2013-06-01T00:00:002013A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.23961531Seyfer SJ, Duvic MCutisDisappearance of seborrheic keratoses following treatment with methotrexate. Cutis. 2013 Jul; 92(1):E2-3.Cutis2013-07-01T00:00:002013Disappearance of seborrheic keratoses following treatment with methotrexate.24151865Aung PP, Climent F, Muzzafar T, Curry JL, Patel KP, Servitje O, Prieto VG, Duvic M, Jaffe ES, Torres-Cabala CAJournal of cutaneous pathologyImmunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases. J Cutan Pathol. 2014 Jan; 41(1):51-7.J Cutan Pathol2013-11-14T00:00:002013Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.24285015Straus DJ, Duvic M, Horwitz SM, Hymes K, Goy A, Hernandez-Ilizaliturri FJ, Feldman T, Wegner B, Myskowski PLAnnals of oncology : official journal of the European Society for Medical OncologyFinal results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma. Ann Oncol. 2014 Jan; 25(1):206-10.Ann Oncol2013-11-26T00:00:002013Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma.24326555Shi Q, Duvic M, Osei JS, Hordinsky MK, Norris DA, Price VH, Amos CI, Christiano AM, Mendoza TRThe journal of investigative dermatology. Symposium proceedingsHealth-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data. J Investig Dermatol Symp Proc. 2013 Dec; 16(1):S49-50.J Investig Dermatol Symp Proc2013-12-01T00:00:002013Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data.24326558Duvic M, Christiano AM, Hordinsky MK, Norris DA, Price VH, Amos CIThe journal of investigative dermatology. Symposium proceedingsThe national alopecia areata registry-update. J Investig Dermatol Symp Proc. 2013 Dec; 16(1):S53.J Investig Dermatol Symp Proc2013-12-01T00:00:002013The national alopecia areata registry-update.25335355Rangwala S, Duvic MSkinmedAntinuclear antibody seropositivity in men with cutaneous B-cell lymphoma of the scalp. Skinmed. 2014 Jul-Aug; 12(4):244-8.Skinmed2014-07-01T00:00:002014Antinuclear antibody seropositivity in men with cutaneous B-cell lymphoma of the scalp.Authorship 2356226Authorship 23574210Authorship 2358352Authorship 2358674Authorship 2358894Authorship 2361021Authorship 2361211Authorship 2361722Authorship 2362833Authorship 2363635Authorship 2366166Authorship 2366433Authorship 2366624Authorship 2367242Authorship 2368893Authorship 2371359Authorship 2373223Authorship 2374241Authorship 2374961Authorship 2375131Authorship 2376036Authorship 2376274Authorship 2377952Authorship 2382241Authorship 238275Authorship 2386864Authorship 2386959Authorship 2388936Authorship 2388972Authorship 2390191Authorship 2390326Authorship 2392505Authorship 2396058Authorship 2397546Authorship 2398811Authorship 2398993Authorship 2401423Authorship 2402166Authorship 2402701Authorship 2402925Authorship 2403937Authorship 2404598Authorship 2405533Authorship 2406073Authorship 2408091Authorship 2408166Authorship 240957Authorship 2409755Authorship 24128715Authorship 2413894Authorship 2423176Authorship 2426031Authorship 2435433Authorship 2437643Authorship 2440128Authorship 2442863Authorship 2443763Authorship 244545Authorship 2446213Authorship 2446352Authorship 2446503Authorship 2448242Authorship 2450728Authorship 2452521Authorship 2453521Authorship 2458404Authorship 2458903Authorship 2460454Authorship 2460911Authorship 2461822Authorship 2465646Authorship 2471553Authorship 247518Authorship 2478451Authorship 24800811Authorship 2480412Authorship 2485015Authorship 24876312Authorship 2490841Authorship 2492273Authorship 2493763Authorship 2493793Authorship 2494492Authorship 2494688Authorship 2501553Authorship 25017014Authorship 2502038Authorship 2503368Authorship 2503913Authorship 2507281Authorship 2511331Authorship 2511613Authorship 2512622Authorship 2521934Authorship 2533084Authorship 2536973Authorship 2542141Authorship 2544606Authorship 2545203Authorship 25471210Authorship 2549453Authorship 2550703Authorship 2552942Authorship 25589711Authorship 2560621Authorship 2561603Authorship 2565912Authorship 2566956Authorship 2567022Authorship 2568552Authorship 25707718Authorship 2571822Authorship 2578993Authorship 2579523Authorship 2580056Authorship 2588382Authorship 2588512Authorship 2591263Authorship 2592825Authorship 2596011Authorship 2599141Authorship 2603316Authorship 2618273Authorship 2621501Authorship 2621801Authorship 2623323Authorship 2625942508371Steinberg AD, Melez KA, Raveche ES, Reeves JP, Boegel WA, Smathers PA, Taurog JD, Weinlein L, Duvic MArthritis and rheumatismApproach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum. 1979 Nov; 22(11):1170-6.Arthritis Rheum1979-11-01T00:00:001979Approach to the study of the role of sex hormones in autoimmunity.1358802Kayes LM, Schroeder WT, Marchuk DA, Collins FS, Riccardi VM, Duvic M, Stephens KGenomicsThe gene for a novel epidermal antigen maps near the neurofibromatosis 1 gene. Genomics. 1992 Oct; 14(2):369-76.Genomics1992-10-01T00:00:001992The gene for a novel epidermal antigen maps near the neurofibromatosis 1 gene.1476157Duvic MThe American journal of the medical sciencesHIV and skin disease: the molecular biology of the human immunodeficiency virus. Am J Med Sci. 1992 Sep; 304(3):180-7.Am J Med Sci1992-09-01T00:00:001992HIV and skin disease: the molecular biology of the human immunodeficiency virus.1603744Morris L, Lynch PM, Gleason WA, Schauder C, Pinkel D, Duvic MPediatric dermatologyBlue rubber bleb nevus syndrome: laser photocoagulation of colonic hemangiomas in a child with microcytic anemia. Pediatr Dermatol. 1992 Jun; 9(2):91-4.Pediatr Dermatol1992-06-01T00:00:001992Blue rubber bleb nevus syndrome: laser photocoagulation of colonic hemangiomas in a child with microcytic anemia.1629625Giro MG, Duvic M, Smith LT, Kennedy R, Rapini R, Arnett FC, Davidson JMThe Journal of investigative dermatologyBuschke-Ollendorff syndrome associated with elevated elastin production by affected skin fibroblasts in culture. J Invest Dermatol. 1992 Aug; 99(2):129-37.J Invest Dermatol1992-08-01T00:00:001992Buschke-Ollendorff syndrome associated with elevated elastin production by affected skin fibroblasts in culture.1676036Mahoney SE, Duvic M, Nickoloff BJ, Minshall M, Smith LC, Griffiths CE, Paddock SW, Lewis DEThe Journal of clinical investigationHuman immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions. J Clin Invest. 1991 Jul; 88(1):174-85.J Clin Invest1991-07-01T00:00:001991Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions.1724378Paddock S, Mahoney S, Minshall M, Smith L, Duvic M, Lewis DBioTechniquesImproved detection of in situ hybridization by laser scanning confocal microscopy. Biotechniques. 1991 Oct; 11(4):486-93.Biotechniques1991-10-01T00:00:001991Improved detection of in situ hybridization by laser scanning confocal microscopy.1769667Schroeder WT, Siciliano MJ, Stewart-Galetka SL, Duvic MGenomicsThe human gene for an epidermal surface antigen (M17S1) is located at 17q11-12. Genomics. 1991 Oct; 11(2):481-2.Genomics1991-10-01T00:00:001991The human gene for an epidermal surface antigen (M17S1) is located at 17q11-12.1892832Durland RH, Kessler DJ, Gunnell S, Duvic M, Pettitt BM, Hogan MEBiochemistryBinding of triple helix forming oligonucleotides to sites in gene promoters. Biochemistry. 1991 Sep 24; 30(38):9246-55.Biochemistry1991-09-24T00:00:001991Binding of triple helix forming oligonucleotides to sites in gene promoters.1962752Olson E, Edmondson D, Wright WE, Lin VK, Guenet JL, Simon-Chazottes D, Thompson LH, Stallings RL, Schroeder WT, Duvic MGenomicsMyogenin is in an evolutionarily conserved linkage group on human chromosome 1q31-q41 and unlinked to other mapped muscle regulatory factor genes. Genomics. 1990 Nov; 8(3):427-34.Genomics1990-11-01T00:00:001990Myogenin is in an evolutionarily conserved linkage group on human chromosome 1q31-q41 and unlinked to other mapped muscle regulatory factor genes.2222538Reveille JD, Conant MA, Duvic MArthritis and rheumatismHuman immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum? Arthritis Rheum. 1990 Oct; 33(10):1574-8.Arthritis Rheum1990-10-01T00:00:001990Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum?2452211Konohana I, Konohana A, Xia PZ, Jordon RE, Geoghegan WD, Duvic MThe Journal of investigative dermatologyExpression of pemphigus vulgaris antigen in cultured human keratinocytes: effect of inhibitors, tunicamycin, and lectins. J Invest Dermatol. 1988 May; 90(5):708-15.J Invest Dermatol1988-05-01T00:00:001988Expression of pemphigus vulgaris antigen in cultured human keratinocytes: effect of inhibitors, tunicamycin, and lectins.2458356Stoler A, Kopan R, Duvic M, Fuchs EThe Journal of cell biologyUse of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol. 1988 Aug; 107(2):427-46.J Cell Biol1988-08-01T00:00:001988Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation.2462349Arnett FC, Goldstein R, Duvic M, Reveille JDThe American journal of medicineMajor histocompatibility complex genes in systemic lupus erythematosus, Sj?gren's syndrome, and polymyositis. Am J Med. 1988 Dec 23; 85(6A):38-41.Am J Med1988-12-23T00:00:001988Major histocompatibility complex genes in systemic lupus erythematosus, Sj?gren's syndrome, and polymyositis.2479695Stoler A, Duvic M, Fuchs EThe Journal of investigative dermatologyUnusual patterns of keratin expression in the overlying epidermis of patients with dermatofibromas: biochemical alterations in the epidermis as a consequence of dermal tumors. J Invest Dermatol. 1989 Dec; 93(6):728-38.J Invest Dermatol1989-12-01T00:00:001989Unusual patterns of keratin expression in the overlying epidermis of patients with dermatofibromas: biochemical alterations in the epidermis as a consequence of dermal tumors.2568334Olsen ML, Goldstein R, Arnett FC, Duvic M, Pollack M, Reveille JDImmunogeneticsC4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus. Immunogenetics. 1989; 30(1):27-33.Immunogenetics1989-01-01T00:00:001989C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus.2887910Duvic M, Rios A, Brewton GWLancet (London, England)Remission of AIDS-associated psoriasis with zidovudine. Lancet. 1987 Sep 12; 2(8559):627.Lancet1987-09-12T00:00:001987Remission of AIDS-associated psoriasis with zidovudine.3579362Duvic MArchives of dermatologyThe Wu Li Masters dance with fibronectin. Arch Dermatol. 1987 Jun; 123(6):821-2.Arch Dermatol1987-06-01T00:00:001987The Wu Li Masters dance with fibronectin.3624557Johnson TM, Rapini RP, Duvic MJournal of the American Academy of DermatologyInflammation of actinic keratoses from systemic chemotherapy. J Am Acad Dermatol. 1987 Aug; 17(2 Pt 1):192-7.J Am Acad Dermatol1987-08-01T00:00:001987Inflammation of actinic keratoses from systemic chemotherapy.3688899Duvic M, Lowe L, Rios A, MacDonald E, Vance PArchives of dermatologySuperficial phaeohyphomycosis of the scrotum in a patient with the acquired immunodeficiency syndrome. Arch Dermatol. 1987 Dec; 123(12):1597-9.Arch Dermatol1987-12-01T00:00:001987Superficial phaeohyphomycosis of the scrotum in a patient with the acquired immunodeficiency syndrome.3782529Duvic MJournal of the American Academy of DermatologyPossible mechanisms of effectiveness of Dead Sea balneotherapy. J Am Acad Dermatol. 1986 Nov; 15(5 Pt 1):1061.J Am Acad Dermatol1986-11-01T00:00:001986Possible mechanisms of effectiveness of Dead Sea balneotherapy.4058535Johnson TM, Duvic M, Rapini RP, Rios AThe New England journal of medicineAIDS exacerbates psoriasis. N Engl J Med. 1985 Nov 28; 313(22):1415.N Engl J Med1985-11-28T00:00:001985AIDS exacerbates psoriasis.6406563Duvic M, Reisner EG, Dawson DV, Ciftan EJournal of the American Academy of DermatologyHLA-B15 association with erythema multiforme. J Am Acad Dermatol. 1983 Apr; 8(4):493-6.J Am Acad Dermatol1983-04-01T00:00:001983HLA-B15 association with erythema multiforme.7165784Surwit RS, Allen LM, Gilgor RS, Duvic MBiofeedback and self-regulationThe combined effect of prazosin and autogenic training on cold reactivity in Raynaud's phenomenon. Biofeedback Self Regul. 1982 Dec; 7(4):537-44.Biofeedback Self Regul1982-12-01T00:00:001982The combined effect of prazosin and autogenic training on cold reactivity in Raynaud's phenomenon.7490360Sendagorta E, Ledo AJournal of the American Academy of DermatologyS?zary syndrome in association with silicone breast implant. J Am Acad Dermatol. 1995 Dec; 33(6):1060-1.J Am Acad Dermatol1995-12-01T00:00:001995S?zary syndrome in association with silicone breast implant.7512583Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA, Sefton J, Duvic MJournal of the American Academy of DermatologyResponse of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol. 1994 Apr; 30(4):581-90.J Am Acad Dermatol1994-04-01T00:00:001994Response of psoriasis to a new topical retinoid, AGN 190168.7593804Friss AB, Cohen PR, Bruce S, Duvic MJournal of the American Academy of DermatologyChronic cutaneous lupus erythematosus mimicking mycosis fungoides. J Am Acad Dermatol. 1995 Nov; 33(5 Pt 2):891-5.J Am Acad Dermatol1995-11-01T00:00:001995Chronic cutaneous lupus erythematosus mimicking mycosis fungoides.7605995Sarris AH, Esgleyes-Ribot T, Crow M, Broxmeyer HE, Karasavvas N, Pugh W, Grossman D, Deisseroth A, Duvic MBloodCytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? Blood. 1995 Jul 15; 86(2):651-8.Blood1995-07-15T00:00:001995Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?7751471Townsend BL, Cohen PR, Duvic MJournal of the American Academy of DermatologyZidovudine for the treatment of HIV-negative patients with psoriasis: a pilot study. J Am Acad Dermatol. 1995 Jun; 32(6):994-9.J Am Acad Dermatol1995-06-01T00:00:001995Zidovudine for the treatment of HIV-negative patients with psoriasis: a pilot study.7909423Duvic M, Crane MM, Conant M, Mahoney SE, Reveille JD, Lehrman SNArchives of dermatologyZidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch Dermatol. 1994 Apr; 130(4):447-51.Arch Dermatol1994-04-01T00:00:001994Zidovudine improves psoriasis in human immunodeficiency virus-positive males.7913841O'Brien S, Kurzrock R, Duvic M, Kantarjian H, Stass S, Robertson LE, Estey E, Pierce S, Keating MJBlood2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders. Blood. 1994 Aug 01; 84(3):733-8.Blood1994-08-01T00:00:0019942-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders.7981684Ikeda S, Welsh EA, Peluso AM, Leyden W, Duvic M, Woodley DT, Epstein EHHuman molecular geneticsLocalization of the gene whose mutations underlie Hailey-Hailey disease to chromosome 3q. Hum Mol Genet. 1994 Jul; 3(7):1147-50.Hum Mol Genet1994-07-01T00:00:001994Localization of the gene whose mutations underlie Hailey-Hailey disease to chromosome 3q.8051082Schroeder WT, Stewart-Galetka S, Mandavilli S, Parry DA, Goldsmith L, Duvic MThe Journal of biological chemistryCloning and characterization of a novel epidermal cell surface antigen (ESA). J Biol Chem. 1994 Aug 05; 269(31):19983-91.J Biol Chem1994-08-05T00:00:001994Cloning and characterization of a novel epidermal cell surface antigen (ESA).8240910Duvic MAdvances in dermatologyMolecular biology for the practitioner. Adv Dermatol. 1993; 8:107-27; discussion 128.Adv Dermatol1993-01-01T00:00:001993Molecular biology for the practitioner.8272935Duvic MSouthern medical journalChemotherapy-induced alopecia. South Med J. 1993 Dec; 86(12):1446.South Med J1993-12-01T00:00:001993Chemotherapy-induced alopecia.8372222Fornage BD, McGavran MH, Duvic M, Waldron CARadiologyImaging of the skin with 20-MHz US. Radiology. 1993 Oct; 189(1):69-76.Radiology1993-10-01T00:00:001993Imaging of the skin with 20-MHz US.8399070Dhingra K, Duvic M, Hymes S, McLaughlin P, Rothberg J, Gutterman JUJournal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological TherapyA phase-I clinical study of low-dose oral interferon-alpha. J Immunother Emphasis Tumor Immunol. 1993 Jul; 14(1):51-5.J Immunother Emphasis Tumor Immunol1993-07-01T00:00:001993A phase-I clinical study of low-dose oral interferon-alpha.8682968Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, Trancik RJ, Bandstra BA, Compton LDJournal of the American Academy of DermatologyA randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol. 1996 Jul; 35(1):74-8.J Am Acad Dermatol1996-07-01T00:00:001996A randomized trial of minoxidil in chemotherapy-induced alopecia.8751973Jackow CM, McHam JB, Friss A, Alvear J, Reveille JR, Duvic MThe Journal of investigative dermatologyHLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma. J Invest Dermatol. 1996 Sep; 107(3):373-6.J Invest Dermatol1996-09-01T00:00:001996HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma.9024524Hardy RD, Duvic M, Bleyer WAMedical and pediatric oncologyThe sign of Leser-Tr?lat. Med Pediatr Oncol. 1997 Mar; 28(3):234-7.Med Pediatr Oncol1997-03-01T00:00:001997The sign of Leser-Tr?lat.9031795Goller MM, Cohen PR, Duvic MDermatology (Basel, Switzerland)Lichen amyloidosis presenting as a papular pruritus syndrome in a human-immunodeficiency-virus-infected man. Dermatology. 1997; 194(1):62-4.Dermatology1997-01-01T00:00:001997Lichen amyloidosis presenting as a papular pruritus syndrome in a human-immunodeficiency-virus-infected man.9204961Nagpal S, Patel S, Jacobe H, DiSepio D, Ghosn C, Malhotra M, Teng M, Duvic M, Chandraratna RAThe Journal of investigative dermatologyTazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol. 1997 Jul; 109(1):91-5.J Invest Dermatol1997-07-01T00:00:001997Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin.9270526Zackheim HS, Kashani-Sabet MJournal of the American Academy of DermatologyResponse rates in photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 1997 Aug; 37(2 Pt 1):287-8.J Am Acad Dermatol1997-08-01T00:00:001997Response rates in photopheresis therapy for cutaneous T-cell lymphoma.9462771Konstantinova NV, Lemak NA, Duong DM, Chuang AZ, Urso R, Duvic MPlastic and reconstructive surgeryArtificial skin equivalent differentiation depends on fibroblast donor site: use of eyelid fibroblasts. Plast Reconstr Surg. 1998 Feb; 101(2):385-91.Plast Reconstr Surg1998-02-01T00:00:001998Artificial skin equivalent differentiation depends on fibroblast donor site: use of eyelid fibroblasts.9486702Cather JC, Jackow C, Yegge J, Hagemeister F, Duvic MJournal of the American Academy of DermatologyMycosis fungoides with focal segmental glomerular sclerosis and nephrotic syndrome. J Am Acad Dermatol. 1998 Feb; 38(2 Pt 2):301-5.J Am Acad Dermatol1998-02-01T00:00:001998Mycosis fungoides with focal segmental glomerular sclerosis and nephrotic syndrome.9520023Jackow C, Puffer N, Hordinsky M, Nelson J, Tarrand J, Duvic MJournal of the American Academy of DermatologyAlopecia areata and cytomegalovirus infection in twins: genes versus environment? J Am Acad Dermatol. 1998 Mar; 38(3):418-25.J Am Acad Dermatol1998-03-01T00:00:001998Alopecia areata and cytomegalovirus infection in twins: genes versus environment?9590158Duvic M, Cather J, Maize J, Frankel AEAmerican journal of hematologyDAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma. Am J Hematol. 1998 May; 58(1):87-90.Am J Hematol1998-05-01T00:00:001998DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma.9684929Daliani D, Ulmer RA, Jackow C, Pugh W, Gansbacher B, Cabanillas F, Duvic M, Sarris AHLeukemia & lymphomaTumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10. Leuk Lymphoma. 1998 Apr; 29(3-4):315-28.Leuk Lymphoma1998-04-01T00:00:001998Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.9694702Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock RBloodTransformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. Blood. 1998 Aug 15; 92(4):1150-9.Blood1998-08-15T00:00:001998Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.9738778Peterson SR, Talpur R, Duvic MJournal of the American Academy of DermatologyAntinuclear antibody seropositivity in patients with cutaneous T-cell lymphoma. J Am Acad Dermatol. 1998 Sep; 39(3):434-8.J Am Acad Dermatol1998-09-01T00:00:001998Antinuclear antibody seropositivity in patients with cutaneous T-cell lymphoma.9787988Duvic MCutisPharmacologic profile of tazarotene. Cutis. 1998 Feb; 61(2 Suppl):22-6.Cutis1998-02-01T00:00:001998Pharmacologic profile of tazarotene.9810916Cather JC, Farmer A, Jackow C, Manning JT, Shin DM, Duvic MJournal of the American Academy of DermatologyUnusual presentation of mycosis fungoides as pigmented purpura with malignant thymoma. J Am Acad Dermatol. 1998 Nov; 39(5 Pt 2):858-63.J Am Acad Dermatol1998-11-01T00:00:001998Unusual presentation of mycosis fungoides as pigmented purpura with malignant thymoma.9922012Breuer-McHam J, Marshall G, Adu-Oppong A, Goller M, Mays S, Berger T, Lewis DE, Duvic MJournal of the American Academy of DermatologyAlterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy. J Am Acad Dermatol. 1999 Jan; 40(1):48-60.J Am Acad Dermatol1999-01-01T00:00:001999Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy.10370786Sarris AH, Kliche KO, Pethambaram P, Preti A, Tucker S, Jackow C, Messina O, Pugh W, Hagemeister FB, McLaughlin P, Rodriguez MA, Romaguera J, Fritsche H, Witzig T, Duvic M, Andreeff M, Cabanillas FAnnals of oncology : official journal of the European Society for Medical OncologyInterleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Ann Oncol. 1999 Apr; 10(4):433-40.Ann Oncol1999-04-01T00:00:001999Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.10674370de Andrade M, Jackow CM, Dahm N, Hordinsky M, Reveille JD, Duvic MThe journal of investigative dermatology. Symposium proceedingsAlopecia areata in families: association with the HLA locus. J Investig Dermatol Symp Proc. 1999 Dec; 4(3):220-3.J Investig Dermatol Symp Proc1999-12-01T00:00:001999Alopecia areata in families: association with the HLA locus.11115156Duvic M, Friedman-Kien AE, Looney DJ, Miles SA, Myskowski PL, Scadden DT, Von Roenn J, Galpin JE, Groopman J, Loewen G, Stevens V, Truglia JA, Yocum RCArchives of dermatologyTopical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. Arch Dermatol. 2000 Dec; 136(12):1461-9.Arch Dermatol2000-12-01T00:00:002000Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.11493100Feasel AM, Donato ML, Duvic MArchives of dermatologyComplete remission of scleromyxedema following autologous stem cell transplantation. Arch Dermatol. 2001 Aug; 137(8):1071-2.Arch Dermatol2001-08-01T00:00:002001Complete remission of scleromyxedema following autologous stem cell transplantation.11783936Breuer-McHam J, Simpson E, Dougherty I, Bonkobara M, Ariizumi K, Lewis DE, Dawson DB, Duvic M, Cruz PDPhotochemistry and photobiologyActivation of HIV in human skin by ultraviolet B radiation and its inhibition by NFkappaB blocking agents. Photochem Photobiol. 2001 Dec; 74(6):805-10.Photochem Photobiol2001-12-01T00:00:002001Activation of HIV in human skin by ultraviolet B radiation and its inhibition by NFkappaB blocking agents.11939819Hoefer HF, Chen SH, Duvic MA, Raimer SSArchives of dermatologyAlopecia, hypohidrosis, and ulcerations in a man: mycosis fungoides. Arch Dermatol. 2002 Apr; 138(4):527-32.Arch Dermatol2002-04-01T00:00:002002Alopecia, hypohidrosis, and ulcerations in a man: mycosis fungoides.12113107Apisarnthanarax N, Duvic MExpert review of anticancer therapyTherapy options in cutaneous T-cell lymphoma. Expert Rev Anticancer Ther. 2001 Oct; 1(3):403-20.Expert Rev Anticancer Ther2001-10-01T00:00:002001Therapy options in cutaneous T-cell lymphoma.12152999Morgan M, Maloney D, Duvic MLeukemia & lymphomaHypomagnesemia and hypocalcemia in mycosis fungoides: a retrospective case series. Leuk Lymphoma. 2002 Jun; 43(6):1297-302.Leuk Lymphoma2002-06-01T00:00:002002Hypomagnesemia and hypocalcemia in mycosis fungoides: a retrospective case series.12592082Krathen RA, Ward S, Duvic MDermatology (Basel, Switzerland)Bexarotene is a new treatment option for lymphomatoid papulosis. Dermatology. 2003; 206(2):142-7.Dermatology2003-01-01T00:00:002003Bexarotene is a new treatment option for lymphomatoid papulosis.12653924Lain T, Talpur R, Duvic MInternational journal of dermatologyLong-term control of mycosis fungoides of the hands with topical bexarotene. Int J Dermatol. 2003 Mar; 42(3):238-41.Int J Dermatol2003-03-01T00:00:002003Long-term control of mycosis fungoides of the hands with topical bexarotene.12734506Weinstein GD, Koo JY, Krueger GG, Lebwohl MG, Lowe NJ, Menter MA, Lew-Kaya DA, Sefton J, Gibson JR, Walker PS, Tazarotene Cream Clinical Study GroupJournal of the American Academy of DermatologyTazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. J Am Acad Dermatol. 2003 May; 48(5):760-7.J Am Acad Dermatol2003-05-01T00:00:002003Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.12833006Duvic M, Apisarnthanarax N, Cohen DS, Smith TL, Ha CS, Kurzrock RJournal of the American Academy of DermatologyAnalysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2003 Jul; 49(1):35-49.J Am Acad Dermatol2003-07-01T00:00:002003Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.12925230Jones D, Duvic MThe Journal of investigative dermatologyThe current state and future of clonality studies in mycosis fungoides. J Invest Dermatol. 2003 Sep; 121(3):ix-x.J Invest Dermatol2003-09-01T00:00:002003The current state and future of clonality studies in mycosis fungoides.12952235Chiao N, Bumgardner A, Duvic MLeukemia & lymphomaClofarabine-induced acral erythema during the treatment of patients with myelodysplasia and acute leukemia: report of two cases. Leuk Lymphoma. 2003 Aug; 44(8):1405-7.Leuk Lymphoma2003-08-01T00:00:002003Clofarabine-induced acral erythema during the treatment of patients with myelodysplasia and acute leukemia: report of two cases.12952756Pinkerton M, Ward S, Duvic MDermatology online journalA perplexing pruritic papular rash. Dermatol Online J. 2003 Aug; 9(3):9.Dermatol Online J2003-08-01T00:00:002003A perplexing pruritic papular rash.14582678Duvic M, Norris D, Christiano A, Hordinsky M, Price VThe journal of investigative dermatology. Symposium proceedingsAlopecia areata registry: an overview. J Investig Dermatol Symp Proc. 2003 Oct; 8(2):219-21.J Investig Dermatol Symp Proc2003-10-01T00:00:002003Alopecia areata registry: an overview.14745875Tsimberidou AM, Giles F, Romaguera J, Duvic M, Kurzrock RCancerActivity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies. Cancer. 2004 Feb 01; 100(3):574-80.Cancer2004-02-01T00:00:002004Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.15073032Lenihan DJ, Alencar AJ, Yang D, Kurzrock R, Keating MJ, Duvic MBloodCardiac toxicity of alemtuzumab in patients with mycosis fungoides/S?zary syndrome. Blood. 2004 Aug 01; 104(3):655-8.Blood2004-04-08T00:00:002004Cardiac toxicity of alemtuzumab in patients with mycosis fungoides/S?zary syndrome.15160932Rubenstein M, Duvic MLeukemia & lymphomaBone marrow transplantation in Jehovah's Witnesses. Leuk Lymphoma. 2004 Mar; 45(3):635-6.Leuk Lymphoma2004-03-01T00:00:002004Bone marrow transplantation in Jehovah's Witnesses.15243507Duvic M, Edelson RJournal of the American Academy of DermatologyCutaneous T-cell lymphoma. J Am Acad Dermatol. 2004 Jul; 51(1 Suppl):S43-5.J Am Acad Dermatol2004-07-01T00:00:002004Cutaneous T-cell lymphoma.15280837Tsimberidou AM, Giles FJ, Duvic M, Kurzrock RJournal of the American Academy of DermatologyPilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas. J Am Acad Dermatol. 2004 Aug; 51(2):200-4.J Am Acad Dermatol2004-08-01T00:00:002004Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas.15289728Hill A, Hanson M, Bogle MA, Duvic MAmerican journal of clinical oncologySevere radiation dermatitis is related to Staphylococcus aureus. Am J Clin Oncol. 2004 Aug; 27(4):361-3.Am J Clin Oncol2004-08-01T00:00:002004Severe radiation dermatitis is related to Staphylococcus aureus.15492257Hazarika P, McCarty MF, Prieto VG, George S, Babu D, Koul D, Bar-Eli M, Duvic MCancer researchUp-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res. 2004 Oct 15; 64(20):7361-9.Cancer Res2004-10-15T00:00:002004Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1.16297208Zhang C, Richon V, Ni X, Talpur R, Duvic MThe Journal of investigative dermatologySelective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. J Invest Dermatol. 2005 Nov; 125(5):1045-52.J Invest Dermatol2005-11-01T00:00:002005Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.16482177The Journal of investigative dermatologyRemembering Irwin Freedberg. J Invest Dermatol. 2006 Mar; 126(3):519-20.J Invest Dermatol2006-03-01T00:00:002006Remembering Irwin Freedberg.16621887Li C, Liu Z, Wang LE, Strom SS, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, Duvic M, Grimm EA, Wei QCarcinogenesisGenetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma. Carcinogenesis. 2006 Sep; 27(9):1894-901.Carcinogenesis2006-04-18T00:00:002006Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma.16960145Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM, Frankel SRBloodPhase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood. 2007 Jan 01; 109(1):31-9.Blood2006-09-07T00:00:002006Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).17014481Zhang C, Duvic MDermatologic therapyTreatment of cutaneous T-cell lymphoma with retinoids. Dermatol Ther. 2006 Sep-Oct; 19(5):264-71.Dermatol Ther2006-09-01T00:00:002006Treatment of cutaneous T-cell lymphoma with retinoids.17052486Duvic M, Sherman ML, Wood GS, Kuzel TM, Olsen E, Foss F, Lalibert? RJ, Ryan JL, Zonno K, Rook AHJournal of the American Academy of DermatologyA phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides. J Am Acad Dermatol. 2006 Nov; 55(5):807-13.J Am Acad Dermatol2006-09-08T00:00:002006A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.17164380Li C, Hu Z, Liu Z, Wang LE, Strom SS, Gershenwald JE, Lee JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, Duvic M, Grimm EA, Wei QCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyPolymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2526-32.Cancer Epidemiol Biomarkers Prev2006-12-01T00:00:002006Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.17224554Lambert TJ, Prieto VG, Duvic MArchives of dermatologyMultiple plaques on the hands and feet. Mycosis fungoides (MF) palmaris et plantaris (MFPP). Arch Dermatol. 2007 Jan; 143(1):109-14.Arch Dermatol2007-01-01T00:00:002007Multiple plaques on the hands and feet. Mycosis fungoides (MF) palmaris et plantaris (MFPP).17236136Martinez-Mir A, Zlotogorski A, Gordon D, Petukhova L, Mo J, Gilliam TC, Londono D, Haynes C, Ott J, Hordinsky M, Nanova K, Norris D, Price V, Duvic M, Christiano AMAmerican journal of human geneticsGenomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet. 2007 Feb; 80(2):316-28.Am J Hum Genet2007-01-05T00:00:002007Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata.17298107Berthelot C, Nash J, Duvic MAmerican journal of clinical dermatologyCoexistent psoriasis and lupus erythematosus treated with alefacept. Am J Clin Dermatol. 2007; 8(1):47-50.Am J Clin Dermatol2007-01-01T00:00:002007Coexistent psoriasis and lupus erythematosus treated with alefacept.17311990Kim YH, Duvic M, Obitz E, Gniadecki R, Iversen L, Osterborg A, Whittaker S, Illidge TM, Schwarz T, Kaufmann R, Cooper K, Knudsen KM, Lisby S, Baadsgaard O, Knox SJBloodClinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Blood. 2007 Jun 01; 109(11):4655-62.Blood2007-02-20T00:00:002007Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma.17328085Li C, Hu Z, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei QCancerPolymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study. Cancer. 2007 Apr 15; 109(8):1570-8.Cancer2007-04-15T00:00:002007Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.17474358Duvic MOncology (Williston Park, N.Y.)Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies. Oncology (Williston Park). 2007 Feb; 21(2 Suppl 1):33-40.Oncology (Williston Park)2007-02-01T00:00:002007Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies.17540844Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S, Wood G, Dummer R, Ranki A, Burg G, Heald P, Pittelkow M, Bernengo MG, Sterry W, Laroche L, Trautinger F, Whittaker S, ISCL/EORTCBloodRevisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007 Sep 15; 110(6):1713-22.Blood2007-05-31T00:00:002007Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).17706321Setyadi HG, Nash JW, Duvic MJournal of the American Academy of DermatologyThe solitary lymphomatous papule, nodule, or tumor. J Am Acad Dermatol. 2007 Dec; 57(6):1072-83.J Am Acad Dermatol2007-08-13T00:00:002007The solitary lymphomatous papule, nodule, or tumor.18039021Vidulich KA, Donley SE, Duvic MAmerican journal of clinical dermatologyMultinodular cutaneous spread in neuroendocrine tumor of the breast : an unusual presentation. Am J Clin Dermatol. 2007; 8(6):379-83.Am J Clin Dermatol2007-01-01T00:00:002007Multinodular cutaneous spread in neuroendocrine tumor of the breast : an unusual presentation.18049450Li C, Chen K, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei QThe Journal of investigative dermatologyPolymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma. J Invest Dermatol. 2008 Jun; 128(6):1585-8.J Invest Dermatol2007-11-29T00:00:002007Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.18329131Rodriguez TA, Duvic M, National Alopecia Areata RegistryJournal of the American Academy of DermatologyOnset of alopecia areata after Epstein-Barr virus infectious mononucleosis. J Am Acad Dermatol. 2008 Jul; 59(1):137-9.J Am Acad Dermatol2008-03-07T00:00:002008Onset of alopecia areata after Epstein-Barr virus infectious mononucleosis.18489053Ahmed AM, Barahmani N, Duvic M, National Alopecia Areata RegistryJournal of the American Academy of DermatologyFamilial alopecia areata and chronic thrombocytopenia. J Am Acad Dermatol. 2008 May; 58(5 Suppl 1):S75-7.J Am Acad Dermatol2008-05-01T00:00:002008Familial alopecia areata and chronic thrombocytopenia.18664158Berthelot C, Rivera A, Duvic MJournal of drugs in dermatology : JDDSkin directed therapy for mycosis fungoides: a review. J Drugs Dermatol. 2008 Jul; 7(7):655-66.J Drugs Dermatol2008-07-01T00:00:002008Skin directed therapy for mycosis fungoides: a review.18717603Duvic MAmerican journal of clinical dermatologyEGFR inhibitor-associated acneiform folliculitis: assessment and management. Am J Clin Dermatol. 2008; 9(5):285-94.Am J Clin Dermatol2008-01-01T00:00:002008EGFR inhibitor-associated acneiform folliculitis: assessment and management.19261011Vidulich KA, Talpur R, Bassett RL, Duvic MInternational journal of dermatologyOverall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma. Int J Dermatol. 2009 Mar; 48(3):243-52.Int J Dermatol2009-03-01T00:00:002009Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.19658449Eubank KV, Nash J, Duvic MAmerican journal of clinical dermatologySweet syndrome associated with celiac disease. Am J Clin Dermatol. 2009; 10(5):343-5.Am J Clin Dermatol2009-01-01T00:00:002009Sweet syndrome associated with celiac disease.19707308Duvic M, Vu JBiologics : targets & therapyUpdate on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat. Biologics. 2007 Dec; 1(4):377-92.Biologics2007-12-01T00:00:002007Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat.19874320Barahmani N, Lopez A, Babu D, Hernandez M, Donley SE, Duvic MClinical and experimental dermatologySerum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy. Clin Exp Dermatol. 2010 Jun; 35(4):409-16.Clin Exp Dermatol2009-10-23T00:00:002009Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy.19909522Mukherjee N, Morrell DS, Duvic M, Stewart PW, Goldsmith LABMC dermatologyAttitudes of dermatologists in the southeastern United States regarding treatment of alopecia areata: a cross-sectional survey study. BMC Dermatol. 2009 Nov 12; 9:11.BMC Dermatol2009-11-12T00:00:002009Attitudes of dermatologists in the southeastern United States regarding treatment of alopecia areata: a cross-sectional survey study.20159328Rodriguez TA, Fernandes KE, Dresser KL, Duvic M, National Alopecia Areata RegistryJournal of the American Academy of DermatologyConcordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol. 2010 Mar; 62(3):525-7.J Am Acad Dermatol2010-03-01T00:00:002010Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors.20213916Talpur R, Cox K, Duvic MExpert opinion on drug metabolism & toxicologyEfficacy and safety of topical tazarotene: a review. Expert Opin Drug Metab Toxicol. 2009 Feb; 5(2):195-210.Expert Opin Drug Metab Toxicol2009-02-01T00:00:002009Efficacy and safety of topical tazarotene: a review.20509718Richmond HM, Duvic M, Macfarlane DFAmerican journal of clinical dermatologyPrimary and metastatic malignant tumors of the scalp: an update. Am J Clin Dermatol. 2010; 11(4):233-46.Am J Clin Dermatol2010-01-01T00:00:002010Primary and metastatic malignant tumors of the scalp: an update.20666189Patel P, Talpur R, Duvic MCutisLangerhans cell histiocytosis arising from a BCC: a case report and review of the literature. Cutis. 2010 Jun; 85(6):295-300.Cutis2010-06-01T00:00:002010Langerhans cell histiocytosis arising from a BCC: a case report and review of the literature.20669795Duvic MOncology (Williston Park, N.Y.)Improved understanding of peripheral T-cell lymphomas. Oncology (Williston Park). 2010 Jun; 24(7):587, 592-3.Oncology (Williston Park)2010-06-01T00:00:002010Improved understanding of peripheral T-cell lymphomas.20889234Rook AH, Wood GS, Duvic M, Vonderheid EC, Tobia A, Cabana BJournal of the American Academy of DermatologyA phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis. J Am Acad Dermatol. 2010 Dec; 63(6):984-90.J Am Acad Dermatol2010-12-01T00:00:002010A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis.21115882Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, Bailey H, Kang S, Linden KG, Heffernan M, Duvic M, Richmond E, Elewski BE, Umar A, Bell W, Gordon GBJournal of the National Cancer InstituteChemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst. 2010 Dec 15; 102(24):1835-44.J Natl Cancer Inst2010-11-29T00:00:002010Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.21575927Talpur R, Demierre MF, Geskin L, Baron E, Pugliese S, Eubank K, Zic JA, Miller DR, Tharp M, Bohjanen K, Duvic MClinical lymphoma, myeloma & leukemiaMulticenter photopheresis intervention trial in early-stage mycosis fungoides. Clin Lymphoma Myeloma Leuk. 2011 Apr; 11(2):219-27.Clin Lymphoma Myeloma Leuk2011-04-08T00:00:002011Multicenter photopheresis intervention trial in early-stage mycosis fungoides.21726213Holcomb M, Duvic M, Cutlan JInternational journal of dermatologyErythema gyratum repens-like eruptions with large cell transformation in a patient with mycosis fungoides. Int J Dermatol. 2012 Oct; 51(10):1231-3.Int J Dermatol2011-07-05T00:00:002011Erythema gyratum repens-like eruptions with large cell transformation in a patient with mycosis fungoides.21841159Kempf W, Pfaltz K, Vermeer MH, Cozzio A, Ortiz-Romero PL, Bagot M, Olsen E, Kim YH, Dummer R, Pimpinelli N, Whittaker S, Hodak E, Cerroni L, Berti E, Horwitz S, Prince HM, Guitart J, Estrach T, Sanches JA, Duvic M, Ranki A, Dreno B, Ostheeren-Michaelis S, Knobler R, Wood G, Willemze RBloodEORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood. 2011 Oct 13; 118(15):4024-35.Blood2011-08-12T00:00:002011EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.22198560Liu H, Wei Q, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wang LEMelanoma researchInfluence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression. Melanoma Res. 2012 Apr; 22(2):169-75.Melanoma Res2012-04-01T00:00:002012Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.22205203Falchook GS, Duvic M, Hong DS, Wheler J, Naing A, Lim J, Kurzrock RCancer chemotherapy and pharmacologyAge-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies. Cancer Chemother Pharmacol. 2012 May; 69(5):1117-26.Cancer Chemother Pharmacol2011-12-29T00:00:002011Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies.22285675Prince HM, Duvic M, Martin A, Sterry W, Assaf C, Straus DJJournal of the American Academy of DermatologyIncidence of spontaneous remission in patients with CD25-positive mycosis fungoides/S?zary syndrome receiving placebo. J Am Acad Dermatol. 2012 Nov; 67(5):867-75.J Am Acad Dermatol2012-01-30T00:00:002012Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/S?zary syndrome receiving placebo.22515221Goswami M, Duvic M, Dougherty A, Ni XJournal of cutaneous pathologyIncreased Twist expression in advanced stage of mycosis fungoides and S?zary syndrome. J Cutan Pathol. 2012 May; 39(5):500-7.J Cutan Pathol2012-05-01T00:00:002012Increased Twist expression in advanced stage of mycosis fungoides and S?zary syndrome.22747928Alexander LJ, Paravar T, Duvic M, Prieto V, Hymes SRDermatology online journalAnnular plaques: An unusual manifestation of graft-versus-host disease. Dermatol Online J. 2012 Jun 15; 18(6):4.Dermatol Online J2012-06-15T00:00:002012Annular plaques: An unusual manifestation of graft-versus-host disease.22809282Nicholson KM, Patel KP, Duvic M, Prieto VG, Tetzlaff MTJournal of cutaneous pathologyBi-clonal, multifocal primary cutaneous marginal zone B-cell lymphoma: report of a case and review of the literature. J Cutan Pathol. 2012 Sep; 39(9):866-71.J Cutan Pathol2012-07-19T00:00:002012Bi-clonal, multifocal primary cutaneous marginal zone B-cell lymphoma: report of a case and review of the literature.22839723Kim YH, Demierre MF, Kim EJ, Lerner A, Rook AH, Duvic M, Robak T, Samtsov A, McCulloch W, Chen SC, Waksman J, Nichols J, Whittaker SLeukemia & lymphomaClinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin. Leuk Lymphoma. 2013 Feb; 54(2):284-9.Leuk Lymphoma2012-08-17T00:00:002012Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin.22971190Knobler R, Duvic M, Querfeld C, Straus D, Horwitz S, Zain J, Foss F, Kuzel T, Campbell K, Geskin LPhotodermatology, photoimmunology & photomedicineLong-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis. Photodermatol Photoimmunol Photomed. 2012 Oct; 28(5):250-7.Photodermatol Photoimmunol Photomed2012-10-01T00:00:002012Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis.22980272Paul LJ, Duvic MJournal of the American Academy of DermatologyMycosis fungoides following skin trauma. J Am Acad Dermatol. 2012 Oct; 67(4):e148.J Am Acad Dermatol2012-10-01T00:00:002012Mycosis fungoides following skin trauma.22981498Duvic M, Dummer R, Becker JC, Poulalhon N, Ortiz Romero P, Grazia Bernengo M, Lebb? C, Assaf C, Squier M, Williams D, Marshood M, Tai F, Prince HMEuropean journal of cancer (Oxford, England : 1990)Panobinostat activity in both bexarotene-exposed and -na?ve patients with refractory cutaneous T-cell lymphoma: results of a phase II trial. Eur J Cancer. 2013 Jan; 49(2):386-94.Eur J Cancer2012-09-13T00:00:002012Panobinostat activity in both bexarotene-exposed and -na?ve patients with refractory cutaneous T-cell lymphoma: results of a phase II trial.23294327Kim S, Diaz LZ, Duvic MLeukemia & lymphomaPrimary cutaneous follicle center lymphoma following deep brain stimulation implants. Leuk Lymphoma. 2013 Aug; 54(8):1806-7.Leuk Lymphoma2013-03-13T00:00:002013Primary cutaneous follicle center lymphoma following deep brain stimulation implants.23519332Shiue LH, Alousi AM, Wei C, Hosing CM, Duvic M, Ni XThe Journal of investigative dermatologyAugmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease. J Invest Dermatol. 2013 Aug; 133(8):2098-100.J Invest Dermatol2013-03-21T00:00:002013Augmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease.23770157Duvic M, Geskin L, Prince HMClinical lymphoma, myeloma & leukemiaDuration of response in cutaneous T-cell lymphoma patients treated with denileukin diftitox: results from 3 phase III studies. Clin Lymphoma Myeloma Leuk. 2013 Aug; 13(4):377-84.Clin Lymphoma Myeloma Leuk2013-06-14T00:00:002013Duration of response in cutaneous T-cell lymphoma patients treated with denileukin diftitox: results from 3 phase III studies.24442249Nadeem S, Hymes S, Kebriaei P, Abruzzo L, Curry JL, Duvic MBone marrow transplantationAlopecia areata after HLA-identical BMT from an affected, sibling donor. Bone Marrow Transplant. 2014 Apr; 49(4):592-4.Bone Marrow Transplant2014-01-20T00:00:002014Alopecia areata after HLA-identical BMT from an affected, sibling donor.24919716Applebaum DS, Daulat S, Duvic MJAMA dermatologyMultiple skin-colored papules with diffuse sclerosis. JAMA Dermatol. 2014 Aug; 150(8):893-4.JAMA Dermatol2014-08-01T00:00:002014Multiple skin-colored papules with diffuse sclerosis.Authorship 2631625Authorship 2632803Authorship 2633962Authorship 2637175Authorship 2637235Authorship 2637507Authorship 2644121Authorship 26443112Authorship 2646671Authorship 2646923Authorship 2647205Authorship 2647744Authorship 2651713Authorship 2652763Authorship 2653495Authorship 2655832Authorship 2656291Authorship 2661939Authorship 2665082Authorship 2666127Authorship 2668183Authorship 2669615Authorship 2670252Authorship 2674344Authorship 26748212Authorship 2678397Authorship 2680561Authorship 2693293Authorship 2695597Authorship 2695862Authorship 2699392Authorship 2700071Authorship 27047610Authorship 2708695Authorship 27203513Authorship 2722811Authorship 27234121975177Goldstein R, Duvic M, Targoff IN, Reichlin M, McMenemy AM, Reveille JD, Warner NB, Pollack MS, Arnett FCArthritis and rheumatismHLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum. 1990 Aug; 33(8):1240-8.Arthritis Rheum1990-08-01T00:00:001990HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis.2536762Lowe L, Hebert AA, Duvic MJournal of the American Academy of DermatologyGianotti-Crosti syndrome associated with Epstein-Barr virus infection. J Am Acad Dermatol. 1989 Feb; 20(2 Pt 2):336-8.J Am Acad Dermatol1989-02-01T00:00:001989Gianotti-Crosti syndrome associated with Epstein-Barr virus infection.3260100Goldstein R, Arnett FC, McLean RH, Bias WB, Duvic MArthritis and rheumatismMolecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus. Arthritis Rheum. 1988 Jun; 31(6):736-44.Arthritis Rheum1988-06-01T00:00:001988Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus.7615989Duvic MThe Journal of investigative dermatologyHuman immunodeficiency virus and the skin: selected controversies. J Invest Dermatol. 1995 Jul; 105(1 Suppl):117S-121S.J Invest Dermatol1995-07-01T00:00:001995Human immunodeficiency virus and the skin: selected controversies.8006427Krueger GG, Duvic MThe Journal of investigative dermatologyEpidemiology of psoriasis: clinical issues. J Invest Dermatol. 1994 Jun; 102(6):14S-18S.J Invest Dermatol1994-06-01T00:00:001994Epidemiology of psoriasis: clinical issues.8601743Wakem P, Ikeda S, Haake A, Polakowska R, Ewing N, Sarret Y, Duvic M, Berg D, Bassett A, Kennedy JL, Tuskis A, Epstein EH, Goldsmith LAThe Journal of investigative dermatologyLocalization of the Darier disease gene to a 2-cM portion of 12q23-24.1. J Invest Dermatol. 1996 Feb; 106(2):365-7.J Invest Dermatol1996-02-01T00:00:001996Localization of the Darier disease gene to a 2-cM portion of 12q23-24.1.8682962Boyd AS, Annarella M, Rapini RP, Adler-Storthz K, Duvic MJournal of the American Academy of DermatologyFalse-positive polymerase chain reaction results for human papillomavirus in lichen planus. Potential laboratory pitfalls of this procedure. J Am Acad Dermatol. 1996 Jul; 35(1):42-6.J Am Acad Dermatol1996-07-01T00:00:001996False-positive polymerase chain reaction results for human papillomavirus in lichen planus. Potential laboratory pitfalls of this procedure.8695829Asadullah K, Haeussler A, Sterry W, D?cke WD, Volk HDBloodInterferon gamma and tumor necrosis factor alpha mRNA expression in mycosis fungoides progression. Blood. 1996 Jul 15; 88(2):757-8.Blood1996-07-15T00:00:001996Interferon gamma and tumor necrosis factor alpha mRNA expression in mycosis fungoides progression.9777790Duvic M, Asano AT, Hager C, Mays SJournal of the American Academy of DermatologyThe pathogenesis of psoriasis and the mechanism of action of tazarotene. J Am Acad Dermatol. 1998 Oct; 39(4 Pt 2):S129-33.J Am Acad Dermatol1998-10-01T00:00:001998The pathogenesis of psoriasis and the mechanism of action of tazarotene.9815669Sarris AH, Daliani D, Ulmer R, Crow M, Broxmeyer HE, Reiss M, Karasavvas N, Zelenetz AD, Pugh W, Cabanillas F, Deisseroth AB, Duvic MClinical cancer research : an official journal of the American Association for Cancer ResearchInterferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas. Clin Cancer Res. 1997 Feb; 3(2):169-77.Clin Cancer Res1997-02-01T00:00:001997Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas.10506607Kurzrock R, Pilat S, Duvic MJournal of clinical oncology : official journal of the American Society of Clinical OncologyPentostatin therapy of T-cell lymphomas with cutaneous manifestations. J Clin Oncol. 1999 Oct; 17(10):3117-21.J Clin Oncol1999-10-01T00:00:001999Pentostatin therapy of T-cell lymphomas with cutaneous manifestations.10626120Duvic M, Cather JCDermatologic clinicsEmerging new therapies for cutaneous T-cell lymphoma. Dermatol Clin. 2000 Jan; 18(1):147-56.Dermatol Clin2000-01-01T00:00:002000Emerging new therapies for cutaneous T-cell lymphoma.10906652Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RMJournal of the American Academy of DermatologyTwo considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol. 2000 Aug; 43(2 Pt 1):281-5.J Am Acad Dermatol2000-08-01T00:00:002000Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?11328624Duvic MDermatology online journalCurrent treatment of Cutaneous T-Cell Lymphoma. Dermatol Online J. 2001 Feb; 7(1):3.Dermatol Online J2001-02-01T00:00:002001Current treatment of Cutaneous T-Cell Lymphoma.11392886Jones D, Dang NH, Duvic M, Washington LT, Huh YOAmerican journal of clinical pathologyAbsence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol. 2001 Jun; 115(6):885-92.Am J Clin Pathol2001-06-01T00:00:002001Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood.11594571Rook AH, Zaki MH, Wysocka M, Wood GS, Duvic M, Showe LC, Foss F, Shapiro M, Kuzel TM, Olsen EA, Vonderheid EC, Laliberte R, Sherman MLAnnals of the New York Academy of SciencesThe role for interleukin-12 therapy of cutaneous T cell lymphoma. Ann N Y Acad Sci. 2001 Sep; 941:177-84.Ann N Y Acad Sci2001-09-01T00:00:002001The role for interleukin-12 therapy of cutaneous T cell lymphoma.11841632Hwong H, Jones D, Prieto VG, Schulz C, Duvic MPediatric dermatologyPersistent atypical lymphocytic hyperplasia following tick bite in a child: report of a case and review of the literature. Pediatr Dermatol. 2001 Nov-Dec; 18(6):481-4.Pediatr Dermatol2001-11-01T00:00:002001Persistent atypical lymphocytic hyperplasia following tick bite in a child: report of a case and review of the literature.11902983Breneman D, Duvic M, Kuzel T, Yocum R, Truglia J, Stevens VJArchives of dermatologyPhase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma. Arch Dermatol. 2002 Mar; 138(3):325-32.Arch Dermatol2002-03-01T00:00:002002Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma.12065565Sarris AH, Phan A, Duvic M, Romaguera J, McLaughlin P, Mesina O, King K, Medeiros LJ, Rassidakis GZ, Samuels B, Cabanillas FJournal of clinical oncology : official journal of the American Society of Clinical OncologyTrimetrexate in relapsed T-cell lymphoma with skin involvement. J Clin Oncol. 2002 Jun 15; 20(12):2876-80.J Clin Oncol2002-06-15T00:00:002002Trimetrexate in relapsed T-cell lymphoma with skin involvement.12665841Apisarnthanarax N, Donato M, K?rbling M, Couriel D, Gajewski J, Giralt S, Khouri I, Hosing C, Champlin R, Duvic M, Anderlini PBone marrow transplantationExtracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant. 2003 Mar; 31(6):459-65.Bone Marrow Transplant2003-03-01T00:00:002003Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.14710892Kempf W, Kettelhack N, Duvic M, Burg GHematology/oncology clinics of North AmericaTopical and systemic retinoid therapy for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 2003 Dec; 17(6):1405-19.Hematol Oncol Clin North Am2003-12-01T00:00:002003Topical and systemic retinoid therapy for cutaneous T-cell lymphoma.15636695Perna AG, Jones DM, Duvic MClinical lymphomaLymphomatoid papulosis from childhood with anaplastic large-cell lymphoma of the small bowel. Clin Lymphoma. 2004 Dec; 5(3):190-3.Clin Lymphoma2004-12-01T00:00:002004Lymphomatoid papulosis from childhood with anaplastic large-cell lymphoma of the small bowel.15816832Ni X, Zhang C, Talpur R, Duvic MThe Journal of investigative dermatologyResistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas. J Invest Dermatol. 2005 Apr; 124(4):741-50.J Invest Dermatol2005-04-01T00:00:002005Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas.16112357Bogle MA, Riddle CC, Triana EM, Jones D, Duvic MJournal of the American Academy of DermatologyPrimary cutaneous B-cell lymphoma. J Am Acad Dermatol. 2005 Sep; 53(3):479-84.J Am Acad Dermatol2005-09-01T00:00:002005Primary cutaneous B-cell lymphoma.16410787Talpur R, Jones DM, Alencar AJ, Apisarnthanarax N, Herne KL, Yang Y, Duvic MThe Journal of investigative dermatologyCD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma. J Invest Dermatol. 2006 Mar; 126(3):575-83.J Invest Dermatol2006-03-01T00:00:002006CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma.16538172Li C, Larson D, Zhang Z, Liu Z, Strom SS, Gershenwald JE, Prieto VG, Lee JE, Ross MI, Mansfield PF, Cormier JN, Duvic M, Grimm EA, Wei QPharmacogenetics and genomicsPolymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics. 2006 Apr; 16(4):253-63.Pharmacogenet Genomics2006-04-01T00:00:002006Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.17366595Straus DJ, Duvic M, Kuzel T, Horwitz S, Demierre MF, Myskowski P, Steckel SCancerResults of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma. Cancer. 2007 May 01; 109(9):1799-803.Cancer2007-05-01T00:00:002007Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma.17594194Duvic M, Vu JExpert opinion on investigational drugsVorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma. Expert Opin Investig Drugs. 2007 Jul; 16(7):1111-20.Expert Opin Investig Drugs2007-07-01T00:00:002007Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma.18183598Li C, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei QInternational journal of cancerHaplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study. Int J Cancer. 2008 May 01; 122(9):2077-84.Int J Cancer2008-05-01T00:00:002008Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study.20596022Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV, Meyer KC, Paus R, Jahoda CA, Amos CI, Gregersen PK, Christiano AMNatureGenome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010 Jul 01; 466(7302):113-7.Nature2010-07-01T00:00:002010Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.20655738Wang LE, Huang YJ, Yin M, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wei QEuropean journal of cancer (Oxford, England : 1990)Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma. Eur J Cancer. 2011 Jan; 47(1):107-15.Eur J Cancer2010-07-23T00:00:002010Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.21252093Chung JS, Shiue LH, Duvic M, Pandya A, Cruz PD, Ariizumi KBloodS?zary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surface. Blood. 2011 Mar 24; 117(12):3382-90.Blood2011-01-20T00:00:002011S?zary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surface.21674574Foss F, Duvic M, Olsen EAAmerican journal of hematologyPredictors of complete responses with denileukin diftitox in cutaneous T-cell lymphoma. Am J Hematol. 2011 Jul; 86(7):627-30.Am J Hematol2011-06-14T00:00:002011Predictors of complete responses with denileukin diftitox in cutaneous T-cell lymphoma.21850406Duvic MCurrent hematologic malignancy reportsCD30+ neoplasms of the skin. Curr Hematol Malig Rep. 2011 Dec; 6(4):245-50.Curr Hematol Malig Rep2011-12-01T00:00:002011CD30+ neoplasms of the skin.21868127Bichakjian CK, Halpern AC, Johnson TM, Foote Hood A, Grichnik JM, Swetter SM, Tsao H, Barbosa VH, Chuang TY, Duvic M, Ho VC, Sober AJ, Beutner KR, Bhushan R, Smith Begolka W, American Academy of DermatologyJournal of the American Academy of DermatologyGuidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol. 2011 Nov; 65(5):1032-47.J Am Acad Dermatol2011-08-25T00:00:002011Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology.22878367Curry JL, Falchook GS, Hwu WJ, Torres-Cabala CA, Duvic M, Tetzlaff MT, Prieto VGThe American Journal of dermatopathologyChanges in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor. Am J Dermatopathol. 2013 Feb; 35(1):125-8.Am J Dermatopathol2013-02-01T00:00:002013Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor.24170769Vin H, Ching G, Ojeda SS, Adelmann CH, Chitsazzadeh V, Dwyer DW, Ma H, Ehrenreiter K, Baccarini M, Ruggieri R, Curry JL, Ciurea AM, Duvic M, Busaidy NL, Tannir NM, Tsai KYMolecular cancer therapeuticsSorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK. Mol Cancer Ther. 2014 Jan; 13(1):221-9.Mol Cancer Ther2013-10-29T00:00:002013Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK.Authorship 2727171Authorship 2730432Authorship 2731545Authorship 2739406Authorship 2740231Authorship 27442718Authorship 2751474Authorship 2751525Authorship 2757011Authorship 2757397Authorship 2758334Authorship 2762054Authorship 27640710Authorship 276421Authorship 2766061Authorship 2768423Authorship 2771193Authorship 2775034Authorship 27769931873930Duvic MDermatologic clinicsPapulosquamous disorders associated with human immunodeficiency virus infection. Dermatol Clin. 1991 Jul; 9(3):523-30.Dermatol Clin1991-07-01T00:00:001991Papulosquamous disorders associated with human immunodeficiency virus infection.2229492Blick M, Bresser J, Lepe-Zuniga JL, Goodacre A, Luethke D, Holder WR, Duvic MJournal of the American Academy of DermatologyIdentification of human immunodeficiency virus hybridizing sequences in the peripheral blood of a patient with systemic lupus erythematosus. J Am Acad Dermatol. 1990 Oct; 23(4 Pt 1):641-5.J Am Acad Dermatol1990-10-01T00:00:001990Identification of human immunodeficiency virus hybridizing sequences in the peripheral blood of a patient with systemic lupus erythematosus.6367665Surwit RS, Gilgor RS, Allen LM, Duvic MArchives of dermatologyA double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma. Arch Dermatol. 1984 Mar; 120(3):329-31.Arch Dermatol1984-03-01T00:00:001984A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.7655806Sterenborg NJ, Thomsen S, Jacques SL, Duvic M, Motamedi M, Wagner RFDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]In vivo fluorescence spectroscopy and imaging of human skin tumors. Dermatol Surg. 1995 Sep; 21(9):821-2.Dermatol Surg1995-09-01T00:00:001995In vivo fluorescence spectroscopy and imaging of human skin tumors.9049966Sarris AH, Daliani D, Ulmer R, Crow M, Broxmeyer HE, Pugh W, Reiss M, Cabanillas F, Deisseroth AB, Duvic MLeukemia & lymphomaInterferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas. Leuk Lymphoma. 1996 Dec; 24(1-2):103-10.Leuk Lymphoma1996-12-01T00:00:001996Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas.9207487Musette P, Bachelez HBloodCutaneous T-cell lymphomas and bacterial superantigens. Blood. 1997 Jul 01; 90(1):472-3.Blood1997-07-01T00:00:001997Cutaneous T-cell lymphomas and bacterial superantigens.9270552Duvic M, Nagpal S, Asano AT, Chandraratna RAJournal of the American Academy of DermatologyMolecular mechanisms of tazarotene action in psoriasis. J Am Acad Dermatol. 1997 Aug; 37(2 Pt 3):S18-24.J Am Acad Dermatol1997-08-01T00:00:001997Molecular mechanisms of tazarotene action in psoriasis.10626101Cather JC, Nelson BR, Duvic MCutisMalignant melanoma--clinical diagnostic techniques. Cutis. 1999 Dec; 64(6):379-88.Cutis1999-12-01T00:00:001999Malignant melanoma--clinical diagnostic techniques.11756953Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L, Olsen E, Pittelkow M, Russell-Jones R, Takigawa M, Willemze R, ISCLJournal of the American Academy of DermatologyUpdate on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol. 2002 Jan; 46(1):95-106.J Am Acad Dermatol2002-01-01T00:00:002002Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.12708999Pielop JA, Brownell I, Duvic MInternational journal of dermatologyMycosis fungoides associated with malignant melanoma and dysplastic nevus syndrome. Int J Dermatol. 2003 Feb; 42(2):116-22.Int J Dermatol2003-02-01T00:00:002003Mycosis fungoides associated with malignant melanoma and dysplastic nevus syndrome.15044256Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones DBloodA systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. 2004 Jul 15; 104(2):328-35.Blood2004-03-25T00:00:002004A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories.15989518Duvic MExpert opinion on investigational drugsTazarotene: a review of its pharmacological profile and potential for clinical use in psoriasis. Expert Opin Investig Drugs. 1997 Oct; 6(10):1537-51.Expert Opin Investig Drugs1997-10-01T00:00:001997Tazarotene: a review of its pharmacological profile and potential for clinical use in psoriasis.16417220Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic MThe Journal of investigative dermatologyMajor histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata. J Invest Dermatol. 2006 Jan; 126(1):74-8.J Invest Dermatol2006-01-01T00:00:002006Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata.16796781Talpur R, Duvic MClinical lymphoma & myelomaTreatment of mycosis fungoides with denileukin diftitox and oral bexarotene. Clin Lymphoma Myeloma. 2006 May; 6(6):488-92.Clin Lymphoma Myeloma2006-05-01T00:00:002006Treatment of mycosis fungoides with denileukin diftitox and oral bexarotene.19951879Duvic M, Olsen EA, Breneman D, Pacheco TR, Parker S, Vonderheid EC, Abuav R, Ricker JL, Rizvi S, Chen C, Boileau K, Gunchenko A, Sanz-Rodriguez C, Geskin LJClinical lymphoma & myelomaEvaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma. Clin Lymphoma Myeloma. 2009 Dec; 9(6):412-6.Clin Lymphoma Myeloma2009-12-01T00:00:002009Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma.20393484Zhang C, Li B, Zhang X, Hazarika P, Aggarwal BB, Duvic MThe Journal of investigative dermatologyCurcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling. J Invest Dermatol. 2010 Aug; 130(8):2110-9.J Invest Dermatol2010-04-15T00:00:002010Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling.21145619Olsen EA, Rook AH, Zic J, Kim Y, Porcu P, Querfeld C, Wood G, Demierre MF, Pittelkow M, Wilson LD, Pinter-Brown L, Advani R, Parker S, Kim EJ, Junkins-Hopkins JM, Foss F, Cacchio P, Duvic MJournal of the American Academy of DermatologyS?zary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J Am Acad Dermatol. 2011 Feb; 64(2):352-404.J Am Acad Dermatol2010-12-09T00:00:002010S?zary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).24335103Querfeld C, Rosen ST, Guitart J, Duvic M, Kim YH, Dusza SW, Kuzel TMBloodResults of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and S?zary syndrome. Blood. 2014 Feb 20; 123(8):1159-66.Blood2013-12-11T00:00:002013Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and S?zary syndrome.24372055Pattanaprichakul P, Tetzlaff MT, Lapolla WJ, Torres-Cabala CA, Duvic M, Prieto VG, Tsai KY, Curry JLJournal of cutaneous pathologySweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma. J Cutan Pathol. 2014 Mar; 41(3):326-8.J Cutan Pathol2013-12-24T00:00:002013Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma.Authorship 27889877908683Duvic M, Nelson DC, Annarella M, Cho M, Esgleyes-Ribot T, Remenyik E, Ulmer R, Rapini RP, Sacks PG, Clayman GLThe Journal of investigative dermatologyKeratinocyte transglutaminase expression varies in squamous cell carcinomas. J Invest Dermatol. 1994 Apr; 102(4):462-9.J Invest Dermatol1994-04-01T00:00:001994Keratinocyte transglutaminase expression varies in squamous cell carcinomas.7557989Cho YJ, Chema D, Moskow JJ, Cho M, Schroeder WT, Overbeek P, Buchberg AM, Duvic MGenomicsEpidermal surface antigen (MS17S1) is highly conserved between mouse and human. Genomics. 1995 May 20; 27(2):251-8.Genomics1995-05-20T00:00:001995Epidermal surface antigen (MS17S1) is highly conserved between mouse and human.1351505Schroeder WT, Thacher SM, Stewart-Galetka S, Annarella M, Chema D, Siciliano MJ, Davies PJ, Tang HY, Sowa BA, Duvic MThe Journal of investigative dermatologyType I keratinocyte transglutaminase: expression in human skin and psoriasis. J Invest Dermatol. 1992 Jul; 99(1):27-34.J Invest Dermatol1992-07-01T00:00:001992Type I keratinocyte transglutaminase: expression in human skin and psoriasis.Authorship 2841051Authorship 28575914Authorship 28806620Authorship 2882973Authorship 2886884Authorship 2890355Authorship 2900853Authorship 2903411Authorship 2910933Authorship 2911264Authorship 2912554Authorship 2913896Authorship 2924709Authorship 2925445Authorship 2926145Authorship 2929093Authorship 2930946Authorship 29314910Authorship 2940931Authorship 2941858Authorship 2941984Authorship 29458611Authorship 2949505Authorship 29518010Authorship 2960046Authorship 2960645Authorship 2960975Authorship 2972831Authorship 29923464Authorship 3007691Authorship 3010285Authorship 3012984Authorship 3016161Authorship 30196216Authorship 3025335Authorship 3058378Authorship 313218414558406Krejci-Manwaring JM, Bogle MA, Diwan HA, Duvic MAJournal of drugs in dermatology : JDDMorbilliform drug reaction with histologic features of pustular dermatosis associated with bryostatin-1. J Drugs Dermatol. 2003 Oct; 2(5):557-61.J Drugs Dermatol2003-10-01T00:00:002003Morbilliform drug reaction with histologic features of pustular dermatosis associated with bryostatin-1.20826403Duvic MClinical lymphoma, myeloma & leukemiaRational clinical trial design in cutaneous lymphoma. Clin Lymphoma Myeloma Leuk. 2010 Sep; 10 Suppl 2:S80-3.Clin Lymphoma Myeloma Leuk2010-09-01T00:00:002010Rational clinical trial design in cutaneous lymphoma.22394596Horwitz SM, Kim YH, Foss F, Zain JM, Myskowski PL, Lechowicz MJ, Fisher DC, Shustov AR, Bartlett NL, Delioukina ML, Koutsoukos T, Saunders ME, O'Connor OA, Duvic MBloodIdentification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma. Blood. 2012 May 03; 119(18):4115-22.Blood2012-03-06T00:00:002012Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.24192036Vin H, Ojeda SS, Ching G, Leung ML, Chitsazzadeh V, Dwyer DW, Adelmann CH, Restrepo M, Richards KN, Stewart LR, Du L, Ferguson SB, Chakravarti D, Ehrenreiter K, Baccarini M, Ruggieri R, Curry JL, Kim KB, Ciurea AM, Duvic M, Prieto VG, Ullrich SE, Dalby KN, Flores ER, Tsai KYeLifeBRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling. Elife. 2013 Nov 05; 2:e00969.Elife2013-11-05T00:00:002013BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling.24313830Singh L, Boulavsky JL, Duvic MLeukemia & lymphomaConcurrent chronic lymphocytic leukemia and cutaneous T cell lymphoma: a case series. Leuk Lymphoma. 2014 Sep; 55(9):2192-5.Leuk Lymphoma2014-02-06T00:00:002014Concurrent chronic lymphocytic leukemia and cutaneous T cell lymphoma: a case series.24586226Dreno B, Urosevic-Maiwald M, Kim Y, Guitart J, Duvic M, Dereure O, Khammari A, Knol AC, Derbij A, Lusky M, Didillon I, Santoni AM, Acres B, Bataille V, Chenard MP, Bleuzen P, Limacher JM, Dummer RPloS oneTG1042 (Adenovirus-interferon-?) in primary cutaneous B-cell lymphomas: a phase II clinical trial. PLoS One. 2014; 9(2):e83670.PLoS One2014-02-24T00:00:002014TG1042 (Adenovirus-interferon-?) in primary cutaneous B-cell lymphomas: a phase II clinical trial.24589156Talpur R, Thompson A, Gangar P, Duvic MClinical lymphoma, myeloma & leukemiaPralatrexate alone or in combination with bexarotene: long-term tolerability in relapsed/refractory mycosis fungoides. Clin Lymphoma Myeloma Leuk. 2014 Aug; 14(4):297-304.Clin Lymphoma Myeloma Leuk2014-02-04T00:00:002014Pralatrexate alone or in combination with bexarotene: long-term tolerability in relapsed/refractory mycosis fungoides.24934807Kyvernitakis A, Duvic M, Mahale P, Torres HAAmerican journal of clinical dermatologyInterferon-based treatment for patients with mycosis fungoides and hepatitis C virus infection: a case series. Am J Clin Dermatol. 2014 Oct; 15(5):451-6.Am J Clin Dermatol2014-10-01T00:00:002014Interferon-based treatment for patients with mycosis fungoides and hepatitis C virus infection: a case series.24950418Curry JL, Tetzlaff MT, Nicholson K, Duvic M, Kim KB, Tsai KY, Hwu WJ, Hong DS, Prieto VG, Torres-Cabala CAThe American Journal of dermatopathologyHistological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy. Am J Dermatopathol. 2014 Jul; 36(7):557-61.Am J Dermatopathol2014-07-01T00:00:002014Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy.25068889Talpur R, Venkatarajan S, Duvic MExpert review of clinical pharmacologyMechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma. Expert Rev Clin Pharmacol. 2014 Sep; 7(5):591-7.Expert Rev Clin Pharmacol2014-07-28T00:00:002014Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.25088535Vin H, Talpur R, Tetzlaff MT, Duvic MClinical lymphoma, myeloma & leukemiaT-cell receptor-? in gamma-delta phenotype cutaneous T-cell lymphoma can be accompanied by atypical expression of CD30, CD4, or TCR?F1 and an indolent clinical course. Clin Lymphoma Myeloma Leuk. 2014 Dec; 14(6):e195-200.Clin Lymphoma Myeloma Leuk2014-06-23T00:00:002014T-cell receptor-? in gamma-delta phenotype cutaneous T-cell lymphoma can be accompanied by atypical expression of CD30, CD4, or TCR?F1 and an indolent clinical course.25148274Bunata K, Jahan-Tigh RR, Curry J, Duvic MDermatology online journalA verrucous presentation of mycosis fungoides. Dermatol Online J. 2014 Aug 17; 20(8).Dermatol Online J2014-08-17T00:00:002014A verrucous presentation of mycosis fungoides.25264240Boulos S, Vaid R, Aladily TN, Ivan DS, Talpur R, Duvic MJournal of the American Academy of DermatologyClinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients. J Am Acad Dermatol. 2014 Dec; 71(6):1117-26.J Am Acad Dermatol2014-09-26T00:00:002014Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.25404094Foss F, Advani R, Duvic M, Hymes KB, Intragumtornchai T, Lekhakula A, Shpilberg O, Lerner A, Belt RJ, Jacobsen ED, Laurent G, Ben-Yehuda D, Beylot-Barry M, Hillen U, Knoblauch P, Bhat G, Chawla S, Allen LF, Pohlman BBritish journal of haematologyA Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma. Br J Haematol. 2015 Mar; 168(6):811-9.Br J Haematol2014-11-17T00:00:002014A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma.25442486Talpur R, Cox KM, Hu M, Geddes ER, Parker MK, Yang BY, Armstrong PA, Liu P, Duvic MClinical lymphoma, myeloma & leukemiaVitamin D deficiency in mycosis fungoides and S?zary syndrome patients is similar to other cancer patients. Clin Lymphoma Myeloma Leuk. 2014 Dec; 14(6):518-24.Clin Lymphoma Myeloma Leuk2014-12-01T00:00:002014Vitamin D deficiency in mycosis fungoides and S?zary syndrome patients is similar to other cancer patients.25458083Polansky M, Talpur R, Daulat S, Hosing C, Dabaja B, Duvic MClinical lymphoma, myeloma & leukemiaLong-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With S?zary Syndrome. Clin Lymphoma Myeloma Leuk. 2015 May; 15(5):e83-93.Clin Lymphoma Myeloma Leuk2014-10-05T00:00:002014Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With S?zary Syndrome.25462188Kash N, Vin H, Danialan R, Prieto VG, Duvic MInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious DiseasesStenotrophomonas maltophilia with histopathological features mimicking cutaneous gamma/delta T-cell lymphoma. Int J Infect Dis. 2015 Jan; 30:7-9.Int J Infect Dis2014-11-13T00:00:002014Stenotrophomonas maltophilia with histopathological features mimicking cutaneous gamma/delta T-cell lymphoma.25476993Hoppe RT, Harrison C, Tavallaee M, Bashey S, Sundram U, Li S, Million L, Dabaja B, Gangar P, Duvic M, Kim YHJournal of the American Academy of DermatologyLow-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials. J Am Acad Dermatol. 2015 Feb; 72(2):286-92.J Am Acad Dermatol2014-12-02T00:00:002014Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.25485578Netchiporouk E, Litvinov IV, Moreau L, Gilbert M, Sasseville D, Duvic MCell cycle (Georgetown, Tex.)Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. Cell Cycle. 2014; 13(21):3331-5.Cell Cycle2014-01-01T00:00:002014Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.25605368Duvic M, Pinter-Brown LC, Foss FM, Sokol L, Jorgensen JL, Challagundla P, Dwyer KM, Zhang X, Kurman MR, Ballerini R, Liu L, Kim YHBloodPhase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma. Blood. 2015 Mar 19; 125(12):1883-9.Blood2015-01-20T00:00:002015Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.25630528Kazmi SM, Pemmaraju N, Patel KP, Cohen PR, Daver N, Tran KM, Ravandi F, Duvic M, Garcia-Manero G, Pierce S, Nazha A, Borthakur G, Kantarjian H, Cortes JClinical lymphoma, myeloma & leukemiaCharacteristics of Sweet Syndrome in patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015 Jun; 15(6):358-363.Clin Lymphoma Myeloma Leuk2014-12-24T00:00:002014Characteristics of Sweet Syndrome in patients with acute myeloid leukemia.25634551Herrmann JL, Syklawer E, Tarrillion M, Duvic M, Hughey LCDermatology (Basel, Switzerland)Concomitant mycosis fungoides and vitiligo: how mycosis fungoides may contribute to melanocyte destruction. Dermatology. 2015; 230(2):143-9.Dermatology2015-01-28T00:00:002015Concomitant mycosis fungoides and vitiligo: how mycosis fungoides may contribute to melanocyte destruction.25666664de la Garza Bravo MM, Patel KP, Loghavi S, Curry JL, Torres Cabala CA, Cason RC, Gangar P, Prieto VG, Medeiros LJ, Duvic M, Tetzlaff MTHuman pathologyShared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin. Hum Pathol. 2015 Apr; 46(4):558-69.Hum Pathol2014-12-31T00:00:002014Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin.25728286Litvinov IV, Tetzlaff MT, Rahme E, Habel Y, Risser DR, Gangar P, Jennings MA, Pehr K, Prieto VG, Sasseville D, Duvic MCancerIdentification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries. Cancer. 2015 Jun 15; 121(12):1993-2003.Cancer2015-02-27T00:00:002015Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries.25772268Shiue LH, Couturier J, Lewis DE, Wei C, Ni X, Duvic MPhotodermatology, photoimmunology & photomedicineThe effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed. 2015 Jul; 31(4):184-94.Photodermatol Photoimmunol Photomed2015-03-28T00:00:002015The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.25791237Kim EJ, Kim YH, Rook AH, Lerner A, Duvic M, Reddy S, Robak T, Becker JC, Samtsov A, McCulloch W, Waksman J, Whittaker SLeukemia & lymphomaClinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma. Leuk Lymphoma. 2015; 56(10):2847-54.Leuk Lymphoma2015-05-20T00:00:002015Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma.25795722Frankel AE, Woo JH, Ahn C, Foss FM, Duvic M, Neville PH, Neville DMHaematologicaResimmune, an anti-CD3e recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma. Haematologica. 2015 Jun; 100(6):794-800.Haematologica2015-03-20T00:00:002015Resimmune, an anti-CD3e recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma.25817937Alberti-Violetti S, Talpur R, Schlichte M, Sui D, Duvic MClinical lymphoma, myeloma & leukemiaAdvanced-stage mycosis fungoides and S?zary syndrome: survival and response to treatment. Clin Lymphoma Myeloma Leuk. 2015 Jun; 15(6):e105-12.Clin Lymphoma Myeloma Leuk2015-03-05T00:00:002015Advanced-stage mycosis fungoides and S?zary syndrome: survival and response to treatment.26136403Litvinov IV, Tetzlaff MT, Rahme E, Jennings MA, Risser DR, Gangar P, Netchiporouk E, Moreau L, Prieto VG, Sasseville D, Duvic MCancer medicineDemographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries. Cancer Med. 2015 Sep; 4(9):1440-7.Cancer Med2015-07-01T00:00:002015Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries.26261247Duvic M, Tetzlaff MT, Gangar P, Clos AL, Sui D, Talpur RJournal of clinical oncology : official journal of the American Society of Clinical OncologyResults of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis. J Clin Oncol. 2015 Nov 10; 33(32):3759-65.J Clin Oncol2015-08-10T00:00:002015Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.26433847Duvic MDermatologic clinicsHistone Deacetylase Inhibitors for Cutaneous T-Cell Lymphoma. Dermatol Clin. 2015 Oct; 33(4):757-64.Dermatol Clin2015-08-29T00:00:002015Histone Deacetylase Inhibitors for Cutaneous T-Cell Lymphoma.26438120Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodr?guez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YHJournal of clinical oncology : official journal of the American Society of Clinical OncologyCutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and S?zary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. J Clin Oncol. 2015 Nov 10; 33(32):3766-73.J Clin Oncol2015-10-05T00:00:002015Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and S?zary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.26476898Brown DN, Wieser I, Wang C, Dabaja BS, Duvic MJournal of the American Academy of DermatologyLeonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature. J Am Acad Dermatol. 2015 Dec; 73(6):976-86.J Am Acad Dermatol2015-10-21T00:00:002015Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.26518172Wieser I, Oh CW, Talpur R, Duvic MJournal of the American Academy of DermatologyLymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients. J Am Acad Dermatol. 2016 Jan; 74(1):59-67.J Am Acad Dermatol2015-10-28T00:00:002015Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients.26551670Wang L, Ni X, Covington KR, Yang BY, Shiu J, Zhang X, Xi L, Meng Q, Langridge T, Drummond J, Donehower LA, Doddapaneni H, Muzny DM, Gibbs RA, Wheeler DA, Duvic MNature geneticsGenomic profiling of S?zary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet. 2015 Dec; 47(12):1426-34.Nat Genet2015-11-09T00:00:002015Genomic profiling of S?zary syndrome identifies alterations of key T cell signaling and differentiation genes.26637769Duvic MHematology. American Society of Hematology. Education ProgramChoosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and S?zary syndrome. Hematology Am Soc Hematol Educ Program. 2015; 2015:529-44.Hematology Am Soc Hematol Educ Program2015-01-01T00:00:002015Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and S?zary syndrome.26702474Talpur R, Sui D, Gangar P, Dabaja BS, Duvic MClinical lymphoma, myeloma & leukemiaRetrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides. Clin Lymphoma Myeloma Leuk. 2016 Jan; 16(1):49-56.Clin Lymphoma Myeloma Leuk2015-12-01T00:00:002015Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.10194237Sherman SI, Gopal J, Haugen BR, Chiu AC, Whaley K, Nowlakha P, Duvic MThe New England journal of medicineCentral hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med. 1999 Apr 08; 340(14):1075-9.N Engl J Med1999-04-08T00:00:001999Central hypothyroidism associated with retinoid X receptor-selective ligands.11900434Mehr?beoglu M, Kehtarnavaz N, Marquez G, Duvic M, Wang LVApplied opticsSkin lesion classification using oblique-incidence diffuse reflectance spectroscopic imaging. Appl Opt. 2002 Jan 01; 41(1):182-92.Appl Opt2002-01-01T00:00:002002Skin lesion classification using oblique-incidence diffuse reflectance spectroscopic imaging.12399756Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem R, Raad IJournal of the American Academy of DermatologySkin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002 Nov; 47(5):659-66.J Am Acad Dermatol2002-11-01T00:00:002002Skin lesions associated with Fusarium infection.1643619Albrecht S, Haber RM, Goodman JC, Duvic MCancerCowden syndrome and Lhermitte-Duclos disease. Cancer. 1992 Aug 15; 70(4):869-76.Cancer1992-08-15T00:00:001992Cowden syndrome and Lhermitte-Duclos disease.14632211Duvic M, Ni X, Talpur R, Herne K, Schulz C, Sui D, Ward S, Joseph A, Hazarika PThe Journal of investigative dermatologyTazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Invest Dermatol. 2003 Oct; 121(4):902-9.J Invest Dermatol2003-10-01T00:00:002003Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application.14675203Shen H, Liu Z, Strom SS, Spitz MR, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Duvic M, Ananthaswamy HN, Wei QThe Journal of investigative dermatologyp53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol. 2003 Dec; 121(6):1510-4.J Invest Dermatol2003-12-01T00:00:002003p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma.74Professor10Assistant Professor14Associate Professor15756021Gaikwad A, Poblenz A, Haridas V, Zhang C, Duvic M, Gutterman JClinical cancer research : an official journal of the American Association for Cancer ResearchTriterpenoid electrophiles (avicins) suppress heat shock protein-70 and x-linked inhibitor of apoptosis proteins in malignant cells by activation of ubiquitin machinery: implications for proapoptotic activity. Clin Cancer Res. 2005 Mar 01; 11(5):1953-62.Clin Cancer Res2005-03-01T00:00:002005Triterpenoid electrophiles (avicins) suppress heat shock protein-70 and x-linked inhibitor of apoptosis proteins in malignant cells by activation of ubiquitin machinery: implications for proapoptotic activity.27300436Napoli M, Venkatanarayan A, Raulji P, Meyers BA, Norton W, Mangala LS, Sood AK, Rodriguez-Aguayo C, Lopez-Berestein G, Vin H, Duvic M, Tetzlaff MB, Curry JL, Rook AH, Abbas HA, Coarfa C, Gunaratne PH, Tsai KY, Flores ERCancer cell?Np63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer. Cancer Cell. 2016 06 13; 29(6):874-888.Cancer Cell2016-06-13T00:00:002016?Np63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer.16595600Ghori F, Polder KD, Pinter-Brown LC, Hoff AO, Gagel RF, Sherman SI, Duvic MThe Journal of clinical endocrinology and metabolismThyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides. J Clin Endocrinol Metab. 2006 Jun; 91(6):2205-8.J Clin Endocrinol Metab2006-04-04T00:00:002006Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides.12591987Wei Q, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Strom SS, Wang LE, Guo Z, Qiao Y, Amos CI, Spitz MR, Duvic MJournal of the National Cancer InstituteRepair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst. 2003 Feb 19; 95(4):308-15.J Natl Cancer Inst2003-02-19T00:00:002003Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.15130003Garcia-Uribe A, Kehtarnavaz N, Marquez G, Prieto V, Duvic M, Wang LVApplied opticsSkin cancer detection by spectroscopic oblique-incidence reflectometry: classification and physiological origins. Appl Opt. 2004 May 01; 43(13):2643-50.Appl Opt2004-05-01T00:00:002004Skin cancer detection by spectroscopic oblique-incidence reflectometry: classification and physiological origins.17884973Kalsotra A, Du L, Wang Y, Ladd PA, Kikuta Y, Duvic M, Boyd AS, Keeney DS, Strobel HWFASEB journal : official publication of the Federation of American Societies for Experimental BiologyInflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways. FASEB J. 2008 Feb; 22(2):538-47.FASEB J2007-09-20T00:00:002007Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways.17975167Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, Guo Z, Qiao Y, Clayman GL, Lee JJ, El-Naggar AK, Prieto VG, Duvic M, Lippman SM, Weber RS, Kripke ML, Wei QClinical cancer research : an official journal of the American Association for Cancer ResearchRepair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res. 2007 Nov 01; 13(21):6532-9.Clin Cancer Res2007-11-01T00:00:002007Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression.12920365Singh A, Prieto VG, Czelusta A, McClain KL, Duvic MDermatology (Basel, Switzerland)Adult Langerhans cell histiocytosis limited to the skin. Dermatology. 2003; 207(2):157-61.Dermatology2003-01-01T00:00:002003Adult Langerhans cell histiocytosis limited to the skin.18444808Awais A, Tam CS, Kontoyiannis D, Ferrajoli A, Duvic M, Cortes J, Keating MJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaRapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia. Clin Infect Dis. 2008 Apr 01; 46(7):e69-71.Clin Infect Dis2008-04-01T00:00:002008Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia.19289586Chandra P, Plaza JA, Zuo Z, Diwan AH, Koeppen H, Duvic M, Medeiros LJ, Prieto VGAmerican journal of clinical pathologyClusterin expression correlates with stage and presence of large cells in mycosis fungoides. Am J Clin Pathol. 2009 Apr; 131(4):511-5.Am J Clin Pathol2009-04-01T00:00:002009Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.15743738Diwan AH, Prieto VG, Herling M, Duvic M, Jone DAmerican journal of clinical pathologyPrimary S?zary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism. Am J Clin Pathol. 2005 Apr; 123(4):510-5.Am J Clin Pathol2005-04-01T00:00:002005Primary S?zary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism.19362750Adeniran AJ, Prieto VG, Chon S, Duvic M, Diwan AHJournal of the American Academy of DermatologyAtypical histologic and immunohistochemical findings in melanocytic nevi after liquid nitrogen cryotherapy. J Am Acad Dermatol. 2009 Aug; 61(2):341-5.J Am Acad Dermatol2009-04-11T00:00:002009Atypical histologic and immunohistochemical findings in melanocytic nevi after liquid nitrogen cryotherapy.16368944Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfield PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman SM, Amos CI, Spitz MR, Wei QJournal of the National Cancer InstituteIn vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31.J Natl Cancer Inst2005-12-21T00:00:002005In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.16841033Wang LE, Hsu TC, Xiong P, Strom SS, Duvic M, Clayman GL, Weber RS, Lippman SM, Goldberg LH, Wei QThe Journal of investigative dermatology4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis. J Invest Dermatol. 2007 Jan; 127(1):196-205.J Invest Dermatol2006-07-13T00:00:0020064-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis.20850703Cho-Vega JH, Tschen JA, Duvic M, Vega FAnnals of diagnostic pathologyEarly-stage mycosis fungoides variants: case-based review. Ann Diagn Pathol. 2010 Oct; 14(5):369-85.Ann Diagn Pathol2010-10-01T00:00:002010Early-stage mycosis fungoides variants: case-based review.22491533Garcia-Uribe A, Zou J, Duvic M, Cho-Vega JH, Prieto VG, Wang LVCancer researchIn vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Res. 2012 Jun 01; 72(11):2738-45.Cancer Res2012-04-05T00:00:002012In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry.21361657Garcia-Uribe A, Smith EB, Zou J, Duvic M, Prieto V, Wang LVJournal of biomedical opticsIn-vivo characterization of optical properties of pigmented skin lesions including melanoma using oblique incidence diffuse reflectance spectrometry. J Biomed Opt. 2011 Feb; 16(2):020501.J Biomed Opt2011-02-01T00:00:002011In-vivo characterization of optical properties of pigmented skin lesions including melanoma using oblique incidence diffuse reflectance spectrometry.Authorship 841291Authorship 842184Authorship 842302Authorship 842520Authorship 843272Authorship 844162Authorship 844677Authorship 844890Authorship 845024Authorship 845672Authorship 845770Authorship 845902Authorship 846230Authorship 846368Authorship 846473Authorship 846894Authorship 847144Authorship 847492Authorship 847942Authorship 849322Authorship 849425Authorship 850231Authorship 850331Authorship 850361Authorship 850550Authorship 851171Authorship 851721Authorship 851894Authorship 851918Authorship 852251Authorship 852484Authorship 852775Authorship 852878Authorship 853005Authorship 853479Authorship 853702Authorship 854770Authorship 854773Authorship 854950Authorship 855500Authorship 855550Authorship 856378Authorship 856436Authorship 858053Authorship 858077Authorship 858198Authorship 858747Authorship 858754Authorship 858771Authorship 858858Authorship 859018Authorship 859308Authorship 860762Authorship 860847Authorship 861059Authorship 861459Authorship 861626Authorship 861811Authorship 861953Authorship 863022Authorship 863481Authorship 863824Authorship 864363Authorship 864522Authorship 864621Authorship 864700Authorship 865017Authorship 865482Authorship 865544Authorship 865600Authorship 866175Authorship 866225Authorship 866381Authorship 866675Authorship 866683Authorship 866814Authorship 866994Authorship 867170Authorship 867381Authorship 867477Authorship 868028Journal of the American Academy of DermatologyTazarotene. Journal of the American Academy of Dermatology. 39.TazaroteneOblique-incidence spatially resolved diffuse reflectance spectroscopic diagnosis of skin cancer. Oblique-incidence spatially resolved diffuse reflectance spectroscopic diagnosis of skin cancerJournal of Investigative MedicineHLA-DQB class II alleles are associated with CTCL. Journal of Investigative Medicine. 44.HLA-DQB class II alleles are associated with CTCLBreast DiseaseDuctal carcinoma after conservative management of Paget's disease of the breast. Breast Disease. 7:361-366.Ductal carcinoma after conservative management of Paget's disease of the breastDermatologic TherapySuperficial fungal infections in HIV and AIDS. Dermatologic Therapy. 3:84-90.Superficial fungal infections in HIV and AIDSJournal of Cutaneous PathologyClinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma. Journal of Cutaneous Pathology. Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphomaExpert Opinion on Orphan DrugsMogamulizumab in the treatment of cutaneous T cell lymphoma. Expert Opinion on Orphan Drugs. 4:1277-1280.Mogamulizumab in the treatment of cutaneous T cell lymphomaJournal of the American Academy of DermatologySelf-Assessment examination of the American Academy of Dermatology. Journal of the American Academy of Dermatology. 22:150-154.Self-Assessment examination of the American Academy of DermatologyDermatology Online JournalCurrent treatment of cutaneous T-cell lymphoma. Dermatology Online Journal. 7:49-58.Current treatment of cutaneous T-cell lymphomaJournal of Cutaneous PathologyErratum. Journal of Cutaneous Pathology. 31:81.ErratumHaematologica Meeting ReportsA Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma. Haematologica Meeting Reports. 2:44-45.A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphomaAmerican Journal of DermatopathologyPrimary Cutaneous Gamma-Delta (γ/δ) T-cell Lymphoma. American Journal of Dermatopathology. Primary Cutaneous Gamma-Delta (γ/δ) T-cell LymphomaJournal of the European Academy of Dermatology and VenereologyHigh-frequency sonography of the skin. Journal of the European Academy of Dermatology and Venereology. 3:47-55.High-frequency sonography of the skinJournal of the American Academy of DermatologyErratum. Journal of the American Academy of Dermatology. 35:587.ErratumBMC Clinical PathologyA stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clinical Pathology. 2:1-7.A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapyAnnales de Dermatologie et de VenereologieNovel treatments for cutaneous T-cell lymphomas. Annales de Dermatologie et de Venereologie. 135.Novel treatments for cutaneous T-cell lymphomasArchives of DermatologyIntra-arterial Reserpine for Raynaud's Syndrome. Archives of Dermatology. 119:733-735.Intra-arterial Reserpine for Raynaud's SyndromeJDDG - Journal of the German Society of DermatologyPrimary cutaneous CD30<sup>+</sup> lymphoproliferative disorders. JDDG - Journal of the German Society of Dermatology. 14:767-782.Primary cutaneous CD30<sup>+</sup> lymphoproliferative disordersEpithelial cancer detection by oblique-incidence optical spectroscopy. Epithelial cancer detection by oblique-incidence optical spectroscopyClinical Lymphoma, Myeloma and LeukemiaRetrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides. Clinical Lymphoma, Myeloma and Leukemia. 16:49-56.Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis FungoidesBritish Journal of CancerClinical and laboratory experience of vorinostat (suberoylanilide hydroxamic acid) in the treatment of cutaneous T-cell lymphoma. British Journal of Cancer. 95.Clinical and laboratory experience of vorinostat (suberoylanilide hydroxamic acid) in the treatment of cutaneous T-cell lymphomaLeukemia and LymphomaClinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma. Leukemia and Lymphoma. 56:2847-2854.Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphomaArchives of DermatologyErratum. Archives of Dermatology. 138:1386.ErratumJournal of Investigative Dermatology Symposium ProceedingsThird International Research Workshop on Alopecia Areata. Journal of Investigative Dermatology Symposium Proceedings. 4:199.Third International Research Workshop on Alopecia AreataInternet Journal of DermatologyFolliculotropic mycosis fungoides. Internet Journal of Dermatology. 8.Folliculotropic mycosis fungoidesInternational Journal of DermatologyVerrucous presentation in patients with mycosis fungoides. International Journal of Dermatology. 55:e126-e129.Verrucous presentation in patients with mycosis fungoidesNoninvasive in-vivo optical properties of skin tumors. Noninvasive in-vivo optical properties of skin tumorsSkin cancer detection using spectroscopic oblique-incidence reflectometry. 2249-2250.Skin cancer detection using spectroscopic oblique-incidence reflectometryAmerican Journal of Clinical DermatologyLymphomatoid Papulosis in Children and Adolescents. American Journal of Clinical Dermatology. 17:319-327.Lymphomatoid Papulosis in Children and AdolescentsOncoImmunologyDepletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab. OncoImmunology. 4:1-2.Depletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumabCancer MedicineDemographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries. Cancer Medicine. 4:1440-1447.Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registriesDermatology Online JournalA perplexing pruritic papular rash. Dermatology Online Journal. 9:122-127.A perplexing pruritic papular rashCancer BulletinDiagnosis and management of premalignant skin lesions. Cancer Bulletin. 47:402-407.Diagnosis and management of premalignant skin lesionsNature GeneticsGenomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. Nature Genetics. 47:1426-1434.Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genesHaematologica Meeting ReportsActivity of Belinostat in patients with recurrent or refractory peripheral or cutaneous T-cell lymphoma. Haematologica Meeting Reports. 3:39-40.Activity of Belinostat in patients with recurrent or refractory peripheral or cutaneous T-cell lymphomaMelanoma Research4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma. Melanoma Research. 4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanomaCancer CellCancer Cell. 29:874-888.Cancer CellHaematologica Meeting ReportsFrom cell biology to therapy. Haematologica Meeting Reports. 2:106-111.From cell biology to therapyDermatology Online JournalAtypical lymphoproliferative disorder-clinical and pathological features. Dermatology Online Journal. 22.Atypical lymphoproliferative disorder-clinical and pathological featuresCase Reports in DermatologyA rare case of mycosis fungoides in the oral cavity and small intestine complicated by perforation. Case Reports in Dermatology. 8:294-302.A rare case of mycosis fungoides in the oral cavity and small intestine complicated by perforationHaematologica Meeting ReportsHistone deacetylase inhibitors. Haematologica Meeting Reports. 2:39-43.Histone deacetylase inhibitorsDermatologic Therapy'Intrinsic' skin disorders in HIV. Dermatologic Therapy. 12:34-44.'Intrinsic' skin disorders in HIVOncoImmunologyInvestigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy. OncoImmunology. Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancyJDDG - Journal of the German Society of DermatologyPrimär kutane CD30<sup>+</sup> lymphoproliferative Erkrankungen. JDDG - Journal of the German Society of Dermatology. 14:767-784.Primär kutane CD30<sup>+</sup> lymphoproliferative ErkrankungenEBioMedicineMolecular signatures define alopecia areata subtypes and transcriptional biomarkers. EBioMedicine. Molecular signatures define alopecia areata subtypes and transcriptional biomarkersArchives of DermatologyGlucan-Induced Keratoderma in Acquired Immunodeficiency Syndrome. Archives of Dermatology. 123:751-756.Glucan-Induced Keratoderma in Acquired Immunodeficiency SyndromeLasers in Medical ScienceIn vivo fluorescence spectroscopy and imaging of human skin tumours. Lasers in Medical Science. 9:191-201.In vivo fluorescence spectroscopy and imaging of human skin tumoursBulletin of Experimental Biology and MedicineRole of fibroblasts as the principal factor in differentiation of the epidermis. Bulletin of Experimental Biology and Medicine. 121:72-76.Role of fibroblasts as the principal factor in differentiation of the epidermisHaematologica ReportsOptimizing denileukin diftitox (Ontak®) therapy. Haematologica Reports. 2:57-60.Optimizing denileukin diftitox (Ontak®) therapyJournal of Cutaneous PathologyDiverse types of dermatologic toxicities from immune checkpoint blockade therapy. Journal of Cutaneous Pathology. 44:158-176.Diverse types of dermatologic toxicities from immune checkpoint blockade therapyJournal of the American Academy of DermatologyAlopecia areata investigational assessment guidelines-Part II. Journal of the American Academy of Dermatology. 51:448-451.Alopecia areata investigational assessment guidelines-Part IIActa Dermato-VenereologicaRemission of AIDS-associated psoriasis with zidovudine. Acta Dermato-Venereologica. 67:627.Remission of AIDS-associated psoriasis with zidovudineJAAD Case ReportsAn unusual case of cytotoxic peripheral T-cell lymphoma. JAAD Case Reports. 1:257-260.An unusual case of cytotoxic peripheral T-cell lymphomaNature CommunicationsGenome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nature Communications. 6.Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility lociDermatologic ClinicsDermatologic Clinics. Dermatologic Clinics. 19.Dermatologic ClinicsExpert Review of DermatologyVorinostat for the treatment of cutaneous T-cell lymphoma. Expert Review of Dermatology. 5:393-401.Vorinostat for the treatment of cutaneous T-cell lymphomaAmerican Journal of Surgical PathologyPrimary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas. American Journal of Surgical Pathology. Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell LymphomasJournal of the American Academy of DermatologyReply. Journal of the American Academy of Dermatology. 33:1061.ReplyOncologyImproved understanding of peripheral T-cell lymphomas. Oncology. 24.Improved understanding of peripheral T-cell lymphomasOncotargetDiscovery and clinical introduction of first-in-class imipridone ONC201. Oncotarget. 7:74380-74392.Discovery and clinical introduction of first-in-class imipridone ONC201Dermatologic SurgeryIn Vivo Fluorescence Spectroscopy and Imaging of Human Skin Tumors. Dermatologic Surgery. 21:821-822.In Vivo Fluorescence Spectroscopy and Imaging of Human Skin TumorsHaematologicaResimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma. Haematologica. 100:794-800.Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphomaClinical Lymphoma, Myeloma and LeukemiaCharacteristics of sweet syndrome in patients with acute myeloid leukemia. Clinical Lymphoma, Myeloma and Leukemia. 15:358-363.Characteristics of sweet syndrome in patients with acute myeloid leukemiaJournal of Cutaneous PathologyLoss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma. Journal of Cutaneous Pathology. Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphomaDermatology Online JournalUnknown presentation. Dermatology Online Journal. 13.Unknown presentationJournal of the American Academy of DermatologyReply. Journal of the American Academy of Dermatology. 32:1064.ReplyJournal of Cutaneous PathologyA case of indeterminate dendritic cell tumor presenting with leonine facies. Journal of Cutaneous Pathology. 43:158-163.A case of indeterminate dendritic cell tumor presenting with leonine faciesBulletin of Experimental Biology and MedicineEffects of fibroblast-keratinocyte interactions on the secretion of interleukin-8. Bulletin of Experimental Biology and Medicine. 121:167-170.Effects of fibroblast-keratinocyte interactions on the secretion of interleukin-8Dermatologic TherapyRetinoid receptor selectivity. Dermatologic Therapy. 7:7-14.Retinoid receptor selectivityHaematologica ReportsOptimizing bexarotene therapy for cutaneous T-cell lymphoma. Haematologica Reports. 2:75-76.Optimizing bexarotene therapy for cutaneous T-cell lymphomaJAAD Case ReportsReed syndrome presenting with leiomyosarcoma. JAAD Case Reports. 1:150-152.Reed syndrome presenting with leiomyosarcomaClinical Lymphoma, Myeloma and LeukemiaA Single-Center Experience with Brentuximab Vedotin in Gamma Delta T-Cell Lymphoma. Clinical Lymphoma, Myeloma and Leukemia. 16:e15-e19.A Single-Center Experience with Brentuximab Vedotin in Gamma Delta T-Cell LymphomaExpert Opinion on Orphan DrugsSézary syndrome. Expert Opinion on Orphan Drugs. 2:889-901.Sézary syndromeAnnals of OncologyAllogeneic stem-cell transplantation in patients with cutaneous lymphoma. Annals of Oncology. 26:2490-2495.Allogeneic stem-cell transplantation in patients with cutaneous lymphomaHaematologica Meeting ReportsInnovative treatments. Haematologica Meeting Reports. 3:96-100.Innovative treatmentsPhotodermatology Photoimmunology and PhotomedicineThe effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>-</sup> T cells in patients with leukemic cutaneous T-cell lymphoma. Photodermatology Photoimmunology and Photomedicine. 31:184-194.The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4<sup>+</sup>Foxp3<sup>+</sup>CD25<sup>-</sup> T cells in patients with leukemic cutaneous T-cell lymphomaUrticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases. 2532-2543.Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic DiseasesHaematologica Meeting ReportsEpigenetic approaches. Histone deacetylase inhibitors. Haematologica Meeting Reports. 3:28-32.Epigenetic approaches. Histone deacetylase inhibitorsAnnals of the New York Academy of SciencesNormal and mutant human collagen genes. Annals of the New York Academy of Sciences. VOL. 460:461-462.Normal and mutant human collagen genesClinical Lymphoma, Myeloma and LeukemiaClinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides. Clinical Lymphoma, Myeloma and Leukemia. 16:637-643.Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis FungoidesWhite light oblique-incidence diffuse reflectance spectroscopy for classification of in vivo pigmented skin lesions. White light oblique-incidence diffuse reflectance spectroscopy for classification of in vivo pigmented skin lesions2753148Appling WD, O'Brien WR, Johnston DA, Duvic MFEBS lettersSynergistic enhancement of type I and III collagen production in cultured fibroblasts by transforming growth factor-beta and ascorbate. FEBS Lett. 1989 Jul 03; 250(2):541-4.FEBS Lett1989-07-03T00:00:001989Synergistic enhancement of type I and III collagen production in cultured fibroblasts by transforming growth factor-beta and ascorbate.2923449Duvic M, Lowe L, Rapini RP, Rodriguez S, Levy MLArchives of dermatologyEruptive dysplastic nevi associated with human immunodeficiency virus infection. Arch Dermatol. 1989 Mar; 125(3):397-401.Arch Dermatol1989-03-01T00:00:001989Eruptive dysplastic nevi associated with human immunodeficiency virus infection.8040416Grossman D, Lewis DE, Ballas ZK, Duvic MJournal of the American Academy of DermatologyIdiopathic CD4+ T lymphocytopenia in a patient with mycosis fungoides. J Am Acad Dermatol. 1994 Aug; 31(2 Pt 1):275-6.J Am Acad Dermatol1994-08-01T00:00:001994Idiopathic CD4+ T lymphocytopenia in a patient with mycosis fungoides.9366845Jackow CM, Papadopoulos E, Nelson B, Tschen JA, Heatherington G, Duvic MJournal of the American Academy of DermatologyFollicular mucinosis associated with scarring alopecia, oligoclonal T-cell receptor V beta expansion, and Staphylococcus aureus: when does follicular mucinosis become mycosis fungoides? J Am Acad Dermatol. 1997 Nov; 37(5 Pt 2):828-31.J Am Acad Dermatol1997-11-01T00:00:001997Follicular mucinosis associated with scarring alopecia, oligoclonal T-cell receptor V beta expansion, and Staphylococcus aureus: when does follicular mucinosis become mycosis fungoides?10955811Duvic M, Helekar B, Schulz C, Cho M, DiSepio D, Hager C, DiMao D, Hazarika P, Jackson B, Breuer-McHam J, Young J, Clayman G, Lippman SM, Chandraratna RA, Robinson NA, Deucher A, Eckert RL, Nagpal SClinical cancer research : an official journal of the American Association for Cancer ResearchExpression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res. 2000 Aug; 6(8):3249-59.Clin Cancer Res2000-08-01T00:00:002000Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer.12376526Duan Z, Shen H, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Duvic M, Strom SS, Spitz MR, Wei QCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyDNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1142-3.Cancer Epidemiol Biomarkers Prev2002-10-01T00:00:002002DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma.15681519Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, Kripke ML, Lippman SMJournal of clinical oncology : official journal of the American Society of Clinical OncologyMortality risk from squamous cell skin cancer. J Clin Oncol. 2005 Feb 01; 23(4):759-65.J Clin Oncol2005-02-01T00:00:002005Mortality risk from squamous cell skin cancer.16263585Polder K, Wang C, Duvic M, Diwan AH, Parks D, Jankov A, Walker PL, Tong AT, Bull J, Dang NHLeukemia & lymphomaToxic epidermal necrolysis associated with denileukin diftitox (DAB389IL-2) administration in a patient with follicular large cell lymphoma. Leuk Lymphoma. 2005 Dec; 46(12):1807-11.Leuk Lymphoma2005-12-01T00:00:002005Toxic epidermal necrolysis associated with denileukin diftitox (DAB389IL-2) administration in a patient with follicular large cell lymphoma.18480841Ni X, Richmond HM, Liao XM, Decker WK, Shiue LH, Shpall EJ, Duvic MThe Journal of investigative dermatologyInduction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA. J Invest Dermatol. 2008 Nov; 128(11):2631-2639.J Invest Dermatol2008-05-15T00:00:002008Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA.18496567Zhang C, Li B, Gaikwad AS, Haridas V, Xu Z, Gutterman JU, Duvic MThe Journal of investigative dermatologyAvicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. J Invest Dermatol. 2008 Nov; 128(11):2728-2735.J Invest Dermatol2008-05-22T00:00:002008Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.19889052Curry JL, Prieto VG, Jones DM, Vega F, Duvic M, Diwan AHJournal of cutaneous pathologyTransient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/S?zary syndrome. J Cutan Pathol. 2011 Mar; 38(3):295-7.J Cutan Pathol2011-03-01T00:00:002011Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/S?zary syndrome.29296637Lewis DJ, Dao H, Nagarajan P, Duvic MJAAD case reportsPrimary cutaneous anaplastic large-cell lymphoma: Complete remission for 13?years after denileukin diftitox. JAAD Case Rep. 2017 Nov; 3(6):501-504.JAAD Case Rep2017-10-25T00:00:002017Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13?years after denileukin diftitox.Authorship 88853711Authorship 8900234D012751Disorders491590.868954Sezary SyndromeD000506Disorders14550.934879Alopecia AreataD016410Disorders602930.765725Lymphoma, T-Cell, CutaneousAuthorship 8960984D012878Disorders71446250.304227Skin NeoplasmsAuthorship 9035266Authorship 9039776Authorship 9041645D009182Disorders743200.764751Mycosis FungoidesAuthorship 9052691Authorship 9053275Authorship 9053884Authorship 9053904Authorship 9058434Authorship 9066354Authorship 9068721Authorship 9069482Authorship 9074394Authorship 9076072Authorship 9076759Authorship 9077107Authorship 90794919Authorship 9080074Authorship 9080756Authorship 9088704Authorship 9091548Authorship 90973616Authorship 9101263Authorship 9109353Authorship 9116826Authorship 9123366Authorship 9125637Authorship 9127153Authorship 9129782Authorship 9133941Authorship 9135998Authorship 9137758Authorship 9141506Authorship 9144475Authorship 9145832Authorship 9148803Authorship 9153015Authorship 9156924Authorship 9160625Authorship 9179487Authorship 9181373Authorship 9184742Authorship 91856210Authorship 91890431Authorship 9190491Authorship 9193454Authorship 9201707Authorship 92107111Authorship 9212444Authorship 9212732Authorship 9225784Authorship 9226275Authorship 9226932Authorship 9229237Authorship 9230524Authorship 9233373Authorship 9234243Authorship 9252903Authorship 9262852Authorship 9266674Authorship 9271316Authorship 9273682Authorship 9275753Authorship 9275826Authorship 9276495Authorship 9277759Authorship 9288174Authorship 9288703Authorship 9294332Authorship 92961915Authorship 9302495Authorship 93256435Authorship 9334747Authorship 9360184Authorship 93650810Authorship 9385135Authorship 938855512475398Washington LT, Huh YO, Powers LC, Duvic M, Jones DBMC clinical pathologyA stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clin Pathol. 2002 Dec 10; 2(1):5.BMC Clin Pathol2002-12-10T00:00:002002A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy.24977319Wang LE, Li C, Xiong P, Gershenwald JE, Prieto VG, Duvic M, Lee JE, Grimm EA, Hsu TC, Wei QMelanoma research4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case-control analysis. Melanoma Res. 2016 Apr; 26(2):181-7.Melanoma Res2016-04-01T00:00:0020164-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case-control analysis.26140234Ni X, Langridge T, Duvic MOncoimmunologyDepletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab. Oncoimmunology. 2015 Jul; 4(7):e1011524.Oncoimmunology2015-03-24T00:00:002015Depletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab.26272726Oh CW, Ivan D, Curry JL, Ellis R, Gerber H, Duvic M, Torres-Cabala CJournal of cutaneous pathologyA case of indeterminate dendritic cell tumor presenting with leonine facies. J Cutan Pathol. 2016 Feb; 43(2):158-63.J Cutan Pathol2015-09-11T00:00:002015A case of indeterminate dendritic cell tumor presenting with leonine facies.26827693Duvic M, Dimopoulos MCancer treatment reviewsThe safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studies. Cancer Treat Rev. 2016 Feb; 43:58-66.Cancer Treat Rev2015-04-09T00:00:002015The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studies.26519087Schlichte MJ, Talpur R, Venkatarajan S, Curry JL, Nagarajan P, Duvic MInternational journal of dermatologyVerrucous presentation in patients with mycosis fungoides. Int J Dermatol. 2016 Mar; 55(3):e126-9.Int J Dermatol2015-10-30T00:00:002015Verrucous presentation in patients with mycosis fungoides.26997441Mudaliar K, Tetzlaff MT, Duvic M, Ciurea A, Hymes S, Milton DR, Tsai KY, Prieto VG, Torres-Cabala CA, Curry JLHuman pathologyBRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression. Hum Pathol. 2016 Apr; 50:79-89.Hum Pathol2015-12-18T00:00:002015BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression.26705678Talpur R, Chockalingam R, Wang C, Tetzlaff MT, Duvic MClinical lymphoma, myeloma & leukemiaA Single-Center Experience With Brentuximab Vedotin in Gamma Delta T-Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2016 Feb; 16(2):e15-9.Clin Lymphoma Myeloma Leuk2015-12-01T00:00:002015A Single-Center Experience With Brentuximab Vedotin in Gamma Delta T-Cell Lymphoma.27529713Wang CM, Nadeem S, Jahan-Tigh RR, Duvic MCutisCutaneous T-cell lymphoma in a patient with celiac disease. Cutis. 2016 Jul; 98(1):E1-2.Cutis2016-07-01T00:00:002016Cutaneous T-cell lymphoma in a patient with celiac disease.27138554Wieser I, Wohlmuth C, Nunez CA, Duvic MAmerican journal of clinical dermatologyLymphomatoid Papulosis in Children and Adolescents: A Systematic Review. Am J Clin Dermatol. 2016 Aug; 17(4):319-27.Am J Clin Dermatol2016-08-01T00:00:002016Lymphomatoid Papulosis in Children and Adolescents: A Systematic Review.27207484Chockalingam R, Duvic MInternational journal of dermatologyScleromyxedema: long-term follow-up after high-dose melphalan with autologous stem cell transplantation. Int J Dermatol. 2016 Oct; 55(10):e539-43.Int J Dermatol2016-05-21T00:00:002016Scleromyxedema: long-term follow-up after high-dose melphalan with autologous stem cell transplantation.27509410Wieser I, Tetzlaff MT, Cabala CA, Duvic MJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDGPrim?r kutane CD30(+) lymphoproliferative Erkrankungen. J Dtsch Dermatol Ges. 2016 Aug; 14(8):767-84.J Dtsch Dermatol Ges2016-08-01T00:00:002016Prim?r kutane CD30(+) lymphoproliferative Erkrankungen.27509411Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic MJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDGPrimary cutaneous CD30(+) lymphoproliferative disorders. J Dtsch Dermatol Ges. 2016 Aug; 14(8):767-82.J Dtsch Dermatol Ges2016-08-01T00:00:002016Primary cutaneous CD30(+) lymphoproliferative disorders.27582487Min HY, Lee SC, Woo JK, Jung HJ, Park KH, Jeong HM, Hyun SY, Cho J, Lee W, Park JE, Kwon SJ, Lee HJ, Ni X, Shin YK, Johnson FM, Duvic M, Lee HYClinical cancer research : an official journal of the American Association for Cancer ResearchEssential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors. Clin Cancer Res. 2017 Mar 01; 23(5):1299-1311.Clin Cancer Res2016-08-31T00:00:002016Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.27637428Foss F, Duvic M, Lerner A, Waksman J, Whittaker SClinical lymphoma, myeloma & leukemiaClinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides. Clin Lymphoma Myeloma Leuk. 2016 11; 16(11):637-643.Clin Lymphoma Myeloma Leuk2016-08-10T00:00:002016Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides.27051714Wang C, Tetzlaff M, Hick R, Duvic MJAAD case reportsReed syndrome presenting with leiomyosarcoma. JAAD Case Rep. 2015 May; 1(3):150-2.JAAD Case Rep2015-05-25T00:00:002015Reed syndrome presenting with leiomyosarcoma.27051746Wang C, Reusser N, Shelton M, Reed J, Doan H, Torres-Cabala CA, Dabaja B, Duvic MJAAD case reportsAn unusual case of cytotoxic peripheral T-cell lymphoma. JAAD Case Rep. 2015 Sep; 1(5):257-60.JAAD Case Rep2015-07-28T00:00:002015An unusual case of cytotoxic peripheral T-cell lymphoma.27247757Duvic M, Evans M, Wang CTherapeutic advances in hematologyMogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential. Ther Adv Hematol. 2016 Jun; 7(3):171-4.Ther Adv Hematol2016-03-17T00:00:002016Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential.27322477Jabbari A, Cerise JE, Chen JC, Mackay-Wiggan J, Duvic M, Price V, Hordinsky M, Norris D, Clynes R, Christiano AMEBioMedicineMolecular signatures define alopecia areata subtypes and transcriptional biomarkers. EBioMedicine. 2016 May; 7:240-7.EBioMedicine2016-03-31T00:00:002016Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.27533072Ramani NS, Curry JL, Merrill ED, Aung PP, Prieto V, Tetzlaff MT, Duvic M, Miranda RN, Torres-Cabala CThe American Journal of dermatopathologyPrimary Cutaneous Gamma-Delta (?/d) T-cell Lymphoma: An Unusual Case With Very Subtle Histopathological Findings. Am J Dermatopathol. 2016 10; 38(10):e147-9.Am J Dermatopathol2016-10-01T00:00:002016Primary Cutaneous Gamma-Delta (?/d) T-cell Lymphoma: An Unusual Case With Very Subtle Histopathological Findings.27531242Al-Rohil RN, Torres-Cabala CA, Patel A, Tetzlaff MT, Ivan D, Nagarajan P, Curry JL, Miranda RN, Duvic M, Prieto VG, Aung PPJournal of cutaneous pathologyLoss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding. J Cutan Pathol. 2016 Dec; 43(12):1161-1166.J Cutan Pathol2016-09-15T00:00:002016Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding.27595880Wieser I, Wohlmuth C, Duvic MPediatric dermatologyGranulomatous Mycosis Fungoides in an Adolescent-A Rare Encounter and Review of the Literature. Pediatr Dermatol. 2016 Sep; 33(5):e296-8.Pediatr Dermatol2016-09-01T00:00:002016Granulomatous Mycosis Fungoides in an Adolescent-A Rare Encounter and Review of the Literature.27879514Merrill ED, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CAThe American journal of surgical pathologyPrimary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (?d) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous ?d T-Cell Lymphomas. Am J Surg Pathol. 2017 Feb; 41(2):204-215.Am J Surg Pathol2017-02-01T00:00:002017Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (?d) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous ?d T-Cell Lymphomas.27975038Messer A, Jenkinson H, Wang W, Duvic MPlastic and reconstructive surgery. Global openNew B-cell Lymphomas in the Setting of a Previous Rare Breast Implant-Associated B-cell Lymphoma. Plast Reconstr Surg Glob Open. 2016 Nov; 4(11):e1148.Plast Reconstr Surg Glob Open2016-11-23T00:00:002016New B-cell Lymphomas in the Setting of a Previous Rare Breast Implant-Associated B-cell Lymphoma.28074163Bassuner J, Miranda RN, Emge DA, DiCicco BA, Lewis DJ, Duvic MCase reports in dermatological medicineMycosis Fungoides of the Oral Cavity: Fungating Tumor Successfully Treated with Electron Beam Radiation and Maintenance Bexarotene. Case Rep Dermatol Med. 2016; 2016:5857935.Case Rep Dermatol Med2016-12-15T00:00:002016Mycosis Fungoides of the Oral Cavity: Fungating Tumor Successfully Treated with Electron Beam Radiation and Maintenance Bexarotene.28128277Guitart J, Martinez-Escala ME, Subtil A, Duvic M, Pulitzer MP, Olsen EA, Kim E, Rook AH, Samimi SS, Wood GS, Girardi M, Junkins-Hopkins J, Ivan DS, Selim MA, Sable KA, Virmani P, Pincus LB, Tetzlaff MT, Kim J, Kim YHModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncPrimary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas. Mod Pathol. 2017 05; 30(5):761-772.Mod Pathol2017-01-27T00:00:002017Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas.27622024Litvinov IV, Shtreis A, Kobayashi K, Glassman S, Tsang M, Woetmann A, Sasseville D, ?dum N, Duvic MOncoimmunologyInvestigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy. Oncoimmunology. 2016 Jul; 5(7):e1175799.Oncoimmunology2016-06-06T00:00:002016Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy.27859479Curry JL, Tetzlaff MT, Nagarajan P, Drucker C, Diab A, Hymes SR, Duvic M, Hwu WJ, Wargo JA, Torres-Cabala CA, Rapini RP, Prieto VGJournal of cutaneous pathologyDiverse types of dermatologic toxicities from immune checkpoint blockade therapy. J Cutan Pathol. 2017 Feb; 44(2):158-176.J Cutan Pathol2016-12-21T00:00:002016Diverse types of dermatologic toxicities from immune checkpoint blockade therapy.27920681Emge DA, Bassuner J, Lewis DJ, Duvic MCase reports in dermatologyA Rare Case of Mycosis Fungoides in the Oral Cavity and Small Intestine Complicated by Perforation. Case Rep Dermatol. 2016 Sep-Dec; 8(3):294-302.Case Rep Dermatol2016-11-14T00:00:002016A Rare Case of Mycosis Fungoides in the Oral Cavity and Small Intestine Complicated by Perforation.27550169Alberti-Violetti S, Torres-Cabala CA, Talpur R, Corti L, Fanoni D, Venegoni L, Berti E, Duvic MJournal of cutaneous pathologyClinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma. J Cutan Pathol. 2016 Dec; 43(12):1121-1130.J Cutan Pathol2016-09-20T00:00:002016Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma.27602582Allen JE, Kline CL, Prabhu VV, Wagner J, Ishizawa J, Madhukar N, Lev A, Baumeister M, Zhou L, Lulla A, Stogniew M, Schalop L, Benes C, Kaufman HL, Pottorf RS, Nallaganchu BR, Olson GL, Al-Mulla F, Duvic M, Wu GS, Dicker DT, Talekar MK, Lim B, Elemento O, Oster W, Bertino J, Flaherty K, Wang ML, Borthakur G, Andreeff M, Stein M, El-Deiry WSOncotargetDiscovery and clinical introduction of first-in-class imipridone ONC201. Oncotarget. 2016 Nov 08; 7(45):74380-74392.Oncotarget2016-11-08T00:00:002016Discovery and clinical introduction of first-in-class imipridone ONC201.28421231Wieser I, Huean A, Bush AE, Dabaja BS, Duvic MActa dermato-venereologicaPeriorbital Involvement in Early Stage Mycosis Fungoides. Acta Derm Venereol. 2017 Aug 31; 97(8):976-978.Acta Derm Venereol2017-08-31T00:00:002017Periorbital Involvement in Early Stage Mycosis Fungoides.28600132Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dr?no B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M, ALCANZA study groupLancet (London, England)Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet. 2017 08 05; 390(10094):555-566.Lancet2017-06-07T00:00:002017Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.28248813Agbay RL, Torres-Cabala CA, Patel KP, Merril ED, Duvic M, Quesada A, Prieto VG, Aung PP, Loghavi S, Young KH, Hu S, Ferrufino-Schmidt MC, Tetzlaff M, Li S, Medeiros LJ, Miranda RNThe American journal of surgical pathologyImmunophenotypic Shifts in Primary Cutaneous ?d T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens. Am J Surg Pathol. 2017 Apr; 41(4):431-445.Am J Surg Pathol2017-04-01T00:00:002017Immunophenotypic Shifts in Primary Cutaneous ?d T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens.28338261Lewis DJ, Duvic MDermatologic therapyExtracorporeal photopheresis for the treatment of early-stage mycosis fungoides. Dermatol Ther. 2017 May; 30(3).Dermatol Ther2017-03-24T00:00:002017Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides.28516243Wieser I, Wang C, Alberti-Violetti S, Lyons G, Tran C, Talpur R, Duvic MArchives of dermatological researchClinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides. Arch Dermatol Res. 2017 Aug; 309(6):453-459.Arch Dermatol Res2017-05-17T00:00:002017Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.28585397Kim EJ, Lewis DJ, Dabaja BS, Duvic MDermatologic therapyCurcumin for the treatment of tumor-stage mycosis fungoides. Dermatol Ther. 2017 Jul; 30(4).Dermatol Ther2017-06-06T00:00:002017Curcumin for the treatment of tumor-stage mycosis fungoides.28653029Lewis DJ, Turkeltaub AE, Dai J, Nagarajan P, Rieger KE, Nunez CA, Kim YH, Duvic MJAAD case reportsAn adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone. JAAD Case Rep. 2017 Jul; 3(4):276-279.JAAD Case Rep2017-06-15T00:00:002017An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone.28167509Duvic M, Kim YH, Zinzani PL, Horwitz SMClinical cancer research : an official journal of the American Association for Cancer ResearchResults from a Phase I/II Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-cell Lymphoma. Clin Cancer Res. 2017 Jul 15; 23(14):3552-3556.Clin Cancer Res2017-02-06T00:00:002017Results from a Phase I/II Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-cell Lymphoma.28329608Wilmas K, Duvic M, Oki YDermatology online journalAtypical lymphoproliferative disorder-clinical and pathological features. Dermatol Online J. 2016 Sep 15; 22(9).Dermatol Online J2016-09-15T00:00:002016Atypical lymphoproliferative disorder-clinical and pathological features.28447489Lewis DJ, Duvic MExpert opinion on investigational drugsForodesine in the treatment of cutaneous T-cell lymphoma. Expert Opin Investig Drugs. 2017 Jun; 26(6):771-775.Expert Opin Investig Drugs2017-05-05T00:00:002017Forodesine in the treatment of cutaneous T-cell lymphoma.28803489Lewis DJ, Kim EJ, Duvic MExpert opinion on pharmacotherapyRecent advances in systemic targeted therapy for cutaneous T-cell lymphoma. Expert Opin Pharmacother. 2017 10; 18(14):1535-1536.Expert Opin Pharmacother2017-08-18T00:00:002017Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma.28853310Duvic M, Bates SE, Piekarz R, Eisch R, Kim YH, Lerner A, Robak T, Samtsov A, Becker JC, McCulloch W, Waksman J, Whittaker SLeukemia & lymphomaResponses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy. Leuk Lymphoma. 2018 04; 59(4):880-887.Leuk Lymphoma2017-08-30T00:00:002017Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy.29018799Lefran?ois P, Tetzlaff MT, Moreau L, Watters AK, Netchiporouk E, Provost N, Gilbert M, Ni X, Sasseville D, Duvic M, Litvinov IVFrontiers in medicineTruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform. Front Med (Lausanne). 2017; 4:153.Front Med (Lausanne)2017-09-22T00:00:002017TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform.28843295Kim EJ, Lewis DJ, Duvic MThe Journal of investigative dermatologyNovel Mutations Involving NF-?B and B-Cell Signaling Pathways in Primary Cutaneous Large B-Cell Lymphoma, Leg-Type and Comparison with S?zary Syndrome. J Invest Dermatol. 2017 09; 137(9):1831-1833.J Invest Dermatol2017-09-01T00:00:002017Novel Mutations Involving NF-?B and B-Cell Signaling Pathways in Primary Cutaneous Large B-Cell Lymphoma, Leg-Type and Comparison with S?zary Syndrome.28920475Li JY, Lewis DJ, Duvic MJournal of cutaneous medicine and surgeryGeneralised Eruptive Keratoacanthomas of Grzybowski. J Cutan Med Surg. 2017 Sep/Oct; 21(5):439.J Cutan Med Surg2017-09-01T00:00:002017Generalised Eruptive Keratoacanthomas of Grzybowski.28977902Ni X, Zhang X, Hu CH, Langridge T, Tarapore RS, Allen JE, Oster W, Duvic MOncotargetONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-?B pathways. Oncotarget. 2017 Sep 22; 8(37):61761-61776.Oncotarget2017-06-27T00:00:002017ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-?B pathways.28980004Lewis DJ, Talpur R, Huen AO, Tetzlaff MT, Duvic MJAMA dermatologyBrentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results. JAMA Dermatol. 2017 12 01; 153(12):1302-1306.JAMA Dermatol2017-12-01T00:00:002017Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results.29114604Smith GL, Duvic M, Yehia ZA, Allen P, Garg N, Suki T, Milgrom SA, Pinnix CC, Oki Y, Khoury JD, Dabaja BSAdvances in radiation oncologyEffectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):363-369.Adv Radiat Oncol2017-06-15T00:00:002017Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma.29241746Lewis DJ, Duvic MClinics in dermatologyImportant considerations for legislation banning commercial tanning beds among minors. Clin Dermatol. 2018 Jan - Feb; 36(1):104-105.Clin Dermatol2017-08-31T00:00:002017Important considerations for legislation banning commercial tanning beds among minors.28712310Lewis DJ, Vin H, Hinojosa T, Tetzlaff MT, Dabaja BS, Duvic MJournal of cutaneous medicine and surgeryPrimary Cutaneous Peripheral T-Cell Lymphoma in a Sporotrichoid Pattern: A Case Report. J Cutan Med Surg. 2017 Nov/Dec; 21(6):568-571.J Cutan Med Surg2017-07-17T00:00:002017Primary Cutaneous Peripheral T-Cell Lymphoma in a Sporotrichoid Pattern: A Case Report.28761921Lewis DJ, Duvic MJAAD case reportsA possible association between mycosis fungoides and Muir-Torre syndrome: Two disorders with microsatellite instability. JAAD Case Rep. 2017 Jul; 3(4):358-361.JAAD Case Rep2017-07-20T00:00:002017A possible association between mycosis fungoides and Muir-Torre syndrome: Two disorders with microsatellite instability.29159918Chan WH, Lewis DJ, Hinojosa T, Curry JL, Duvic MPediatric dermatologyJuvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation. Pediatr Dermatol. 2018 Jan; 35(1):e13-e16.Pediatr Dermatol2017-11-21T00:00:002017Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation.28635518Lewis DJ, Byekova YA, Emge DA, Duvic MThe Journal of dermatological treatmentComplete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series. J Dermatolog Treat. 2017 Sep; 28(6):567-569.J Dermatolog Treat2017-03-02T00:00:002017Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series.28638728Litvinov IV, Tetzlaff MT, Thibault P, Gangar P, Moreau L, Watters AK, Netchiporouk E, Pehr K, Prieto VG, Rahme E, Provost N, Gilbert M, Sasseville D, Duvic MOncoimmunologyGene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators. Oncoimmunology. 2017; 6(5):e1306618.Oncoimmunology2017-03-17T00:00:002017Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.28748653Lewis DJ, Huang S, Duvic MDermatologic therapyOral bexarotene for post-transplant cutaneous T-cell lymphoma. Dermatol Ther. 2017 Sep; 30(5).Dermatol Ther2017-07-26T00:00:002017Oral bexarotene for post-transplant cutaneous T-cell lymphoma.28756726Winsett FT, Lewis DJ, Duvic MExpert review of hematologyMogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma. Expert Rev Hematol. 2017 09; 10(9):757-760.Expert Rev Hematol2017-08-21T00:00:002017Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma.29030090Jour G, Aung PP, Merrill ED, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Duvic M, Miranda RN, Torres-Cabala CAJournal of dermatological scienceDifferential expression of CCR4 in primary cutaneous gamma/delta (?/d) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy. J Dermatol Sci. 2018 Jan; 89(1):88-91.J Dermatol Sci2017-09-01T00:00:002017Differential expression of CCR4 in primary cutaneous gamma/delta (?/d) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy.29318909Emge DA, Lewis DJ, Aung PP, Duvic MJournal of cutaneous medicine and surgeryHow to Discern Folliculotropic Mycosis Fungoides From Follicular Mucinosis Using a Pediatric Case. J Cutan Med Surg. 2018 May/Jun; 22(3):336-340.J Cutan Med Surg2018-01-10T00:00:002018How to Discern Folliculotropic Mycosis Fungoides From Follicular Mucinosis Using a Pediatric Case.29469737Wilmas K, Wohlmuth-Wieser I, Duvic MDermatology online journalTelangiectasia macularis eruptiva perstans: an old terminology, still frequently used. Dermatol Online J. 2017 Aug 15; 23(8).Dermatol Online J2017-08-15T00:00:002017Telangiectasia macularis eruptiva perstans: an old terminology, still frequently used.29469761Wilmas K, Aria A, Torres-Cabala CA, Lu H, Duvic MDermatology online journalSchnitzler syndrome in a patient with a family history of monoclonal gammopathy. Dermatol Online J. 2018 Jan 15; 24(1).Dermatol Online J2018-01-15T00:00:002018Schnitzler syndrome in a patient with a family history of monoclonal gammopathy.29469767Emge DA, Lewis DJ, Aung PP, Duvic MDermatology online journalEosinophilic infiltrate resembling eosinophilic cellulitis (Wells syndrome) in a patient with mycosis fungoides. Dermatol Online J. 2018 01 15; 24(1).Dermatol Online J2018-01-15T00:00:002018Eosinophilic infiltrate resembling eosinophilic cellulitis (Wells syndrome) in a patient with mycosis fungoides.29543675Gru AA, Kim J, Pulitzer M, Guitart J, Battistella M, Wood GS, Cerroni L, Kempf W, Willemze R, Pawade J, Querfeld C, Schaffer A, Pincus L, Tetzlaff M, Duvic M, Scarisbrick J, Porcu P, Mangold AR, DiCaudo DJ, Shinohara M, Hong EK, Horton B, Kim YHThe American journal of surgical pathologyThe Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and S?zary Syndrome: A Multi-institutional and International Pathology Study. Am J Surg Pathol. 2018 06; 42(6):726-734.Am J Surg Pathol2018-06-01T00:00:002018The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and S?zary Syndrome: A Multi-institutional and International Pathology Study.29548423Korta DZ, Christiano AM, Bergfeld W, Duvic M, Ellison A, Fu J, Harris JE, Hordinsky MK, King B, Kranz D, Mackay-Wiggan J, McMichael A, Norris DA, Price V, Shapiro J, Atanaskova Mesinkovska NJournal of the American Academy of DermatologyAlopecia areata is a medical disease. J Am Acad Dermatol. 2018 04; 78(4):832-834.J Am Acad Dermatol2018-04-01T00:00:002018Alopecia areata is a medical disease.29152728Lewis DJ, Holder BB, Duvic MInternational journal of dermatologyThe "Duvic regimen" for erythrodermic flares secondary to Staphylococcus aureus in mycosis fungoides and S?zary syndrome. Int J Dermatol. 2018 01; 57(1):123-124.Int J Dermatol2017-11-20T00:00:002017The "Duvic regimen" for erythrodermic flares secondary to Staphylococcus aureus in mycosis fungoides and S?zary syndrome.29273105Mendoza TR, Osei J, Duvic MThe journal of investigative dermatology. Symposium proceedingsThe Utility and Validity of the Alopecia Areata Symptom Impact Scale in Measuring Disease-Related Symptoms and their Effect on Functioning. J Investig Dermatol Symp Proc. 2018 01; 19(1):S41-S46.J Investig Dermatol Symp Proc2018-01-01T00:00:002018The Utility and Validity of the Alopecia Areata Symptom Impact Scale in Measuring Disease-Related Symptoms and their Effect on Functioning.29280139Huang S, Kim EJ, Lewis DJ, Chan WH, Miranda RN, Duvic MThe Australasian journal of dermatologyMycosis fungoides occurring at the site of previous herpes zoster eruption. Australas J Dermatol. 2018 Aug; 59(3):217-219.Australas J Dermatol2017-12-26T00:00:002017Mycosis fungoides occurring at the site of previous herpes zoster eruption.29334143Wohlmuth-Wieser I, Osei JS, Norris D, Price V, Hordinsky MK, Christiano A, Duvic MPediatric dermatologyChildhood alopecia areata-Data from the National Alopecia Areata Registry. Pediatr Dermatol. 2018 Mar; 35(2):164-169.Pediatr Dermatol2018-01-15T00:00:002018Childhood alopecia areata-Data from the National Alopecia Areata Registry.30282836de Jong A, Jabbari A, Dai Z, Xing L, Lee D, Li MM, Duvic M, Hordinsky M, Norris DA, Price V, Mackay-Wiggan J, Clynes R, Christiano AMJCI insightHigh-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata. JCI Insight. 2018 10 04; 3(19).JCI Insight2018-10-04T00:00:002018High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.30125933Seto AG, Beatty X, Lynch JM, Hermreck M, Tetzlaff M, Duvic M, Jackson ALBritish journal of haematologyCobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma. Br J Haematol. 2018 11; 183(3):428-444.Br J Haematol2018-08-20T00:00:002018Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma.29892660Chan WH, Lewis DJ, Kim EJ, Aung PP, Duvic MJAAD case reportsGeneralized morphea/eosinophilic fasciitis overlap after epoxy exposure. JAAD Case Rep. 2018 Mar; 4(2):175-178.JAAD Case Rep2018-02-04T00:00:002018Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure.30100375Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M, MAVORIC InvestigatorsThe Lancet. OncologyMogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2018 09; 19(9):1192-1204.Lancet Oncol2018-08-09T00:00:002018Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.30221071Lefran?ois P, Xie P, Wang L, Tetzlaff MT, Moreau L, Watters AK, Netchiporouk E, Provost N, Gilbert M, Ni X, Sasseville D, Wheeler DA, Duvic M, Litvinov IVOncoimmunologyGene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients. Oncoimmunology. 2018; 7(8):e1467856.Oncoimmunology2018-05-31T00:00:002018Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients.30637808M?hul B, M?nigot C, Fogel P, Seraidaris A, Genette A, Pascual T, Duvic M, Voegel JJExperimental dermatologyProteomic analysis of stratum corneum in Cutaneous T-Cell Lymphomas and psoriasis. Exp Dermatol. 2019 03; 28(3):317-321.Exp Dermatol2019-02-11T00:00:002019Proteomic analysis of stratum corneum in Cutaneous T-Cell Lymphomas and psoriasis.30301395Fountain E, Mistry H, Jain P, Duvic M, Fowler NLeukemia & lymphomaResponse to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides. Leuk Lymphoma. 2019 04; 60(4):1079-1082.Leuk Lymphoma2018-10-10T00:00:002018Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides.30430444Welborn M, Duvic MAmerican journal of clinical dermatologyAntibody-Based Therapies for Cutaneous T-Cell Lymphoma. Am J Clin Dermatol. 2019 Feb; 20(1):115-122.Am J Clin Dermatol2019-02-01T00:00:002019Antibody-Based Therapies for Cutaneous T-Cell Lymphoma.30677830Aria AB, Wilmas K, Kim EJ, Aung PP, Duvic MDermatology online journalThe development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar. Dermatol Online J. 2018 Sep 15; 24(9).Dermatol Online J2018-09-15T00:00:002018The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar.DermatologyPathologyAuthorship 9406488Authorship 9408257Authorship 942174630548331Kim EJ, Aria AB, Wilmas K, Lewis DJ, Torres-Cabala CA, Nunez C, Dabaja BS, Duvic MPediatric dermatologyPrimary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation. Pediatr Dermatol. 2019 Jan; 36(1):e23-e26.Pediatr Dermatol2018-12-11T00:00:002018Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation.30773193An Y, Jiang W, Andraos TY, Reddy JP, Yehia ZA, Lloyd S, Duvic M, D'Souza NM, Milgrom SA, Pinnix CC, Oki Y, Smith GL, Wilson LD, Dabaja BSRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and OncologyMulti-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides. Radiother Oncol. 2019 02; 131:88-92.Radiother Oncol2018-12-31T00:00:002018Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides.30519174Jensen GL, Dabaja BS, Pinnix CC, Gunther JR, Huen A, Duvic M, Oki Y, Fanale M, Hosing C, Milgrom SACase reports in oncologyRadiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement. Case Rep Oncol. 2018 Sep-Dec; 11(3):721-728.Case Rep Oncol2018-11-12T00:00:002018Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement.Authorship 945591931018069Pemmaraju N, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, Rizzieri DA, Wang ES, Duvic M, Sloan JM, Spence S, Shemesh S, Brooks CL, Balser J, Bergstein I, Lancet JE, Kantarjian HM, Konopleva MThe New England journal of medicineTagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm. N Engl J Med. 2019 04 25; 380(17):1628-1637.N Engl J Med2019-04-25T00:00:002019Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.20351328Duvic M, Donato M, Dabaja B, Richmond H, Singh L, Wei W, Acholonu S, Khouri I, Champlin R, Hosing CJournal of clinical oncology : official journal of the American Society of Clinical OncologyTotal skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. J Clin Oncol. 2010 May 10; 28(14):2365-72.J Clin Oncol2010-03-29T00:00:002010Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.22850569Talpur R, Singh L, Daulat S, Liu P, Seyfer S, Trynosky T, Wei W, Duvic MClinical cancer research : an official journal of the American Association for Cancer ResearchLong-term outcomes of 1,263 patients with mycosis fungoides and S?zary syndrome from 1982 to 2009. Clin Cancer Res. 2012 Sep 15; 18(18):5051-60.Clin Cancer Res2012-07-31T00:00:002012Long-term outcomes of 1,263 patients with mycosis fungoides and S?zary syndrome from 1982 to 2009.23868752Merritt BY, Curry JL, Duvic M, Vega F, Sheehan AM, Curry CVPediatric blood & cancerPediatric subcutaneous panniculitis-like T-cell lymphoma with features of hemophagocytic syndrome. Pediatr Blood Cancer. 2013 Nov; 60(11):1916-7.Pediatr Blood Cancer2013-07-19T00:00:002013Pediatric subcutaneous panniculitis-like T-cell lymphoma with features of hemophagocytic syndrome.Authorship 9476334Authorship 9477554Authorship 947810731116823Park K, Reed J, Talpur R, Duvic MCutisNail irregularities associated with S?zary syndrome. Cutis. 2019 Apr; 103(4):E11-E16.Cutis2019-04-01T00:00:002019Nail irregularities associated with S?zary syndrome.31141854Kubicki SL, Park KE, Aung PP, Duvic MJournal of drugs in dermatology : JDDComplete Resolution of Primary Cutaneous Anaplastic Large Cell Lymphoma With Topical Imiquimod J Drugs Dermatol. 2019 May 01; 18(5):460-462.J Drugs Dermatol2019-05-01T00:00:002019Complete Resolution of Primary Cutaneous Anaplastic Large Cell Lymphoma With Topical Imiquimod31139332Ying Z, Shiue L, Park K, Kollet J, Bijani P, Goswami M, Duvic M, Ni XOncotargetBlood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma. Oncotarget. 2019 May 07; 10(34):3183-3197.Oncotarget2019-05-07T00:00:002019Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma.Authorship 950103331209865Ramachandran V, Park KE, Duvic MInternational journal of dermatologyLong-term control of mycosis fungoides of the hands with topical bexarotene: an update 15?years later. Int J Dermatol. 2019 Nov; 58(11):e221-e222.Int J Dermatol2019-06-17T00:00:002019Long-term control of mycosis fungoides of the hands with topical bexarotene: an update 15?years later.Authorship 9513121131254410Tetzlaff MT, Tang S, Duke T, Grabell DA, Cabanillas ME, Zuo Z, Yao JC, Nagarajan P, Aung PP, Torres-Cabala CA, Duvic M, Prieto VG, Huen A, Curry JLJournal of cutaneous pathologyLichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features. J Cutan Pathol. 2019 Nov; 46(11):872-877.J Cutan Pathol2019-07-15T00:00:002019Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features.Authorship 952413431329384Lewis DJ, Wu JH, Boyd M, Duvic M, Feldman SRDermatology online journalCutaneous manifestations of genodermatoses and primary immunodeficiency. Dermatol Online J. 2019 Jun 15; 25(6).Dermatol Online J2019-06-15T00:00:002019Cutaneous manifestations of genodermatoses and primary immunodeficiency.Authorship 955739731534633Ying Z, Shiue L, Park K, Kollet J, Bijani P, Goswami M, Duvic M, Ni XOncotargetCorrection: Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma. Oncotarget. 2019 Sep 10; 10(52):5492.Oncotarget2019-09-10T00:00:002019Correction: Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma.Authorship 9617693Authorship 961871631776647Emge DA, Bassett RL, Duvic M, Huen AOArchives of dermatological researchMethicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients. Arch Dermatol Res. 2020 May; 312(4):283-288.Arch Dermatol Res2019-11-27T00:00:002019Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients.31782708Oh CW, Thorne A, Duke T, Lewis DJ, Talpur R, Duvic MSkinmedWaistband Mycosis Fungoides: A New Clinical Variant of Early-Stage Disease. Skinmed. 2019; 17(5):329-332.Skinmed2019-09-01T00:00:002019Waistband Mycosis Fungoides: A New Clinical Variant of Early-Stage Disease.Authorship 975277931904333Lewis DJ, Falck BA, Kantrow SM, Pozadzides JV, Hinojosa T, Huang S, Diwan AH, Prieto VG, Duvic MSkinmedNecrotizing Granulomatous Dermatitis and Panniculitis Masquerading as T Cell Lymphoma. Skinmed. 2019; 17(6):406-408.Skinmed2019-11-01T00:00:002019Necrotizing Granulomatous Dermatitis and Panniculitis Masquerading as T Cell Lymphoma.Authorship 976013331953789Morris L, Tran J, Duvic MAmerican journal of clinical dermatologyNon-Classic Signs of S?zary Syndrome: A Review. Am J Clin Dermatol. 2020 Jun; 21(3):383-391.Am J Clin Dermatol2020-06-01T00:00:002020Non-Classic Signs of S?zary Syndrome: A Review.Authorship 977817432045145Ramachandran V, Park KE, Shah JR, Duvic MDermatology online journalDiagnosis of cutaneous T-cell lymphoma by insurance type before and after the Affordable Care Act: a national database study. Dermatol Online J. 2019 Nov 15; 25(11).Dermatol Online J2019-11-15T00:00:002019Diagnosis of cutaneous T-cell lymphoma by insurance type before and after the Affordable Care Act: a national database study.Authorship 9793537Authorship 979567532187738Ni X, Austin M, Langridge T, Bojaxhi P, Bijani P, Wang X, Duvic MPhotodermatology, photoimmunology & photomedicineCD209+ monocyte-derived myeloid dendritic cells were increased in patients with leukemic cutaneous T-cell lymphoma undergoing extracorporeal photopheresis via the CELLEXTM system. Photodermatol Photoimmunol Photomed. 2020 Jul; 36(4):290-298.Photodermatol Photoimmunol Photomed2020-04-16T00:00:002020CD209+ monocyte-derived myeloid dendritic cells were increased in patients with leukemic cutaneous T-cell lymphoma undergoing extracorporeal photopheresis via the CELLEXTM system.32114498Anand K, Ensor J, Pingali SR, Hwu P, Duvic M, Chiang S, Miranda R, Zu Y, Iyer SJournal for immunotherapy of cancerT-cell lymphoma secondary to checkpoint inhibitor therapy. J Immunother Cancer. 2020 02; 8(1).J Immunother Cancer2020-02-01T00:00:002020T-cell lymphoma secondary to checkpoint inhibitor therapy.Authorship 987227432278799Ramachandran V, Park KE, Loya A, Duvic MJournal of the American Academy of DermatologySecond primary malignancies in blastic plasmacytoid dendritic cell neoplasm: A national database study. J Am Acad Dermatol. 2020 Dec; 83(6):1786-1789.J Am Acad Dermatol2020-04-09T00:00:002020Second primary malignancies in blastic plasmacytoid dendritic cell neoplasm: A national database study.Authorship 9907125Authorship 9910982532305443Zic JA, Ai W, Akilov OE, Carter JB, Duvic M, Foss F, Girardi M, Gru AA, Kim E, Musiek A, Olsen EA, Schieke SM, Shinohara M, Zain JM, Geskin LJJournal of the American Academy of DermatologyUnited States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic. J Am Acad Dermatol. 2020 Aug; 83(2):703-704.J Am Acad Dermatol2020-04-16T00:00:002020United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic.32502876Dummer R, Prince HM, Whittaker S, Horwitz SM, Kim YH, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Eradat H, Pinter-Brown L, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Huen A, Walewski J, Wang Y, Lisano J, Richhariya A, Feliciano J, Zhu Y, Bunn V, Little M, Zagadailov E, Dalal MR, Duvic MEuropean journal of cancer (Oxford, England : 1990)Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study. Eur J Cancer. 2020 07; 133:120-130.Eur J Cancer2020-06-02T00:00:002020Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study.Authorship 992471232568843Tran J, Duvic M, Torres-Cabala CAThe American Journal of dermatopathologyLymphomatoid Papulosis With a Unique T Follicular Helper-Like Phenotype. Am J Dermatopathol. 2020 Oct; 42(10):776-779.Am J Dermatopathol2020-10-01T00:00:002020Lymphomatoid Papulosis With a Unique T Follicular Helper-Like Phenotype.Authorship 993277432621690Tran J, Morris L, Vu A, Duvic MDermatology online journalDevelopment of S?zary syndrome following the administration of dupilumab. Dermatol Online J. 2020 Apr 15; 26(4).Dermatol Online J2020-04-15T00:00:002020Development of S?zary syndrome following the administration of dupilumab.Authorship 994418432667737Lyapichev KA, Bah I, Huen A, Duvic M, Routbort MJ, Wang W, Jorgensen JL, Medeiros LJ, Vega F, Craig FE, Wang SACytometry. Part B, Clinical cytometryDetermination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/S?zary syndrome than quantification of CD26- or CD7- CD4+ T-cells. Cytometry B Clin Cytom. 2021 03; 100(2):183-191.Cytometry B Clin Cytom2020-07-15T00:00:002020Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/S?zary syndrome than quantification of CD26- or CD7- CD4+ T-cells.Authorship 996674432770556Aung PP, Pemmaraju N, Torres-Cabala CA, Duvic M, Konopleva M, Khoury JD, Prieto VGThe Journal of dermatologyApparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy: A novel finding and possible diagnostic pitfall. J Dermatol. 2020 Oct; 47(10):e354-e355.J Dermatol2020-08-07T00:00:002020Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy: A novel finding and possible diagnostic pitfall.Authorship 1001043332989422Tran J, Vega F, Duvic MJAAD case reportsUnmasking a T cell lymphoma: Folliculotropic mycosis fungoides with a gamma-delta phenotype. JAAD Case Rep. 2020 Dec; 6(12):1316-1319.JAAD Case Rep2020-09-23T00:00:002020Unmasking a T cell lymphoma: Folliculotropic mycosis fungoides with a gamma-delta phenotype.Authorship 1002830533054950Tran J, Morris L, Vu A, Reddy S, Duvic MDermatology online journalAnaphylaxis following administration of extracorporeal photopheresis for cutaneous T cell lymphoma. Dermatol Online J. 2020 Sep 15; 26(9).Dermatol Online J2020-09-15T00:00:002020Anaphylaxis following administration of extracorporeal photopheresis for cutaneous T cell lymphoma.Authorship 100463715Authorship 1004912333158772Porcu P, Hudgens S, Horwitz S, Quaglino P, Cowan R, Geskin L, Beylot-Barry M, Floden L, Bagot M, Tsianakas A, Moskowitz A, Huen A, Dreno B, Dalle S, Caballero D, Leoni M, Dale S, Herr F, Duvic MClinical lymphoma, myeloma & leukemiaQuality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2021 02; 21(2):97-105.Clin Lymphoma Myeloma Leuk2020-09-18T00:00:002020Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma.33178469Tran J, Huen A, Duvic MCase reports in nephrologyRenal Cell Carcinoma Associated with Mycosis Fungoides: A Paraneoplastic Syndrome. Case Rep Nephrol. 2020; 2020:8897183.Case Rep Nephrol2020-10-29T00:00:002020Renal Cell Carcinoma Associated with Mycosis Fungoides: A Paraneoplastic Syndrome.Authorship 10118471033604757Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CAVirchows Archiv : an international journal of pathologyIs immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? Virchows Arch. 2021 Aug; 479(2):377-383.Virchows Arch2021-02-18T00:00:002021Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?Authorship 1014139833741766Morse DC, Park KE, Chitsazzadeh V, Li S, Young K, Gunther JR, Dabaja BS, Duvic MInternational journal of gynecological pathology : official journal of the International Society of Gynecological PathologistsVulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma. Int J Gynecol Pathol. 2021 May 01; 40(3):229-233.Int J Gynecol Pathol2021-05-01T00:00:002021Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma.Authorship 10152772Authorship 1015692533835345Farr MA, Duvic M, Joshi TPAmerican journal of clinical dermatologyTeledermatology During COVID-19: An Updated Review. Am J Clin Dermatol. 2021 Jul; 22(4):467-475.Am J Clin Dermatol2021-04-09T00:00:002021Teledermatology During COVID-19: An Updated Review.33794441Kim YH, Prince HM, Whittaker S, Horwitz SM, Duvic M, Bechter O, Sanches JA, Stadler R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Eradat H, Pinter-Brown LC, Ortiz-Romero PL, Akilov OE, Trotman J, Taylor K, Weichenthal M, Walewski J, Fisher D, McNeeley M, Gru AA, Brown L, Palanca-Wessels MC, Lisano J, Onsum M, Bunn V, Little M, Trepicchio WL, Dummer REuropean journal of cancer (Oxford, England : 1990)Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis. Eur J Cancer. 2021 05; 148:411-421.Eur J Cancer2021-03-29T00:00:002021Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.Authorship 1020590934096089S Mehta R, Torres Cabala CA, DiNardo CD, Daver N, Dabaja B, Rezvani K, Champlin RE, Shpall E, Duvic MAmerican journal of hematologyPost-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant hemophagocytic lymphohistiocytosis. Am J Hematol. 2021 09 01; 96(9):E350-E353.Am J Hematol2021-06-28T00:00:002021Post-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant hemophagocytic lymphohistiocytosis.Authorship 10292902Authorship 1029425434495491Joshi TP, Duvic MAmerican journal of clinical dermatologyGranuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options. Am J Clin Dermatol. 2022 Jan; 23(1):37-50.Am J Clin Dermatol2021-09-08T00:00:002021Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options.34507350Horwitz SM, Scarisbrick JJ, Dummer R, Whittaker S, Duvic M, Kim YH, Quaglino P, Zinzani PL, Bechter O, Eradat H, Pinter-Brown L, Akilov OE, Geskin L, Sanches JA, Ortiz-Romero PL, Weichenthal M, Fisher DC, Walewski J, Trotman J, Taylor K, Dalle S, Stadler R, Lisano J, Bunn V, Little M, Prince HMBlood advancesRandomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data. Blood Adv. 2021 12 14; 5(23):5098-5106.Blood Adv2021-12-14T00:00:002021Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data.Authorship 1030112534543492Ni X, Maiti S, Redko A, Bijani P, Duvic MPhotodermatology, photoimmunology & photomedicineMonitoring malignant T-cell clones by direct TCR expression assay in patients with leukemic cutaneous T-cell lymphoma during extracorporeal photopheresis. Photodermatol Photoimmunol Photomed. 2022 Mar; 38(2):158-168.Photodermatol Photoimmunol Photomed2021-09-26T00:00:002021Monitoring malignant T-cell clones by direct TCR expression assay in patients with leukemic cutaneous T-cell lymphoma during extracorporeal photopheresis.Authorship 10318721934676056Allen JE, Kline CLB, Prabhu VV, Wagner J, Ishizawa J, Madhukar N, Lev A, Baumeister M, Zhou L, Lulla A, Stogniew M, Schalop L, Benes C, Kaufman HL, Pottorf RS, Nallaganchu BR, Olson GL, Al-Mulla F, Duvic M, Wu GS, Dicker DT, Talekar MK, Lim B, Elemento O, Oster W, Bertino J, Flaherty K, Wang ML, Borthakur G, Andreeff M, Stein M, El-Deiry WSOncotargetCorrection: Discovery and clinical introduction of first-in-class imipridone ONC201. Oncotarget. 2021 Oct 12; 12(21):2231.Oncotarget2021-10-12T00:00:002021Correction: Discovery and clinical introduction of first-in-class imipridone ONC201.Authorship 10339381334758074Olsen EA, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J, Kim YH, Wood GS, Duvic M, Ai W, Girardi M, Gru A, Guenova E, Hodak E, Hoppe R, Kempf W, Kim E, Lechowicz MJ, Ortiz-Romero P, Papadavid E, Quaglino P, Pittelkow M, Prince HM, Sanches JA, Sugaya M, Vermeer M, Zain J, Knobler R, Stadler R, Bagot M, Scarisbrick JBloodPrimary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood. 2022 08 04; 140(5):419-437.Blood2022-08-04T00:00:002022Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.Authorship 1037114335011675Chan WH, Lewis DJ, Duvic M, Feldman SRCellsStrategies to Optimize Adherence in Patients with Mycosis Fungoides. Cells. 2021 12 30; 11(1).Cells2021-12-30T00:00:002021Strategies to Optimize Adherence in Patients with Mycosis Fungoides.Authorship 1039855435157247Joshi TP, Friske SK, Hsiou DA, Duvic MAmerican journal of clinical dermatologyNew Practical Aspects of Sweet Syndrome. Am J Clin Dermatol. 2022 May; 23(3):301-318.Am J Clin Dermatol2022-02-14T00:00:002022New Practical Aspects of Sweet Syndrome.35416914Joshi TP, Duvic M, Torres-Cabala CA, Tschen JJAMA dermatologyTreatment With Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma. JAMA Dermatol. 2022 06 01; 158(6):697-699.JAMA Dermatol2022-06-01T00:00:002022Treatment With Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma.18337626Awar O, Duvic MOncologyTreatment of transformed mycosis fungoides with intermittent low-dose gemcitabine. Oncology. 2007; 73(1-2):130-5.Oncology2008-03-13T00:00:002008Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine.Authorship 1046998635646447Park KE, Ramachandran V, Tran J, Joshi TP, Garg N, Duvic MDermatology practical & conceptualAssociation of Flame-Retardant Clothing With Mycosis Fungoides: A Retrospective Analysis. Dermatol Pract Concept. 2022 May; 12(2):e2022091.Dermatol Pract Concept2022-04-01T00:00:002022Association of Flame-Retardant Clothing With Mycosis Fungoides: A Retrospective Analysis.Authorship 10475609Authorship 1047728635662661Joshi TP, Chen V, Dong JL, Golden K, Iacobucci A, Lim Y, Morrow B, Khalfe N, Duvic MJournal of the American Academy of DermatologyPsychiatric comorbidities associated with granuloma annulare: A case-control study in the All of Us database. J Am Acad Dermatol. 2022 09; 87(3):e119-e120.J Am Acad Dermatol2022-06-03T00:00:002022Psychiatric comorbidities associated with granuloma annulare: A case-control study in the All of Us database.35670681Wilmas KM, Aria AB, Landis LN, Chaitanya SK, Prieto VG, Duvic MDermatology online journalCD4/CD8 double-negative mycosis fungoides with large cell transformation and involvement of the lungs and leptomeninges. Dermatol Online J. 2022 Mar 15; 28(2).Dermatol Online J2022-03-15T00:00:002022CD4/CD8 double-negative mycosis fungoides with large cell transformation and involvement of the lungs and leptomeninges.Authorship 10482426Authorship 1048071235695215Bagot M, Dalle S, Sokol L, Tsianakas A, Musiek A, Ortiz-Romero PL, Poligone B, Duvic M, Elmets C, Leoni M, Dwyer K, Ito T, Herr F, Kim YHDermatologic therapyLong-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma. Dermatol Ther. 2022 08; 35(8):e15634.Dermatol Ther2022-06-28T00:00:002022Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma.Authorship 1050516735817334Joshi TP, Black TA, Fernandez B, Friske S, Stafford H, Strouphauer E, Duvic MJournal of the American Academy of DermatologyComorbidities associated with mycosis fungoides: A case-control study in the All of Us database. J Am Acad Dermatol. 2023 03; 88(3):686-688.J Am Acad Dermatol2022-07-08T00:00:002022Comorbidities associated with mycosis fungoides: A case-control study in the All of Us database.Authorship 10509342535857290Kim EJ, Mangold AR, DeSimone JA, Wong HK, Seminario-Vidal L, Guitart J, Appel J, Geskin L, Lain E, Korman NJ, Zeitouni N, Nikbakht N, Dawes K, Akilov O, Carter J, Shinohara M, Kuzel TM, Piette W, Bhatia N, Musiek A, Pariser D, Kim YH, Elston D, Boh E, Duvic M, Huen A, Pacheco T, Zwerner JP, Lee ST, Girardi M, Querfeld C, Bohjanen K, Olsen E, Wood GS, Rumage A, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH, Poligone BJAMA dermatologyEfficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2022 09 01; 158(9):1031-1039.JAMA Dermatol2022-09-01T00:00:002022Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.Authorship 10580046Authorship 10575104Authorship 10612002Authorship 10557652Authorship 105630826Authorship 105604314Authorship 10612051736439783Joshi TP, Duvic MJAAD case reportsAcute onset painful acral granuloma annulare: Work-up and therapeutic strategies. JAAD Case Rep. 2022 Dec; 30:120.JAAD Case Rep2022-10-29T00:00:002022Acute onset painful acral granuloma annulare: Work-up and therapeutic strategies.36054317Wilkinson AJ, Nader ME, Roberts D, Duvic M, Gunther JR, Dabaja BS, Gidley PWThe LaryngoscopeSurvival Outcomes of Patients with Mycosis Fungoides Involving the External Ear and Ear Canal. Laryngoscope. 2023 06; 133(6):1486-1491.Laryngoscope2022-08-31T00:00:002022Survival Outcomes of Patients with Mycosis Fungoides Involving the External Ear and Ear Canal.36399715Pemmaraju N, Kantarjian H, Sweet K, Wang E, Senapati J, Wilson NR, Konopleva M, Frankel AE, Gupta V, Mesa R, Ulrickson M, Gorak E, Bhatia S, Budak-Alpdogan T, Mason J, Garcia-Romero MT, Lopez-Santiago N, Cesarman-Maus G, Vachhani P, Lee S, Bhatt VR, Blum W, Walter RB, Bixby D, Gojo I, Duvic M, Rampal RK, de Lima M, Foran J, Fathi AT, Hall AC, Jacoby MA, Lancet J, Mannis G, Stein AS, Mims A, Rizzieri D, Olin R, Perl A, Schiller G, Shami P, Stone RM, Strickland S, Wieduwilt MJ, Daver N, Ravandi F, Vasu S, Guzman M, Roboz GJ, Khoury J, Qazilbash M, Aung PP, Cuglievan B, Madanat Y, Kharfan-Dabaja MA, Pawlowska A, Taylor J, Tallman M, Dhakal P, Lane AABloodNorth American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need. Blood. 2023 02 09; 141(6):567-578.Blood2023-02-09T00:00:002023North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.36636103Joshi TP, Duvic MJAAD internationalUnderstanding itch in cutaneous T-cell lymphoma: Exploring the impact of comorbidities, treatment regimens, and racial differences on quality of life. JAAD Int. 2023 Mar; 10:55-56.JAAD Int2022-11-23T00:00:002022Understanding itch in cutaneous T-cell lymphoma: Exploring the impact of comorbidities, treatment regimens, and racial differences on quality of life.36001337Guitart J, Mangold AR, Martinez-Escala ME, Walker CJ, Comfere NI, Pulitzer M, Rieger KE, Torres-Cabala CA, Pincus LB, Kumar ES, Wang EBK, Park KE, Espinosa ML, Duvic M, Kim YH, Horwitz SJAMA dermatologyClinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders. JAMA Dermatol. 2022 Oct 01; 158(10):1167-1174.JAMA Dermatol2022-10-01T00:00:002022Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders.36441011Joshi TP, Fernandez B, Friske S, Garcia D, Gedeon F, Gonzalez C, Hanania H, Hinson D, Holla S, Iacobucci A, Okundia F, Stafford H, Strouphauer E, Terrell M, Tomaras M, Zhu H, Duvic MInternational journal of dermatologyBurden of atopic disease in Black and Hispanic patients with alopecia areata: a case-control study in the All of Us research program. Int J Dermatol. 2023 07; 62(7):e393-e394.Int J Dermatol2022-11-28T00:00:002022Burden of atopic disease in Black and Hispanic patients with alopecia areata: a case-control study in the All of Us research program.35948003Jagadeesh D, Horwitz S, Bartlett NL, Kim Y, Jacobsen E, Duvic M, Little M, Trepicchio W, Fenton K, Onsum M, Lisano J, Advani RThe oncologistResponse to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma. Oncologist. 2022 Oct 01; 27(10):864-873.Oncologist2022-10-01T00:00:002022Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma.Authorship 1064292836804573Joshi TP, Chen V, Dong JL, Golden K, Iacobucci A, Lim Y, Morrow B, Duvic MJournal of the American Academy of DermatologyAtopic comorbidities associated with granuloma annulare: A case-control study of the All of Us database. J Am Acad Dermatol. 2023 07; 89(1):145-146.J Am Acad Dermatol2023-02-18T00:00:002023Atopic comorbidities associated with granuloma annulare: A case-control study of the All of Us database.Authorship 10649672Authorship 1064955236858155Joshi TP, Duvic MJournal of the American Academy of DermatologyUnmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment. J Am Acad Dermatol. 2023 06; 88(6):e305-e306.J Am Acad Dermatol2023-02-28T00:00:002023Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment.36862846Dai J, Duvic MOncology (Williston Park, N.Y.)Cutaneous T-Cell Lymphoma: Current and Emerging Therapies. Oncology (Williston Park). 2023 02 24; 37(2):55-62.Oncology (Williston Park)2023-02-24T00:00:002023Cutaneous T-Cell Lymphoma: Current and Emerging Therapies.Authorship 1068484337004644Nguyen CN, Iyer SP, Duvic M, Barde PJ, Nair A, Routhu KV, Huen AOInvestigational new drugsComplete Response to tenalisib and romidepsin with long-term maintenance using tenalisib monotherapy in a patient with relapsed and refractory s?zary syndrome. Invest New Drugs. 2023 04; 41(2):350-355.Invest New Drugs2023-04-01T00:00:002023Complete Response to tenalisib and romidepsin with long-term maintenance using tenalisib monotherapy in a patient with relapsed and refractory s?zary syndrome.Authorship 10746143Authorship 10737446Authorship 1073166537315799Joshi TP, Bancroft A, Garcia D, Kahla JA, McBee DB, Duvic MJournal of the American Academy of DermatologyAssociation of atopic dermatitis with Graves' disease and Hashimoto's thyroiditis: A case-control study in the All of Us research program. J Am Acad Dermatol. 2023 10; 89(4):e175-e176.J Am Acad Dermatol2023-06-12T00:00:002023Association of atopic dermatitis with Graves' disease and Hashimoto's thyroiditis: A case-control study in the All of Us research program.37448588Wu SY, Fang PQ, Wang EB, Ahmed S, Duvic M, Jain P, Castillo LEM, Nair R, Steiner RE, Strati P, Huen AO, Iyer SP, Pinnix CC, Dabaja BS, Gunther JRAdvances in radiation oncologySafety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma. Adv Radiat Oncol. 2023 Nov-Dec; 8(6):101279.Adv Radiat Oncol2023-06-02T00:00:002023Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma.37424285Joshi TP, Friske S, Duvic MInternational journal of dermatologyAssociation of lichen planopilaris with hypothyroidism: a systematic review and meta-analysis. Int J Dermatol. 2023 Nov; 62(11):e606-e608.Int J Dermatol2023-07-10T00:00:002023Association of lichen planopilaris with hypothyroidism: a systematic review and meta-analysis.Authorship 1075675237487830Joshi TP, Duvic MJournal of the American Academy of DermatologyHeterogenous cytokine profiles in patients with granuloma annulare may indicate immune dysregulation spanning multiple T-cell axes. J Am Acad Dermatol. 2023 11; 89(5):e241-e242.J Am Acad Dermatol2023-07-22T00:00:002023Heterogenous cytokine profiles in patients with granuloma annulare may indicate immune dysregulation spanning multiple T-cell axes.Authorship 1080901737830594Velatooru LR, Hu CH, Bijani P, Wang X, Bojaxhi P, Chen H, Duvic M, Ni XCellsNew JAK3-INSL3 Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma. Cells. 2023 09 29; 12(19).Cells2023-09-29T00:00:002023New JAK3-INSL3 Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma.Authorship 1086175238159213Joshi TP, Duvic MAmerican journal of clinical dermatologyPityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options. Am J Clin Dermatol. 2024 Mar; 25(2):243-259.Am J Clin Dermatol2023-12-30T00:00:002023Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options.Authorship 1090486838474383Marques-Piubelli ML, Navarrete J, Ledesma DA, Hudgens CW, Lazcano RN, Alani A, Huen A, Duvic M, Nagarajan P, Aung PP, Wistuba II, Curry JL, Miranda RN, Torres-Cabala CACellsDifferential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides. Cells. 2024 Feb 27; 13(5).Cells2024-02-27T00:00:002024Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professor24118002McQuitty E, Curry JL, Tetzlaff MT, Prieto VG, Duvic M, Torres-Cabala CJournal of cutaneous pathologyThe differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis. J Cutan Pathol. 2014 Feb; 41(2):88-100.J Cutan Pathol2013-10-30T00:00:002013The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis.24247574Gera S, Dekmezian MS, Duvic M, Tschen JA, Vega F, Cho-Vega JHThe American Journal of dermatopathologyBlastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement. Am J Dermatopathol. 2014 Mar; 36(3):244-51.Am J Dermatopathol2014-03-01T00:00:002014Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.